Honeywell International (HON) 8-K 25 Apr 24 Other Events Financial data

COVER PAGE

COVER PAGE	Apr. 25, 2024
Entity Information [Line Items]
Document Type	8-K
Document Period End Date	Apr. 25, 2024
Entity Registrant Name	HONEYWELL INTERNATIONAL INC
Entity Incorporation, State or Country Code	DE
Entity File Number	1-8974
Entity Tax Identification Number	22-2640650
Entity Address, Address Line One	855 S. MINT STREET
Entity Address, City or Town	CHARLOTTE
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	28202
City Area Code	704
Local Phone Number	627-6200
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false
Amendment Flag	false
Entity Central Index Key	0000773840
Common stock, par value
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, par value $1 per share
Trading Symbol	HON
Security Exchange Name	NASDAQ
3.500% Senior Notes due 2027
Entity Information [Line Items]
Title of 12(b) Security	3.500% Senior Notes due 2027
Trading Symbol	HON 27
Security Exchange Name	NASDAQ
2.25% Euro notes due 2028
Entity Information [Line Items]
Title of 12(b) Security	2.250% Senior Notes due 2028
Trading Symbol	HON 28A
Security Exchange Name	NASDAQ
3.375% Senior Notes due 2030
Entity Information [Line Items]
Title of 12(b) Security	3.375% Senior Notes due 2030
Trading Symbol	HON 30
Security Exchange Name	NASDAQ
0.75% Euro notes due 2032
Entity Information [Line Items]
Title of 12(b) Security	0.750% Senior Notes due 2032
Trading Symbol	HON 32
Security Exchange Name	NASDAQ
3.750% Senior Notes due 2032
Entity Information [Line Items]
Title of 12(b) Security	3.750% Senior Notes due 2032
Trading Symbol	HON 32A
Security Exchange Name	NASDAQ
4.125% Euro notes due 2034
Entity Information [Line Items]
Title of 12(b) Security	4.125% Senior Notes due 2034
Trading Symbol	HON 34
Security Exchange Name	NASDAQ
3.750% Senior Notes due 2036
Entity Information [Line Items]
Title of 12(b) Security	3.750% Senior Notes due 2036
Trading Symbol	HON 36
Security Exchange Name	NASDAQ

CONSOLIDATED STATEMENT OF OPERA

CONSOLIDATED STATEMENT OF OPERATIONS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Net sales	$ 36,662	$ 35,466	$ 34,392
Costs, expenses and other
Cost of products and services sold	22,995	22,347	22,061
Research and development expenses	1,456	1,478	1,333
Selling, general and administrative expenses	5,127	5,214	4,798
Other (income) expense	(840)	(366)	(1,378)
Interest and other financial charges	765	414	343
Total costs, expenses and other	29,503	29,087	27,157
Total Income before taxes	7,159	6,379	7,235
Tax expense	1,487	1,412	1,625
Net income	5,672	4,967	5,610
Less: Net income attributable to noncontrolling interest	14	1	68
Net income attributable to Honeywell	$ 5,658	$ 4,966	$ 5,542
Earnings per share of common stock - basic (in dollars per share)	$ 8.53	$ 7.33	$ 8.01
Earnings per share of common stock - assuming dilution (in dollars per share)	$ 8.47	$ 7.27	$ 7.91
Product
Net sales	$ 25,773	$ 25,960	$ 25,643
Costs, expenses and other
Cost of products and services sold	16,977	16,955	17,082
Service
Net sales	10,889	9,506	8,749
Costs, expenses and other
Cost of products and services sold	$ 6,018	$ 5,392	$ 4,979

CONSOLIDATED STATEMENT OF COMPR

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 5,672	$ 4,967	$ 5,610
Other comprehensive income (loss), net of tax
Foreign exchange translation adjustment	(274)	(372)	302
Actuarial gains (losses) recognized	(468)	(452)	256
Prior service credit recognized	0	0	7
Prior service credit recognized during year	(48)	(64)	(87)
Actuarial losses recognized during year	118	454	5
Foreign exchange translation and other	(9)	(171)	5
Pension and other postretirement benefit adjustments	(407)	(233)	186
Changes in fair value of available for sale investments	5	(8)	(3)
Cash flow hedges recognized in other comprehensive income (loss)	60	71	17
Less: Reclassification adjustment for gains included in net income	49	56	20
Changes in fair value of cash flow hedges	11	15	(3)
Other comprehensive income (loss), net of tax	(665)	(598)	482
Comprehensive income	5,007	4,369	6,092
Less: Comprehensive income (loss) attributable to the noncontrolling interest	9	(17)	64
Comprehensive income attributable to Honeywell	$ 4,998	$ 4,386	$ 6,028

CONSOLIDATED BALANCE SHEET

CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 7,925	$ 9,627
Short-term investments	170	483
Accounts receivable, less allowances of $323 and $326, respectively	7,530	7,440
Inventories	6,178	5,538
Other current assets	1,699	1,894
Total current assets	23,502	24,982
Investments and long-term receivables	939	945
Property, plant and equipment—net	5,660	5,471
Goodwill	18,049	17,497
Other intangible assets—net	3,231	3,222
Insurance recoveries for asbestos-related liabilities	170	224
Deferred income taxes	392	421
Other assets	9,582	9,513
Total assets	61,525	62,275
Current liabilities
Accounts payable	6,849	6,329
Commercial paper and other short-term borrowings	2,085	2,717
Current maturities of long-term debt	1,796	1,730
Accrued liabilities	7,809	9,162
Total current liabilities	18,539	19,938
Long-term debt	16,562	15,123
Deferred income taxes	2,094	2,093
Postretirement benefit obligations other than pensions	134	146
Asbestos-related liabilities	1,490	1,180
Other liabilities	6,265	6,469
Redeemable noncontrolling interest	7	7
SHAREOWNERS’ EQUITY
Capital—common stock issued	958	958
Capital - additional paid in capital	9,062	8,564
Common stock held in treasury, at cost	(38,008)	(34,443)
Accumulated other comprehensive income (loss)	(4,135)	(3,475)
Retained earnings	47,979	45,093
Total Honeywell shareowners’ equity	15,856	16,697
Noncontrolling interest	578	622
Total shareowners’ equity	16,434	17,319
Total liabilities, redeemable noncontrolling interest and shareowners’ equity	$ 61,525	$ 62,275

CONSOLIDATED BALANCE SHEET (Par

CONSOLIDATED BALANCE SHEET (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Allowance for credit loss	$ 323	$ 326

CONSOLIDATED STATEMENT OF CASH

CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities
Net income	$ 5,672	$ 4,967	$ 5,610
Less: Net income attributable to noncontrolling interest	14	1	68
Net income attributable to Honeywell	5,658	4,966	5,542
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities
Depreciation	659	657	674
Amortization	517	547	549
Gain on sale of non-strategic businesses and assets	(5)	(22)	(102)
Repositioning and other charges	860	1,266	569
Net payments for repositioning and other charges	(459)	(512)	(692)
NARCO Buyout payment	(1,325)	0	0
Pension and other postretirement income	(406)	(510)	(1,114)
Pension and other postretirement benefit payments	(38)	(23)	(43)
Stock compensation expense	202	188	217
Deferred income taxes	153	(180)	178
Other	(837)	(358)	(28)
Changes in assets and liabilities, net of the effects of acquisitions and divestitures
Accounts receivable	(42)	(739)	(8)
Inventories	(626)	(440)	(685)
Other current assets	17	232	(276)
Accounts payable	518	(155)	744
Accrued liabilities	494	357	513
Net cash provided by operating activities	5,340	5,274	6,038
Cash flows from investing activities
Capital expenditures	(1,039)	(766)	(895)
Proceeds from disposals of property, plant and equipment	43	29	27
Increase in investments	(560)	(1,211)	(2,373)
Decrease in investments	971	1,255	2,525
Receipts from Garrett Motion Inc.	0	409	586
Receipts (payments) from settlements of derivative contracts	6	369	192
Cash paid for acquisitions, net of cash acquired	(718)	(178)	(1,326)
Proceeds from sales of businesses, net of fees paid	4	0	203
Net cash used for investing activities	(1,293)	(93)	(1,061)
Cash flows from financing activities
Proceeds from issuance of commercial paper and other short-term borrowings	12,991	7,661	5,194
Payments of commercial paper and other short-term borrowings	(13,663)	(8,447)	(5,190)
Proceeds from issuance of common stock	196	320	229
Proceeds from issuance of long-term debt	2,986	2,953	2,517
Payments of long-term debt	(1,731)	(1,850)	(4,917)
Repurchases of common stock	(3,715)	(4,200)	(3,380)
Cash dividends paid	(2,855)	(2,719)	(2,626)
Other	28	(48)	(81)
Net cash used for financing activities	(5,763)	(6,330)	(8,254)
Effect of foreign exchange rate changes on cash and cash equivalents	14	(183)	(39)
Net decrease in cash and cash equivalents	(1,702)	(1,332)	(3,316)
Cash and cash equivalents at beginning of period	9,627	10,959	14,275
Cash and cash equivalents at end of period	$ 7,925	$ 9,627	$ 10,959

CONSOLIDATED STATEMENT OF SHARE

CONSOLIDATED STATEMENT OF SHAREOWNERS EQUITY - USD ($) shares in Millions	Total	Common stock, par value	Additional paid-in capital	Treasury stock	Retained earnings	Accumulated other comprehensive income (loss)	Noncontrolling interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total shareowners' equity (in shares)		957.6
Beginning balance at Dec. 31, 2020		$ 958,000,000	$ 7,292,000,000	$ (27,229,000,000)	$ 39,905,000,000	$ (3,377,000,000)	$ 241,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issued for employee savings and option plans			184,000,000	$ 147,000,000
Stock compensation expense			217,000,000
Impact of Quantinuum contribution	$ 460,000,000		448,000,000
Treasury stock, beginning balance (in shares) at Dec. 31, 2020				(260.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reacquired stock or repurchases of common stock (in shares)				(15.8)
Reacquired stock or repurchases of common stock				$ (3,380,000,000)
Issued for employee savings and option plans (in shares)				3.8
Net income attributable to Honeywell	5,542,000,000				5,542,000,000
Dividends on common stock					(2,620,000,000)
Foreign exchange translation adjustment	302,000,000					302,000,000	(4,000,000)
Pension and other postretirement benefit adjustments	186,000,000					186,000,000
Changes in fair value of available for sale investments						(3,000,000)
Changes in fair value of cash flow hedges	(3,000,000)					(3,000,000)
Acquisitions, divestitures, and other							397,000,000
Net income attributable to noncontrolling interest	(68,000,000)						68,000,000
Dividends paid							(33,000,000)
Contributions from noncontrolling interest holders							4,000,000
Treasury stock, ending balance (in shares) at Dec. 31, 2021				(272.8)
Ending balance at Dec. 31, 2021	$ 19,242,000,000	$ 958,000,000	8,141,000,000	$ (30,462,000,000)	42,827,000,000	(2,895,000,000)	673,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends per common share (in dollars per share)	$ 3.77
Total shareowners' equity (in shares)	684.8	957.6
Issued for employee savings and option plans			235,000,000	$ 219,000,000
Stock compensation expense			188,000,000
Impact of Quantinuum contribution	$ 0		0
Reacquired stock or repurchases of common stock (in shares)				(21.9)
Reacquired stock or repurchases of common stock	0			$ (4,200,000,000)
Issued for employee savings and option plans (in shares)				4.7
Net income attributable to Honeywell	4,966,000,000				4,966,000,000
Dividends on common stock					(2,700,000,000)
Foreign exchange translation adjustment	(372,000,000)					(354,000,000)	(18,000,000)
Pension and other postretirement benefit adjustments	(233,000,000)					(233,000,000)
Changes in fair value of available for sale investments						(8,000,000)
Changes in fair value of cash flow hedges	15,000,000					15,000,000
Acquisitions, divestitures, and other							0
Net income attributable to noncontrolling interest	(1,000,000)						1,000,000
Dividends paid							(48,000,000)
Contributions from noncontrolling interest holders							14,000,000
Treasury stock, ending balance (in shares) at Dec. 31, 2022				(290)
Ending balance at Dec. 31, 2022	$ 17,319,000,000	$ 958,000,000	8,564,000,000	$ (34,443,000,000)	45,093,000,000	(3,475,000,000)	622,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends per common share (in dollars per share)	$ 3.97
Total shareowners' equity (in shares)	667.6	957.6
Issued for employee savings and option plans			214,000,000	$ 150,000,000
Stock compensation expense			202,000,000
Impact of Quantinuum contribution	$ 0		82,000,000
Reacquired stock or repurchases of common stock (in shares)				(19.2)
Reacquired stock or repurchases of common stock	(200,000,000)			$ (3,715,000,000)
Issued for employee savings and option plans (in shares)				3.4
Net income attributable to Honeywell	5,658,000,000				5,658,000,000
Dividends on common stock					(2,772,000,000)
Foreign exchange translation adjustment	(274,000,000)					(269,000,000)	(5,000,000)
Pension and other postretirement benefit adjustments	(407,000,000)					(407,000,000)
Changes in fair value of available for sale investments						5,000,000
Changes in fair value of cash flow hedges	11,000,000					11,000,000
Acquisitions, divestitures, and other							(5,000,000)
Net income attributable to noncontrolling interest	(14,000,000)						14,000,000
Dividends paid							(107,000,000)
Contributions from noncontrolling interest holders							59,000,000
Treasury stock, ending balance (in shares) at Dec. 31, 2023				(305.8)
Ending balance at Dec. 31, 2023	$ 16,434,000,000		$ 9,062,000,000	$ (38,008,000,000)	$ 47,979,000,000	$ (4,135,000,000)	$ 578,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends per common share (in dollars per share)	$ 4.17
Total shareowners' equity (in shares)	651.8

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	ACCOUNTING PRINCIPLES The financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. The following is a description of Honeywell’s significant accounting policies. PRINCIPLES OF CONSOLIDATION The Consolidated Financial Statements include the accounts of Honeywell International Inc. and all of its subsidiaries and entities in which a controlling interest is maintained. The Company's consolidation policy requires equity investments that the Company exercises significant influence over, but does not control the investee and are not the primary beneficiary of the investee’s activities, to be accounted for using the equity method. Investments through which the Company is not able to exercise significant influence over the investee and which the Company does not have readily determinable fair values are accounted for under the cost method. All intercompany transactions and balances are eliminated in consolidation. RECLASSIFICATIONS Certain prior year amounts are reclassified to conform to the current year presentation. Historically, the Company included Company-sponsored costs and costs that relate to contracts with customers for research and development projects as a component of Cost of products and services sold on the Consolidated Statement of Operations. Effective January 1, 2023, the Company began classifying Company-sponsored costs for research and development projects as a separate financial statement line item, titled Research and development expenses, on the Consolidated Statement of Operations and recast prior period results for this reclassification. This reclassification had no impact on the Company's net income, earnings per share, cash flows, segment reporting, or financial position. The Company revised historical periods to reflect this change in presentation. RECENT ACCOUNTING PRONOUNCEMENTS The Company considers the applicability and impact of all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB). ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company's Consolidated Statement of Operations, Balance Sheet, and Cash Flows (Consolidated Financial Statements). In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Taxes Disclosures , which requires greater disaggregation of income tax disclosures. The new standard requires additional information to be disclosed with respect to the income tax rate reconciliation and income taxes paid disaggregated by jurisdiction. This ASU should be applied prospectively for fiscal years beginning after December 15, 2024, with retrospective application permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which requires companies to enhance the disclosures about segment expenses. The new standard requires the disclosure of the Company’s Chief Operating Decision Maker (CODM), expanded incremental line-item disclosures of significant segment expenses used by the CODM for decision-making, and the inclusion of previous annual only segment disclosure requirements on a quarterly basis. This ASU should be applied retrospectively for fiscal years beginning after December 15, 2023, and early adoption is permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements. In September 2022, the FASB issued ASU 2022-04, Liabilities—Supplier Finance Programs (Topic 405): Disclosure of Supplier Finance Program Obligations , to enhance the transparency of supplier finance programs. The new standard requires annual disclosure of the key terms of the program, a description of where in the financial statements amounts outstanding under the program are presented, a rollforward of such amounts, and interim disclosure of amounts outstanding as of the end of each period. The guidance does not affect recognition, measurement, or financial statement presentation of supplier finance programs. The ASU is effective on January 1, 2023, except for the rollforward, which is effective on January 1, 2024. The Company adopted this guidance on January 1, 2023, with the exception of the rollforward that is effective on January 1, 2024. The adoption of this standard does not have a material impact on the Company’s Consolidated Financial Statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805) : Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. This ASU should be applied prospectively to acquisitions occurring on or after the effective date of December 15, 2022, and early adoption was permitted. The Company adopted this guidance on January 1, 2022. The adoption of this standard does not have a material impact on the Company’s Consolidated Financial Statements. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by the transition away from reference rates expected to be discontinued to alternative reference rates. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope , to expand the scope of this guidance to include derivatives. The guidance was effective upon issuance and may be applied prospectively to contract modifications made and hedging relationships entered into on or before December 31, 2022. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 , which extends the period of time entities can utilize the reference rate reform relief guidance under ASU 2020-04 from December 31, 2022, to December 31, 2024. The Company will apply the guidance to impacted transactions during the transition period. The adoption of this standard does not have a material impact on the Company’s Consolidated Financial Statements. RESEARCH AND DEVELOPMENT Research and development costs for projects are expensed as incurred, unless these costs relate to contracts with customers where the Company receives reimbursements. Amounts expensed as incurred for Company-sponsored research and development projects are included in Research and development expenses and were $1,456 million, $1,478 million, and $1,333 million for the years ended December 31, 2023, 2022, and 2021, respectively. Costs related to contracts with customers for customer-sponsored research and development projects are included as a contract cost and included in Cost of products and services sold when revenue from such contracts is recognized, consistent with the Company's sales recognition policies. This revenue was $1,303 million, $1,336 million, and $1,284 million for the years ended December 31, 2023, 2022, and 2021, respectively. CASH AND CASH EQUIVALENTS Cash and cash equivalents include cash on hand and highly liquid investments having an original maturity of three months or less. INVENTORIES Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Carrying value adjustments for inventory obsolescence is equal to the difference between the cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. PROPERTY, PLANT AND EQUIPMENT Property, plant and equipment are recorded at cost, including any asset retirement obligations, less accumulated depreciation. For financial reporting, the straight-line method of depreciation is used over the estimated useful lives of 10 to 50 years for buildings and improvements an d 3 to 16 years for machinery and equipment. Recognition of the fair value of obligations associated with the retirement of tangible long-lived assets is required when there is a legal obligation to incur such costs. Upon initial recognition of a liability, the cost is capitalized as part of the related long-lived asset and depreciated over the corresponding asset’s useful life. GOODWILL AND INDEFINITE-LIVED INTANGIBLE ASSETS Goodwill and indefinite-lived intangible assets are subject to impairment testing annually as of the first day of the fourth quarter, or if a triggering event occurs or changes in circumstances indicate that the carrying amount may not be fully recoverable. This testing compares carrying values to fair values and, when appropriate, the carrying value of these assets is reduced to fair value, not to exceed the carrying value of goodwill. The Company completed its annual goodwill impairment test as of the first day of the fourth quarter and determined there was no impairment as of that date. The Company is not aware of any additional triggering events. Prior to 2022, the Company performed its annual goodwill and intangible asset impairment test as of the last day of the first quarter. In 2022, the Company changed the date of its annual goodwill and intangible asset impairment assessment to the first day of the fourth quarter. The Company believes this change does not represent a material change in method of applying an accounting principle. This change has been applied prospectively as of the date of the change, as retrospective application is deemed impracticable due to the inability to objectively determine the assumptions used in earlier periods without the benefit of hindsight. This voluntary change is preferable under the circumstances as it results in better alignment with the timing of the Company’s forecasting process and reduces the time period between the assessment date and annual financial statements. This change in accounting principle does not delay, accelerate, or avoid an impairment of goodwill. In 2022, due to this change, the Company performed annual goodwill and intangible asset impairment tests as of the last day of the first quarter and the first day of the fourth quarter. DEFINITE-LIVED INTANGIBLE ASSETS Other intangible assets with definite lives consist of customer relationships, patents and technology, trademarks, and other intangibles and are amortized over their estimated u seful lives, ranging from 2 to 20 years. CAPITALIZED SOFTWARE The Company capitalizes costs of software developed or obtained for internal use during the application development stage of a project and amortizes those costs using the straight-line method over the expected useful life of the software, not to exceed 7 years. Costs incurred during the preliminary and post-implementation stages are expensed as incurred. Development costs for software held for sale are capitalized once a project has reached the point of technological feasibility. Completed projects are amortized after reaching the point of general availability using the straight-line method based on the expected useful life, not to exceed 7 years. At each balance sheet date, or earlier if an indicator of an impairment exists, the Company evaluates the recoverability of unamortized capitalized software costs based on estimated future undiscounted revenues net of estimated related costs over the remaining amortization period. Capitalized software held for internal use and held for sale is included in Other assets in the Consolidated Balance Sheet. FOREIGN CURRENCY TRANSLATION Assets and liabilities of subsidiaries operating outside the United States with a functional currency other than the U.S. Dollar are translated into U.S. Dollars using year-end exchange rates. Sales, costs, and expenses are translated at the average exchange rates in effect during the year. Foreign currency translation gains and losses are included as a component of Accumulated other comprehensive income (loss). For subsidiaries operating in highly inflationary environments, inventories and property, plant and equipment, including related expenses, are remeasured at the exchange rate in effect on the date the assets were acquired, while monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these subsidiaries are included in earnings. DERIVATIVE FINANCIAL INSTRUMENTS All derivative financial instruments are recorded on the balance sheet as assets or liabilities and measured at fair value. For derivatives designated as hedges of the fair value of assets or liabilities, the changes in fair values of both the derivatives and the hedged items are recorded in current earnings. For derivatives designated as cash flow hedges, the changes in fair value of the derivatives are recorded in Accumulated other comprehensive income (loss) and subsequently recognized in earnings when the hedged items impact earnings. Derivative financial instruments designated as hedges must be designated and effective as a hedge of the identified risk exposure at the inception of the contract. Changes in fair value of the derivative contract must be highly correlated with changes in fair value of the underlying hedged item at inception and over the life of the hedge contract. Cash flows of such derivative financial instruments are classified consistent with the underlying hedged item. The Company elected to exclude the time value of the derivatives (i.e., the forward points) from the assessment of hedge effectiveness and to recognize the initial value of the excluded component in earnings using the amortization approach. For derivative instruments that are designated and qualify as a net investment hedge, the gain or loss is reported as a component of Other comprehensive income (loss) and recorded in Accumulated other comprehensive income (loss). The gain or loss will be subsequently reclassified into earnings when the hedged net investment is either sold or substantially liquidated. LEASES At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. The assessment is based on (i) whether the contract involves the use of a distinct identified asset, (ii) whether the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the period, and (iii) whether the Company has the right to direct the use of the asset. All significant lease arrangements are generally recognized at lease commencement. Operating lease right-of-use (ROU) assets and lease liabilities are recognized at commencement. A ROU asset and corresponding lease liability are not recorded for leases with an initial term of 12 months or less (short-term leases); however, lease expense for these leases is recognized as incurred over the lease term. ROU assets represent the Company's right to use an underlying asset during the reasonably certain lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Lease payments may be fixed or variable, however, only fixed payments or in-substance fixed payments are included in determining the lease liability. Variable lease payments are recognized in operating expenses in the period in which the obligation for those payments are incurred. The operating lease ROU asset also includes any lease payments related to initial direct costs and prepayments and excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are generally accounted for separately. The Company primarily uses its incremental borrowing rate, which is based on the information available at the lease commencement date, in determining the present value of the lease payments. In determining the borrowing rate, the Company considers the lease term, secured incremental borrowing rate, and for leases denominated in a currency different than the U.S. dollar, the collateralized borrowing rate in the foreign currency using the U.S. dollar and foreign currency swap spread, when available. PENSION BENEFITS The Company presents net periodic pension costs by disaggregating the service cost component of such costs and reports those costs in the same line item or items in the Consolidated Statement of Operations as other compensation costs arising from services rendered by the pertinent employees during the period. The other non-service components of such costs are required to be presented separately from the service cost component. The Company records the service cost component of Pension ongoing (income) expense in Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. The remaining components of costs within Pension ongoing (income) expense, primarily interest costs and assumed return on plan assets, are recorded in Other (income) expense. The Company recognizes net actuarial gains or losses in excess of 10% of the greater of the fair value of plan assets or the plan's projected benefit obligation (the corridor) annually in the fourth quarter each year (MTM Adjustment). The MTM Adjustment is also reported in Other (income) expense. SUPPLY CHAIN FINANCING The Company maintains agreements with third-party financial institutions that offer voluntary supply chain financing (SCF) programs to suppliers. The SCF programs enable suppliers, at their sole discretion, to sell their receivables to third-party financial institutions in order to receive payment on receivables earlier than the negotiated commercial terms between suppliers and the Company. Supplier sale of receivables to third-party financial institutions is on terms negotiated between the supplier and the respective third-party financial institution. The Company agrees on commercial terms for the goods and services procured from suppliers, including prices, quantities, and payment terms, which normally range between 60 and 120 days, regardless of whether the supplier elects to participate in the SCF programs. A suppliers’ voluntary participation in the SCF programs has no bearing on the Company's payment terms and the Company has no economic interest in a supplier’s decision to participate in the SCF programs. The Company agrees to pay participating third-party financial institutions the stated amounts of confirmed invoices from suppliers on the original maturity dates of the invoices. Amounts outstanding related to SCF programs are included in Accounts payable in the Consolidated Balance Sheet. Accounts payable included approximately $1,112 million and $992 million as of December 31, 2023, and 2022, respectively. The impact of these programs is not material to the Company's overall liquidity. SALES RECOGNITION Product and service sales are recognized when or as the Company transfers control of the promised products or services to its customers. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Service sales, principally representing repair, maintenance, and engineering activities, are recognized over the contractual period or as services are rendered. Sales under long-term contracts with performance obligations satisfied over time are recognized using either an input or output method. The Company recognizes revenue over time as the Company performs on these contracts because of the continuous transfer of control to the customer. With control transferring over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. The Company generally uses the cost-to-cost input method of progress for contracts because it best depicts the transfer of control to the customer that occurs as the Company incurs costs. Under the cost-to-cost input method, the extent of progress towards completion is measured based on the proportion of costs incurred to date to the total estimated costs at completion of the performance obligation. The Company reviews its cost estimates on significant contracts on a periodic basis, or when circumstances change and warrant a modification to a previous estimate. Cost estimates are largely based on negotiated or estimated purchase contract terms, historical performance trends, and other economic projections. Significant factors that influence these estimates include inflationary trends, technical and schedule risks, internal and subcontractor performance trends, business volume assumptions, asset utilization, and anticipated labor agreements. Provisions for anticipated losses on long-term contracts are recorded in full when such losses become evident, to the extent required. The customer funding for costs incurred for nonrecurring engineering and development activities of the Company's products under agreements with commercial customers is deferred and subsequently recognized as revenue as products are delivered to the customers. Additionally, expenses incurred, up to the customer agreed funded amount, are deferred as an asset and recognized as cost of sales when products are delivered to the customer. The deferred customer funding and costs result in recognition of deferred costs (asset) and deferred revenue (liability) within Other assets and Accrued liabilities, respectively, in the Consolidated Balance Sheet. Deferred contract fulfillment costs were approximately $1.2 billion and $1.3 billion as of December 31, 2023, and 2022, respectively. The amounts recognized as Cost of products and services sold were approximately $0.1 billion for the year ended December 31, 2023, and $0.2 billion and $0.1 billion for 2022 and 2021, respectively. Revenues for the Company's mechanical service programs are recognized as performance obligations that are satisfied over time, with recognition reflecting a series of distinct services using the output method. The terms of a contract or the historical business practice can give rise to variable consideration due to, but not limited to, cash-based incentives, rebates, performance awards, or credits. The Company estimates variable consideration at the most likely amount the Company will receive from customers. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The Company's estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company's anticipated performance and all information (historical, current and forecasted) that is reasonably available to the Company. STOCK-BASED COMPENSATION PLANS The principal awards issued under the Company's stock-based compensation plans, which are described in Note 15 Stock-Based Compensation Plans, are non-qualified stock options and restricted stock units. The cost for such awards is measured at the grant date based on the fair value of the award. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods (generally the vesting period of the equity award) and is included in Selling, general and administrative expenses. Forfeitures are estimated at the time of grant to recognize expense for those awards expected to vest and are based on the Company's historical forfeiture rates. INCOME TAXES Significant judgment is required in evaluating tax positions. The Company establishes reserves for income taxes when, despite the belief that tax positions are fully supportable, certain positions remain that do not meet the minimum recognition threshold. The approach for evaluating certain and uncertain tax positions is defined by the authoritative guidance which determines when a tax position is more likely than not to be sustained upon examination by the applicable taxing authority. In the normal course of business, the Company and its subsidiaries are examined by various federal, state, and foreign tax authorities. The Company regularly assesses the potential outcomes of these examinations and any future examinations for the current or prior years in determining the adequacy of the Company's provision for income taxes. The Company continually assesses the likelihood and amount of potential adjustments and adjusts the income tax provision, the current tax liability, and deferred taxes in the period in which the facts that give rise to a change in estimate become known. See Note 5 Income Taxes for additional information. EARNINGS PER SHARE Basic earnings per share is based on the weighted average number of common shares outstanding. Diluted earnings per share is based on the weighted average number of common shares outstanding and all dilutive potential common shares outstanding. ENVIRONMENTAL The Company accrues costs related to environmental matters when it is probable that it has incurred a liability related to a contaminated site and the amount can be reasonably estimated. See Note 19 Commitments and Contingencies for additional information. REIMBURSEMENT RECEIVABLES In conjunction with the Resideo Technologies, Inc. (Resideo) spin-off, the Company entered into a reimbursement agreement under which Honeywell receives cash payments as reimbursement primarily related to net spending for environmental matters at certain sites as defined in the reimbursement agreement. Accordingly, the Company recorded receivables based on estimates of the underlying reimbursable Honeywell environmental spend, and the Company monitors the recoverability of such receivables, which are subject to the terms of applicable credit agreements and general ability to pay. ASBESTOS-RELATED LIABILITIES AND INSURANCE RECOVERIES The Company recognizes a liability for any asbestos-related contingency that is probable of occurrence and reasonably estimable. In connection with the recognition of liabilities for asbestos-related matters, the Company records asbestos-related insurance recoveries that are deemed probable. See Note 19 Commitments and Contingencies for additional information.

ACQUISITIONS AND DIVESTITURES

ACQUISITIONS AND DIVESTITURES	12 Months Ended
	Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]
ACQUISITIONS AND DIVESTITURES	ACQUISITIONS On December 8, 2023, the Company agreed to acquire Carrier Global Corporation's Global Access Solutions business in an all-cash transaction for $5.0 billion. The transaction is subject to regulatory review and approval and customary closing conditions. The transaction is expected to close by the end of the third quarter of 2024 and the business will be reported within the Building Automation reportable business segment. On August 25, 2023, the Company acquired 100% of the outstanding equity interests of SCADAfence, a provider of operational technology and Internet of Things cybersecurity solutions for monitoring large scale networks, for total consideration of $52 million, net of cash acquired. The business is included in the Industrial Automation reportable business segment. The assets and liabilities acquired with SCADAfence are included in the Consolidated Balance Sheet as of December 31, 2023, including $17 million of intangible assets and $42 million of goodwill, which is not deductible for tax purposes. The purchase accounting is subject to final adjustment, primarily for the value of intangible assets, amounts allocated to goodwill, and tax balances. On June 30, 2023, the Company acquired 100% of the outstanding equity interests of Compressor Controls Corporation, a turbomachinery services and controls company based in the United States, for total cash consideration of $673 million, net of cash acquired. The business is included in the Industrial Automation reportable business segment. The assets and liabilities acquired with Compressor Controls Corporation are included in the Consolidated Balance Sheet as of December 31, 2023, including $282 million of intangible assets and $350 million allocated to goodwill, which is deductible for tax purposes. The identifiable intangible assets primarily include customer relationships amortized over an estimated life of 15 years using an excess earnings amortization method. The purchase accounting is subject to final adjustment, primarily for the valuation of intangible assets, amounts allocated to goodwill, and tax balances. On January 18, 2022, the Company acquired 100% of the issued and outstanding shares of US Digital Designs, Inc., a leading provider of technologies for first responders, for total consideration of $186 million. The business is included within the Building Automation reportable business segment. The Company finalized the evaluation for the fair value of all the assets and liabilities acquired with US Digital Designs, Inc. during the first quarter of 2023. Management recorded intangible assets of $53 million and allocated $129 million to goodwill, which is deductible for tax purposes. On November 29, 2021, Honeywell Quantum Solutions, a wholly-owned subsidiary of Honeywell, and Cambridge Quantum Computing, a leading developer of quantum computing and quantum software, combined to form Quantinuum. Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing. As part of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority-owner of Quantinuum, with an overall 54% ownership in the business. Assets and liabilities of Quantinuum are consolidated by Honeywell and included in the Consolidated Balance Sheet. The business is included within Corporate and All Other, which is not a reportable business segment. Upon close of the transaction, Honeywell recorded a non-cash adjustment of $460 million in Additional paid-in capital in the Consolidated Balance Sheet as the contribution of ownership interest in Honeywell Quantum Solutions and Cambridge Quantum Computing for the formation of Quantinuum. In addition, Honeywell recognized a gain of $22 million related to the fair value remeasurement of Honeywell's existing 4.2% ownership interest in Cambridge Quantum Computing, which was recorded in Other (income) expense in the Consolidated Statement of Operations. At close of the transaction, the fair value of Cambridge Quantum Computing's noncontrolling interest in Quantinuum was $419 million. In December 2021, Cambridge Quantum Computing contributed cash of $12 million to Quantinuum, increasing their noncontrolling interest and decreasing Honeywell's additional paid-in capital. In the fourth quarter of 2022, the Company completed its evaluation of the fair value of all the assets and liabilities acquired. Management recorded intangible assets of $90 million and allocated $945 million to goodwill, which is non-deductible for tax purposes. On February 12, 2021, the Company acquired 100% of the shares outstanding of Sparta Systems, a leading provider of enterprise quality management software for the life sciences industry, for $1,303 million. The business is included within the Industrial Automation reportable business segment. The assets and liabilities acquired with Sparta Systems are included in the Consolidated Balance Sheet as of December 31, 2021, including $383 million of intangible assets and $1,011 million allocated to goodwill, which is non-deductible for tax purposes. DIVESTITURES During 2023, there were no significant divestitures individually or in the aggregate. In conjunction with the wind down of the Company's businesses and operations in Russia (the Wind down), during 2022 the Company completed the sale of three entities domiciled in Russia in exchange for gross cash consideration of less than $1 million. The Company recognized a pre-tax gain of $22 million, which was recorded in Other (income) expense in the Consolidated Statement of Operations, driven by favorable foreign currency cumulative translation adjustment positions in the entities at the time of sale. The financial results of the entities were previously included in the historical Performance Materials and Technologies, Honeywell Building Technologies, and Safety and Productivity Solutions reportable business segments.

REVENUE RECOGNITION AND CONTRAC

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS	12 Months Ended
	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS	REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS The Company has a comprehensive offering of products and services, including software and technologies, that are sold to a variety of customers in multiple end markets. See the following disaggregated revenue table and related discussions by reportable business segment for details: Years Ended December 31, 2023 2022 2021 Aerospace Technologies Commercial Aviation Original Equipment $ 2,397 $ 2,089 $ 1,720 Commercial Aviation Aftermarket 6,241 5,108 4,155 Defense and Space 4,986 4,630 5,151 Net Aerospace Technologies sales 13,624 11,827 11,026 Industrial Automation Sensing and Safety Technologies 2,733 2,860 3,123 Productivity Solutions and Services 1,313 1,739 1,778 Process Solutions 5,267 4,731 4,611 Warehouse and Workflow Solutions 1,443 2,308 2,913 Net Industrial Automation sales 10,756 11,638 12,425 Building Automation Products 3,583 3,638 3,173 Building Solutions 2,448 2,362 2,366 Net Building Automation sales 6,031 6,000 5,539 Energy and Sustainability Solutions UOP 2,586 2,404 2,348 Advanced Materials 3,653 3,592 3,054 Net Energy and Sustainability Solutions sales 6,239 5,996 5,402 Corporate and All Other 12 5 — Net sales $ 36,662 $ 35,466 $ 34,392 In July 2022, the Company realigned certain business units within the Industrial Automation reportable business segment. The Safety and Retail business unit, which included the gas detection and safety business, combined with the Advanced Sensing Technologies business unit to form the Sensing and Safety Technologies business unit. The Company recast historical periods to reflect this realignment. Aerospace Technologies – A global supplier of products, software, and services for aircrafts that it sells to original equipment manufacturers (OEM) and other customers in a variety of end markets including: air transport, regional, business and general aviation aircraft, airlines, aircraft operators, and defense and space contractors. Aerospace Technologies products and services include auxiliary power units, propulsion engines, environmental control systems, integrated avionics, wireless connectivity services, electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, management and technical services, advanced systems and instruments, satellite and space components, aircraft wheels and brakes, and thermal systems. Aerospace Technologies also provides spare parts, repair, overhaul, and maintenance services (principally to aircraft operators), and sells licenses or intellectual property to other parties. Our Honeywell Forge solutions enable our customers to turn data into predictive maintenance and predictive analytics to enable better fleet management and make flight operations more efficient. Industrial Automation – A global provider of industrial automation solutions that deliver intelligent, sustainable, and secure operations for customers in oil and gas, petrochemicals, life sciences, metals and mining, and warehouse and logistics segments. With millions of installed assets, Industrial Automation deploys outcome-based solutions to increase asset utilization; improve operational efficiency and labor productivity; reduce carbon emissions with less energy consumption; and enhance cyber security for critical infrastructure and operational assets. Industrial Automation offerings include automation control and instrumentation products and services; smart energy products; sensing technologies with an array of custom-engineered sensors and services; gas detection technologies and personal protective equipment; and system design, advanced automation equipment, software and analytics for manufacturing, distribution and fulfillment operations. These products and services are combined with proprietary machine learning and artificial intelligence algorithms in products and projects which are digitally enabled through our industry leading industrial Internet of Things (IoT) platform, Honeywell Forge. Building Automation – A global provider of products, software, solutions, and technologies that enable building owners and occupants to ensure their facilities are safe, energy efficient, sustainable, and productive. Building Automation products and services include advanced software applications for building control and optimization; sensors, switches, control systems, and instruments for energy management; access control; video surveillance; fire products; and installation, maintenance, and upgrades of systems. Our Honeywell Forge solutions enable our customers to digitally manage buildings, connecting data from different assets to enable smart maintenance, improve building performance, and even protect from incoming security threats. Energy and Sustainability Solutions – A global provider of industry leading technology, processing, and licensing capabilities combined with material science capabilities and innovative chemistry to offer focused solutions that are integral to facilitating the world's energy transition. The reportable business segment is comprised of UOP and Advanced Materials business units. The UOP business provides sustainable aviation fuels, petrochemical & refining technologies, and carbon management solutions across multiple sectors through process technology solutions, products, including catalysts and adsorbents, equipment and aftermarket services. The Advanced Materials business provides customers with its Solstice lower global warming potential refrigeration and heating solutions, Spectra fibers for high end protective armor and medical applications, and leading-edge semiconductor materials. Our Honeywell Forge solutions serve customer asset productivity and efficiency needs by providing connectivity, data integration, and software solutions to generate a holistic view of their operations. Corporate and All Other – Corporate and All Other includes revenue from Honeywell's majority-owned investment in Quantinuum. Through Quantinuum, Honeywell provides a wide range of service offerings of fully integrated quantum computing hardware and software solutions. See Note 22 Segment Financial Data for a summary by disaggregated product and services sales for each reportable business segment. The Company recognizes revenue arising from performance obligations outlined in contracts with its customers that are satisfied at a point in time and over time. The disaggregation of the Company's revenue based off timing of recognition is as follows: Years Ended December 31, 2023 2022 2021 Products, transferred point in time 58 % 59 % 58 % Products, transferred over time 12 14 17 Net product sales 70 73 75 Services, transferred point in time 10 8 8 Services, transferred over time 20 19 17 Net service sales 30 27 25 Net sales 100 % 100 % 100 % CONTRACT BALANCES The Company tracks progress on satisfying performance obligations under contracts with customers. The related billings and cash collections are recorded in the Consolidated Balance Sheet in Accounts receivable—net and Other assets (unbilled receivables (contract assets) and billed receivables), and Accrued liabilities and Other liabilities (customer advances and deposits (contract liabilities)). Unbilled receivables arise when the timing of cash collected from customers differs from the timing of revenue recognition, such as when contract provisions require specific milestones to be met before a customer can be billed. Contract assets are recognized when the revenue associated with the contract is recognized prior to billing and derecognized when billed in accordance with the terms of the contract. Contract liabilities are recorded when customers remit contractual cash payments in advance of the Company satisfying performance obligations under contractual arrangements, including those with performance obligations to be satisfied over a period of time. Contract liabilities are derecognized when revenue is recorded, either when a milestone is met triggering the contractual right to bill or when the performance obligation is satisfied. Contract balances are classified as assets or liabilities on a contract-by-contract basis at the end of each reporting period. The following table summarizes the Company's contract assets and liabilities balances: 2023 2022 Contract assets—January 1 $ 2,294 $ 2,060 Contract assets—December 31 2,013 2,294 Change in contract assets—increase (decrease) (281) 234 Contract liabilities—January 1 (4,583) (4,290) Contract liabilities—December 31 (4,326) (4,583) Change in contract liabilities—decrease (increase) 257 (293) Net change $ (24) $ (59) For the years ended December 31, 2023, and 2022, the Company recognized revenue of $2,070 million and $1,838 million, respectively, that was previously included in the beginning balance of contract liabilities. Contract assets included $1,949 million and $2,265 million of unbilled balances under long-term contracts as of December 31, 2023, and 2022, respectively. These amounts are billed in accordance with the terms of customer contracts to which they relate. When contracts are modified to account for changes in contract specifications and requirements, the Company considers whether the modification either creates new or changes the existing enforceable rights and obligations. Contract modifications for goods or services and not distinct from the existing contract, due to the significant integration with the original good or service provided, are accounted for as if they were part of that existing contract. The effect of a contract modification on the transaction price and the Company's measure of progress for the performance obligation to which it relates, is recognized as an adjustment to revenue (either as an increase in or a reduction of revenue) on a cumulative catch-up basis. When the modifications include additional performance obligations that are distinct and at relative stand-alone selling price, they are accounted for as a new contract and performance obligation, which are recognized prospectively. PERFORMANCE OBLIGATIONS A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is defined as the unit of account. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When the Company's contracts with customers require highly complex integration or manufacturing services that are not separately identifiable from other promises in the contracts and, therefore, not distinct, then the entire contract is accounted for as a single performance obligation. In situations when the Company's contracts include distinct goods or services that are substantially the same and have the same pattern of transfer to the customer over time, they are recognized as a series of distinct goods or services. For any contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation based on the estimated relative stand-alone selling price of each distinct good or service in the contract. For product sales, each product sold to a customer typically represents a distinct performance obligation. In such cases, the observable stand-alone sales are used to determine the stand-alone selling price. Performance obligations are satisfied as of a point in time or over time. Performance obligations are supported by contracts with customers, providing a framework for the nature of the distinct goods, services or bundle of goods and services. The timing of satisfying the performance obligation is typically indicated by the terms of the contract. The following table outlines the Company's remaining performance obligations disaggregated by reportable business segment: December 31, 2023 Aerospace Technologies $ 13,898 Industrial Automation 6,227 Building Automation 7,302 Energy and Sustainability Solutions 4,303 Corporate and All Other 1 47 Total performance obligations 2 $ 31,777 1 The remaining performance obligations within Corporate and All Other relate to the Quantinuum business. 2 Effective March 31, 2022, performance obligations exclude contracts with customers related to Russia as collectability is not reasonably assured. Performance obligations recognized as of December 31, 2023 will be satisfied over the course of future periods. The Company's disclosure of the timing for satisfying the performance obligation is based on the requirements of contracts with customers. However, from time to time, these contracts may be subject to modifications, impacting the timing of satisfying the performance obligations. Performance obligations expected to be satisfied within one year and greater than one year are 60% and 40%, respectively. The timing of satisfaction of the Company's performance obligations does not significantly vary from the typical timing of payment. Typical payment terms of the Company's fixed price over time contracts include progress payments based on specified events or milestones or based on project progress. For some contracts, the Company may be entitled to receive an advance payment. The Company applied the practical expedient for certain revenue streams to exclude the value of remaining performance obligations for (i) contracts with an original expected term of one year or less or (ii) contracts for which the Company recognizes revenue in proportion to the amount the Company has the right to invoice for services performed.

REPOSITIONING AND OTHER CHARGES

REPOSITIONING AND OTHER CHARGES	12 Months Ended
	Dec. 31, 2023
Restructuring and Related Activities [Abstract]
REPOSITIONING AND OTHER CHARGES	REPOSITIONING AND OTHER CHARGES A summary of net repositioning and other charges follows: Years Ended December 31, 2023 2022 2021 Severance $ 162 $ 122 $ 80 Asset impairments 41 176 117 Exit costs 139 122 134 Reserve adjustments (56) (56) (13) Total net repositioning charges 286 364 318 Asbestos-related charges, net of insurance and reimbursements 534 532 129 Probable and reasonably estimable environmental liabilities, net of reimbursements 44 28 22 Other charges (4) 342 100 Total net repositioning and other charges $ 860 $ 1,266 $ 569 The following table summarizes the pre-tax distribution of total net repositioning and other charges by classification in the Consolidated Statement of Operations: Years Ended December 31, 2023 2022 2021 Cost of products and services sold $ 680 $ 572 $ 457 Selling, general and administrative expenses 172 309 112 Other (income) expense 8 385 — Total net repositioning and other charges $ 860 $ 1,266 $ 569 The following table summarizes the pre-tax amount of total net repositioning and other charges by reportable business segment. These amounts are excluded from segment profit as described in Note 22 Segment Financial Data: Years Ended December 31, 2023 2022 2021 Aerospace Technologies $ 23 $ 41 $ 62 Industrial Automation 139 395 280 Building Automation 58 63 13 Energy and Sustainability Solutions 23 125 12 Corporate and All Other 617 642 202 Total net repositioning and other charges $ 860 $ 1,266 $ 569 NET REPOSITIONING CHARGES In 2023, the Company recognized gross repositioning charges totaling $342 million, including severance costs of $162 million related to workforce reductions of 5,854 manufacturing and administrative positions mainly in the Company's Industrial Automation and Building Automation reportable business segments. The workforce reductions related to productivity and ongoing functional transformation initiatives. The repositioning charges included asset impairments of $41 million related to the write-down of certain assets within the Company's Industrial Automation reportable business segment and corporate function. The repositioning charges included exit costs of $139 million related to current period costs incurred for closure obligations associated with site transitions in the Company's Industrial Automation reportable business segment. Also, $56 million of previously established reserves, primarily for severance, were returned to income due to higher-than-expected voluntary exits and adjustments to the scope of previously announced repositioning actions. In 2022, the Company recognized repositioning charges totaling $420 million, including severance costs of $122 million related to workforce reductions of 4,345 manufacturing and administrative positions mainly in the Company's Industrial Automation reportable business segment. The workforce reductions related to our productivity and ongoing functional transformation initiatives. The repositioning charges included asset impairments of $176 million related to the write-down of certain manufacturing and other equipment, primarily related to closing and relocating the production of certain respiratory manufacturing from a U.S.-based facility to a non-U.S. facility in the Company's Industrial Automation reportable business segment. The repositioning charges included exit costs of $122 million related to current period costs incurred for closure obligations associated with site transitions in the Company's Energy and Sustainability Solutions, Aerospace Technologies, and Industrial Automation reportable business segments. Also, $56 million of previously established reserves, primarily for severance, were returned to income due to higher than expected voluntary exits and adjustments to the scope of previously announced repositioning actions. In 2021, the Company recognized repositioning charges totaling $331 million, including severance costs of $80 million related to workforce reductions of 6,432 manufacturing and administrative positions mainly in the Company's Industrial Automation and Aerospace Technologies reportable business segments. The workforce reductions were primarily related to the realignment of a product line in the Company's Industrial Automation reportable business segment, site transitions, mainly in the Aerospace Technologies reportable business segment, to more cost-effective locations, and the Company's productivity and ongoing functional transformation initiati ves. The repositioning charges included asset impairments of $117 million primarily related to the write-down of certain manufacturing and other equipment. The repositioning charges included exit costs of $134 million primarily for current period exit costs incurred for previously approved repositioning projects, closure obligations associated with site transitions, and lease obligations for equipment. Also, $13 million of previously established reserves, primarily for severance, were returned to income due to adjustments to the scope of previously announced repositioning actions. The following table summarizes the status of the Company's total repositioning reserves: Severance Asset Exit Total Balance at December 31, 2020 $ 527 $ — $ 74 $ 601 Charges 80 117 134 331 Usage—cash (299) — (83) (382) Usage—noncash — (119) — (119) Divestitures — — — — Adjustments (14) 2 (1) (13) Foreign currency translation (5) — (2) (7) Balance at December 31, 2021 289 — 122 411 Charges 122 176 122 420 Usage—cash (135) — (140) (275) Usage—noncash — (168) (15) (183) Divestitures — — — — Adjustments (42) (8) (6) (56) Foreign currency translation 1 — (9) (8) Balance at December 31, 2022 235 — 74 309 Charges 162 41 139 342 Usage—cash (173) — (121) (294) Usage—noncash — (36) — (36) Divestitures — (4) (5) (9) Adjustments (42) (1) (13) (56) Foreign currency translation 6 — 17 23 Balance at December 31, 2023 $ 188 $ — $ 91 $ 279 Certain repositioning projects will recognize exit costs in future periods when the actual liability is incurred. Such exit costs incurred in 2023, 2022, and 2021 were $62 million, $63 million, and $45 million, respectively. OTHER CHARGES In 2022, the Company recognized $295 million of Other charges related to the initial suspension and the wind down of our business and operations in Russia. These costs impacted all reportable business segments, with the most significant impact within the Industrial Automation and Energy and Sustainability Solutions reportable business segments. The Other charges include costs recorded in Cost of products sold, Selling, general and administrative expenses, or Other (income) expense in the Consolidated Statement of Operations. Cost of products and services sold includes $65 million primarily related to inventory reserves and the write-down of other assets, Selling, general and administrative includes $185 million primarily related to reserves against outstanding accounts receivable and contract assets, impairment of intangible assets, the write-down of other assets, and employee severance, and Other (income) expense includes $45 million related to foreign exchange revaluation on an intercompany loan with a Russian affiliate, impairment of property, plant and equipment, and expenses for called guarantees. Directly attributable to our wind down of businesses and operations in Russia, but excluded from Other charges, is a $2 million tax valuation allowance recorded to Tax expense in the Consolidated Statement of Operations. Given the uncertainty inherent in the Company's remaining obligations related to contracts with Russian counterparties, the Company does not believe it is possible to develop estimates of reasonably possible loss in excess of current accruals for these matters (other than as specifically set forth above). Based on available information to date, the Company’s estimate of potential future losses or other contingencies related to suspension and wind down activities, including any guarantee payments or any litigation costs or as otherwise related to the Company's wind down in Russia, could adversely affect the Company's consolidated results of operations in the periods recognized but would not be material with respect to the Company's consolidated financial position. See Note 19 Commitments and Contingencies for a discussion of the recognition and measurement of estimate for contingencies.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES INCOME BEFORE TAXES Years Ended December 31, 2023 2022 2021 U.S. $ 2,368 $ 3,305 $ 3,955 Non-U.S. 4,791 3,074 3,280 Total Income before taxes $ 7,159 $ 6,379 $ 7,235 TAX EXPENSE (BENEFIT) Tax expense (benefit) consists of: Years Ended December 31, 2023 2022 2021 Current U.S. Federal $ 176 $ 653 $ 415 U.S. State 60 124 146 Non-U.S. 1,098 815 886 Total current tax expense (benefit) 1,334 1,592 1,447 Deferred U.S. Federal 27 (175) 173 U.S. State 11 (36) 37 Non-U.S. 115 32 (32) Total deferred tax expense (benefit) 153 (180) 178 Total Tax expense $ 1,487 $ 1,412 $ 1,625 The U.S. federal statutory income tax rate is reconciled to the effective income tax rate as follows: Years Ended December 31, 2023 2022 2021 U.S. federal statutory income tax rate 21.0 % 21.0 % 21.0 % Taxes on non-U.S. earnings 1,2,3 (2.0) (0.4) (1.4) U.S. state income taxes 1 0.5 1.4 1.5 Reserves for tax contingencies 3.4 1.1 2.2 Employee share-based payments (0.3) (0.9) (0.7) Restructuring — 0.7 (1.4) U.S. federal tax credits (1.6) (0.9) (0.6) U.S. valuation allowance (0.1) (0.2) 2.0 All other items—net (0.1) 0.3 (0.1) Effective income tax rate 20.8 % 22.1 % 22.5 % 1 Net of changes in valuation allowance. 2 Includes U.S. taxes on non-U.S. earnings, net of foreign tax credits. 3 2023 includes (3.6)% deferred tax benefit resulting from a non-U.S. legislative change, offset by 3.6% deferred tax expense resulting from a full valuation allowance. The effective tax rate decreased by 1.3 percentage points in 2023 compared to 2022. The decrease was primarily attributable to the increased benefit of taxes on non-U.S. earnings and lower expense related to unremitted withholding taxes on non-U.S. earnings, partially offset by incremental tax expense for reserves. The Company’s 2023 non-U.S. effective tax rate was 25.3%, a decrease of approximately 2.2 percentage points compared to 2022. The decrease in the non-U.S. effective tax rate was primarily attributable to increased benefit of taxes on non-U.S. earnings and lower expense related to unremitted withholding taxes on non-U.S. earnings, partially offset by incremental tax expense for reserves. The effective tax rate decreased by 0.4 percentage points in 2022 compared to 2021. The decrease was primarily a result of additional tax expense reported in 2021 arising from a valuation allowance established against a capital loss, partially offset by a tax benefit related to restructuring transactions. In 2022, the valuation allowance was partially released as losses were utilized against a capital gain. Additionally, in 2022, there was lower tax expense reported for contingencies as a result of the release of certain state income tax reserves. The Company’s 2022 non-U.S. effective tax rate was 27.5%, an increase of approximately 1.5 percentage points compared to 2021. The increase in the non-U.S. effective tax rate was primarily attributable to a 2021 tax benefit recorded for the release of a valuation allowance on net operating losses due to restructuring in Canada, which resulted in more tax expense in 2022 compared to 2021. This increase was partially offset by lower tax expense recorded in 2022 related to tax reserves when compared to 2021. DEFERRED TAX ASSETS (LIABILITIES) The tax effects of temporary differences and tax carryforwards which give rise to future income tax benefits and payables are as follows: Deferred tax assets December 31, 2023 2022 Postretirement benefits other than pensions $ 55 $ 59 Asbestos and environmental 405 545 Capitalized research and development 582 — Employee compensation and benefits 148 142 Lease liabilities 258 233 Other accruals and reserves 196 363 Net operating losses 687 695 Capital loss limitation and carryover 385 126 Tax credit carryforwards and other attributes 420 163 Gross deferred tax assets 3,136 2,326 Valuation allowance (1,292) (812) Total deferred tax assets 1,844 1,514 Deferred tax liabilities Pension (1,132) (1,088) Property, plant and equipment (441) (233) Right-of-use asset (240) (212) Intangibles (817) (818) Unremitted earnings of foreign subsidiaries (542) (517) Other asset basis differences (369) (317) Other (5) (1) Total deferred tax liabilities (3,546) (3,186) Net deferred tax liability $ (1,702) $ (1,672) The Company's gross deferred tax assets include $1,378 million related to non-U.S. operations comprised primarily of net operating losses and other tax attribute carryforwards in Canada, France, Germany, Luxembourg, Switzerland, and the United Kingdom. The Company maintains a valuation allowance of $1,176 million against a portion of the non-U.S. gross deferred tax assets and a valuation allowance of $116 million against the U.S. gross deferred tax asset, primarily related to capital loss carryovers . The change in the valuation allowance resulted in an in crease of $458 million, a decrease of $8 million, and an increase of $124 million to income tax expense in 2023, 2022, and 2021, respectively. The majority of the $458 million increase in 2023 tax expense relates to a $257 million valuation allowance resulting from uncertainty regarding the realizability of a $257 million deferred tax asset established as a result of a non-U.S. tax legislative change. The remaining $201 million relates to other tax attribute carryforwards. If the Company determines that the likelihood of realization of existing deferred tax assets changes, a corresponding increase or decrease to valuation allowances will be recognized as an increase or reduction to income tax expense in the period that determination is made. As of December 31, 2023, the Company recorded a $542 million deferred tax liability on all unremitted foreign earnings based on estimated earnings and profits of approximately $15 billion as of the balance sheet date. As of December 31, 2023, the Company's net operating loss, capital loss, tax credit carryforwards, and other attributes were as follows: Jurisdiction Net Operating Tax Credit Carryforwards and Other Attributes U.S. Federal $ 532 $ 96 U.S. State 675 25 Non-U.S. 3,720 304 Total $ 4,927 $ 425 Many jurisdictions impose limitations on the timing and utilization of net operating loss and tax credit carryforwards. Approximately $3,140 million of the non-U.S. net operating loss has no expiration period. The U.S. federal capital loss carryforward of $502 million expires in 2026. The remaining net operating loss, capital loss and credit carryforwards, and other tax attributes have expiration periods through 2043. Years Ended December 31, 2023 2022 2021 Change in unrecognized tax benefits Balance at beginning of year $ 1,086 $ 1,061 $ 991 Gross increases related to current period tax positions 89 64 93 Gross increases related to prior periods tax positions 181 31 39 Gross decreases related to prior periods tax positions — (19) (27) Decrease related to resolutions of audits with tax authorities (132) (3) (1) Expiration of the statute of limitations for the assessment of taxes (3) (8) (12) Foreign currency translation 4 (40) (22) Balance at end of year $ 1,225 $ 1,086 $ 1,061 As of December 31, 2023, 2022, and 2021, there were $1,225 million, $1,086 million, and $1,061 million, respectively, of unrecognized tax benefits that if recognized would be recorded as a component of Tax expense. The following table summarizes tax years that remain subject to examination by major tax jurisdictions as of December 31, 2023: Jurisdiction Open Tax Years Examination in progress Examination not yet initiated U.S. Federal 2017-2021 2022-2023 U.S. State 2013-2021 2022-2023 China 2013-2022 2023 Germany 2013-2020 2021-2023 India 2013-2020 2021-2023 Puerto Rico N/A 2020-2023 Switzerland 2019-2020 2021-2023 United Kingdom 2013-2021 2022-2023 Based on the outcome of these examinations, or as a result of the expiration of statute of limitations for specific jurisdictions, it is reasonably possible that certain unrecognized tax benefits for tax positions taken on previously filed tax returns will materially change from those recorded as liabilities in the Company's financial statements. In addition, the outcome of these examinations may impact the valuation of certain deferred tax assets (such as net operating losses) in future periods. Unrecognized tax benefits for examinations in progress were $803 million, $640 million, and $592 million as of December 31, 2023, 2022, and 2021, respectively. Estimated interest and penalties related to the underpayment of income taxes are classified as a component of Tax expense in the Consolidated Statement of Operations and totaled $74 million, $5 million, and $79 million for the years ended December 31, 2023, 2022, and 2021, respectively. Accrued interest and penalties were $612 million, $557 million, and $580 million as of December 31, 2023, 2022, and 2021, respectively.

INVENTORIES

INVENTORIES	12 Months Ended
	Dec. 31, 2023
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES December 31, 2023 2022 Raw materials $ 1,704 $ 1,407 Work in process 1,217 1,049 Finished products 3,257 3,082 Total Inventories $ 6,178 $ 5,538

PROPERTY, PLANT AND EQUIPMENT-N

PROPERTY, PLANT AND EQUIPMENT-NET	12 Months Ended
	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT-NET	PROPERTY, PLANT AND EQUIPMENT—NET December 31, 2023 2022 Land and improvements $ 211 $ 216 Machinery and equipment 10,717 10,383 Buildings and improvements 3,528 3,394 Construction in progress 878 769 Total Property, plant and equipment 15,334 14,762 Less—Accumulated depreciation (9,674) (9,291) Total Property, plant and equipment—net $ 5,660 $ 5,471 Depreciation expense was $659 million, $657 million, and $674 million for the years ended December 31, 2023, 2022, and 2021, respectively.

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS-NET	12 Months Ended
	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS-NET	GOODWILL AND OTHER INTANGIBLE ASSETS—NET The following table summarizes the change in the carrying amount of goodwill for the years ended December 31, 2023, and 2022, by reportable business segment: December 31, 2022 Acquisitions/ Currency December 31, 2023 Aerospace Technologies $ 2,376 $ — $ 10 $ 2,386 Industrial Automation 9,183 392 75 9,650 Building Automation 3,338 — 42 3,380 Energy and Sustainability Solutions 1,726 — 1 1,727 Corporate and All Other 874 — 32 906 Total Goodwill $ 17,497 $ 392 $ 160 $ 18,049 Other intangible assets are comprised of: December 31, 2023 December 31, 2022 Gross Accumulated Net Gross Accumulated Net Definite-life intangibles Patents and technology $ 2,399 $ (1,837) $ 562 $ 2,313 $ (1,759) $ 554 Customer relationships 4,199 (2,601) 1,598 3,989 (2,397) 1,592 Trademarks 362 (284) 78 371 (273) 98 Other 299 (277) 22 299 (274) 25 Total definite-life intangibles—net 7,259 (4,999) 2,260 6,972 (4,703) 2,269 Indefinite-life intangibles Trademarks 971 — 971 953 — 953 Total Other intangible assets—net $ 8,230 $ (4,999) $ 3,231 $ 7,925 $ (4,703) $ 3,222 Intangible assets amortization expense was $292 million, $333 million, and $465 million for the years ended December 31, 2023, 2022, and 2021, respectively. Estimated intangible asset amortization expense for each of the next five years approximates $287 million in 2024, $262 million in 2025, $257 million in 2026, $247 million in 2027, and $249 million in 2028.

LONG-TERM DEBT AND CREDIT AGREE

LONG-TERM DEBT AND CREDIT AGREEMENTS	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
LONG-TERM DEBT AND CREDIT AGREEMENTS	LONG-TERM DEBT AND CREDIT AGREEMENTS December 31, 2023 2022 1.30% Euro notes due 2023 $ — $ 1,334 3.35% notes due 2023 — 300 0.00% Euro notes due 2024 547 534 2.30% notes due 2024 750 750 4.85% notes due 2024 400 400 1.35% notes due 2025 1,250 1,250 2.50% notes due 2026 1,500 1,500 1.10% notes due 2027 1,000 1,000 3.50% Euro notes due 2027 711 — 4.95% notes due 2028 500 500 2.25% Euro notes due 2028 820 800 4.25% notes due 2029 750 — 2.70% notes due 2029 750 750 1.95% notes due 2030 1,000 1,000 1.75% notes due 2031 1,500 1,500 0.75% Euro notes due 2032 547 534 3.75% Euro notes due 2032 547 — 5.00% notes due 2033 1,100 1,100 4.50% notes due 2034 1,000 — 4.125% Euro notes due 2034 1,094 1,067 5.70% notes due 2036 441 441 5.70% notes due 2037 462 462 5.375% notes due 2041 417 417 3.812% notes due 2047 442 445 2.80% notes due 2050 750 750 Industrial development bond obligations, floating rate maturing at various dates through 2037 22 22 6.625% debentures due 2028 201 201 9.065% debentures due 2033 51 51 Other (including capitalized leases), 7.0% weighted average interest rate maturing at various dates through 2029 217 265 Fair value of hedging instruments (166) (287) Debt issuance costs (245) (233) Total Long-term debt and current related maturities 18,358 16,853 Less: Current maturities of long-term debt 1,796 1,730 Total Long-term debt $ 16,562 $ 15,123 The schedule of principal payments on long-term debt is as follows: December 31, 2023 2024 $ 1,796 2025 1,314 2026 1,528 2027 1,718 2028 1,527 Thereafter 10,475 Total Long-term debt and current related maturities 18,358 Less: Current maturities of long-term debt 1,796 Total Long-term debt $ 16,562 On December 1, 2023, the Company repaid its 3.35% notes due 2023. On May 17, 2023, the Company issued $750 million 4.25% Senior Notes due 2029 and $1.0 billion 4.50% Senior Notes due 2034 (collectively, the 2023 USD Notes). The Company may redeem the 2023 USD Notes at any time, and from time to time, in whole or in part, at the Company's option at the applicable redemption price. The offering provided gross proceeds of $1.8 billion, offset by $20 million in discount and closing costs related to the offering. On May 17, 2023, the Company issued €650 million 3.50% Senior Notes due 2027 and €500 million 3.75% Senior Notes due 2032 (collectively, the 2023 Euro Notes). The Company may redeem the 2023 Euro Notes at any time, and from time to time, in whole or in part, at the Company's option at the applicable redemption price. The offering provided gross proceeds of $1.2 billion, offset by $12 million in discount and closing costs related to the offering. The 2023 USD Notes and 2023 Euro Notes are senior unsecured and unsubordinated obligations of the Company and rank equally with each other and with all of the Company's existing and future senior unsecured debt and senior to all of the Company's subordinated debt. The Company intends to use the proceeds from the issuances for the repayment of commercial paper and general corporate purposes. On February 22, 2023, the Company repaid its 1.30% Euro notes due 2023. On March 20, 2023, the Company entered into a $1.5 billion 364-day credit agreement (the 364-Day Credit Agreement) and a $4.0 billion amended and restated five-year credit agreement (the 5-Year Credit Agreement). The 364-Day Credit Agreement replaced the $1.5 billion 364-day credit agreement dated as of March 24, 2022, which was terminated in accordance with its terms effective March 20, 2023. Amounts borrowed under the 364-Day Credit Agreement are required to be repaid no later than March 18, 2024, unless (i) Honeywell elects to convert all then outstanding amounts into a term loan, upon which such amounts shall be repaid in full on March 18, 2025, or (ii) the 364-Day Credit Agreement is terminated earlier pursuant to its terms. The 5-Year Credit Agreement amended and restated the previously reported $4.0 billion amended and restated five-year credit agreement dated as of March 24, 2022. Commitments under the 5-Year Credit Agreement can be increased pursuant to the terms of the 5-Year Credit Agreement to an aggregate amount not to exceed $4.5 billion. The 364-Day Credit Agreement and 5-Year Credit Agreement are maintained for general corporate purposes. As of December 31, 2023, there were no outstanding borrowings under the 364-Day Credit Agreement or 5-Year Credit Agreement. On November 2, 2022, the Company issued $400 million 4.85% Senior Notes due 2024, $500 million 4.95% Senior Notes due 2028, and $1.1 billion 5.00% Senior Notes due 2033 (collectively, the 2022 USD Notes). The Company may redeem the 2022 USD Notes at any time, and from time to time, in whole or in part, at the Company's option at the applicable redemption price. The offering provided gross proceeds of $2.0 billion, offset by $22 million in discount and closing costs related to the offering. On November 2, 2022, the Company issued €1.0 billion 4.125% Senior Notes due 2034 (the 2022 Euro Notes). The Company may redeem the 2022 Euro Notes at any time, and from time to time, in whole or in part, at the Company's option at the applicable redemption price. The offering provided gross proceeds of $990 million, offset by $17 million in discount and closing costs related to the offering. The 2022 USD Notes and 2022 Euro Notes are senior unsecured and unsubordinated obligations of the Company and rank equally with each other and with all of the Company's existing and future senior unsecured debt and senior to all of the Company's subordinated debt. The Company intends to use the proceeds from the issuance for general corporate purposes. On August 8, 2022, the Company repaid its 2.15% and its Floating rate notes due 2022. On August 19, 2022, the Company repaid its 0.483% notes due 2022.

LEASES

LEASES	12 Months Ended
	Dec. 31, 2023
Leases [Abstract]
LEASES	LEASES A significant portion of the Company's operating and finance lease portfolio includes corporate offices, research and development facilities, manufacturing sites, information technology equipment, and automobiles. The majority of the Company's leases have remaining lease terms of 1 year to 20 years, some of which include options to extend the leases for 5 years or more. Operating lease ROU assets are included in Other assets. The current portion of operating lease liabilities are included in Accrued liabilities, and the non-current portion of operating lease liabilities are included in Other liabilities in the Consolidated Balance Sheet. Finance lease ROU assets are included in Property, plant and equipment—net. The current portion of finance lease liabilities are included in Current maturities of long-term debt, and the non-current portion of finance lease liabilities are included in Long-term debt in the Consolidated Balance Sheet. A portion of the Company's real estate leases are generally subject to annual changes in the Consumer Price Index (CPI). The changes to the CPI are treated as variable lease payments and recognized in the period in which the obligation for those payments was incurred. In addition, a subset of the Company's automobile leases are considered variable. The variable lease payments for such automobile leases are based on actual mileage incurred at the stated contractual rate and recognized in the period in which the obligation for those payments was incurred. Years Ended December 31, 2023 2022 Operating lease cost $ 239 $ 224 Variable lease cost 4 8 Short-term lease cost 13 18 Finance lease cost Amortization of right-of-use assets 74 72 Interest on lease liability 19 21 Total finance lease cost 93 93 Total lease cost $ 349 $ 343 Supplemental cash flow information related to leases was as follows: Years Ended December 31, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows for operating leases $ 237 $ 225 Operating cash flows for finance leases 19 21 Financing cash flows for finance leases 87 79 Right-of-use assets obtained in exchange for lease obligations Operating leases $ 339 $ 251 Finance leases 42 61 Supplemental balance sheet information related to leases was as follows: December 31, 2023 2022 Operating leases Other assets $ 1,004 $ 881 Accrued liabilities 196 192 Other liabilities 897 775 Total operating lease liabilities $ 1,093 $ 967 Finance leases Property, plant and equipment $ 402 $ 383 Accumulated depreciation (204) (161) Property, plant and equipment—net $ 198 $ 222 Current maturities of long-term debt $ 86 $ 77 Long-term debt 99 145 Total finance lease liabilities $ 185 $ 222 Weighted average remaining lease term Operating leases 9 years 8 years Finance leases 3 years 4 years Weighted average discount rate Operating leases 3.0 % 2.1 % Finance leases 8.5 % 7.8 % As of December 31, 2023, maturities of lease liabilities were as follows: Operating Leases Finance Leases 2024 $ 222 $ 98 2025 185 53 2026 155 24 2027 131 12 2028 105 11 Thereafter 443 7 Total lease payments 1,241 205 Less: Interest 148 20 Total maturities of lease liabilities $ 1,093 $ 185

DERIVATIVE INSTRUMENTS AND HEDG

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS	12 Months Ended
	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS	DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS DERIVATIVES AND HEDGING ACTIVITIES The Company uses derivative financial instruments to manage its risks related to interest rates, foreign currency exchange rates, and commodity prices. Derivative financial instruments are not used for trading or other speculative purposes. To qualify as a hedge, derivative financial instruments must be evaluated for hedge effectiveness at the inception of the contract and designated as a hedge. Changes in fair value of the derivative contract must be highly correlated with changes in fair value of the underlying hedged item at inception and over the life of the hedge contract. FOREIGN CURRENCY RISK MANAGEMENT The Company operates a global business in a wide variety of foreign currencies. The Company's exposure to market risk for changes in foreign currency exchange rates arises from international financing activities between subsidiaries, foreign currency denominated monetary assets and liabilities, and transactions arising from international trade. The Company's objective is to preserve the U.S. Dollar value of foreign currency denominated cash flows and earnings. The Company monitors its collective foreign currency exposure and enters into foreign currency exchange forward and option contracts (foreign currency exchange contracts) with third parties, when necessary, to minimize the impact of changes in foreign currency exchange rates. The Company has monetary assets and liabilities denominated in non-functional currencies. Prior to conversion into U.S. Dollars, these assets and liabilities are remeasured at spot exchange rates as of the balance sheet date. The Company recognizes effects of changes in spot rates in Other (income) expense. The Company uses foreign currency exchange contracts to hedge foreign currency exposure. These contracts are marked-to-market in net income and offset gains and losses on the non-functional currency denominated monetary assets and liabilities being hedged. The Company also uses foreign currency contracts to hedge forecasted sales and purchases, which are denominated in non-functional currencies. Changes in the forecasted non-functional currency cash flows due to movements in exchange rates are substantially offset by changes in the fair value of these foreign currency exchange contracts designated as hedges. Market value gains and losses on these contracts are recognized in earnings when the hedged transaction is recognized. As of December 31, 2023, and 2022, the Company held contracts with notional amounts of $8,910 million and $10,545 million, respectively, to exchange foreign currencies, principally the U.S. Dollar, Euro, Canadian Dollar, British Pound, Mexican Peso, Chinese Renminbi, and Indian Rupee. The Company also designates certain foreign currency debt and derivative contracts as hedges against portions of its net investment in foreign operations. Gains or losses of the foreign currency debt and derivative contracts designated as net investment hedges are recorded in the same manner as foreign currency translation adjustments. INTEREST RATE RISK MANAGEMENT Financial instruments, including derivatives, expose the Company to market risk related to changes in interest rates. The Company uses a combination of financial instruments, including long-term, medium-term, and short-term financing, variable-rate commercial paper, and interest rate swaps to convert the interest rate mix of the Company's total debt portfolio and related overall cost of borrowing. CREDIT RISK MANAGEMENT The Company continues to monitor the creditworthiness of its counterparties to mitigate the risk of nonperformance. Financial instruments, including derivatives, expose the Company to counterparty credit risk. In addition, the Company grants credit terms to its customers in the normal course of business. The terms and conditions of the Company's credit sales are designed to mitigate or eliminate concentrations of credit risk with any single customer. The Company's sales are not materially dependent on a single customer or a small group of customers. COMMODITY PRICE RISK MANAGEMENT The Company's operations subject the Company to risk related to the price volatility of certain commodities. To mitigate the commodity price risk associated with the Company's operations, the Company may enter into commodity derivative instruments. In both 2023 and 2022, the Company entered into various contracts to mitigate commodity price volatility. The Company elected to apply hedge accounting to these contracts. DERIVATIVE AND HEDGING INSTRUMENTS The following table summarizes the notional amounts and fair values of the Company’s outstanding derivatives by risk category and instrument type within the Consolidated Balance Sheet: Notional Fair Value Asset Fair Value (Liability) December 31, 2023 December 31, 2022 December 31, 2023 December 31, 2022 December 31, 2023 December 31, 2022 Derivatives in fair value hedging relationships Interest rate swap agreements $ 4,717 $ 4,984 $ 18 $ 16 $ (184) $ (303) Derivatives in cash flow hedging relationships Foreign currency exchange contracts 712 866 28 19 (4) (5) Commodity contracts 6 9 — — (1) (1) Derivatives in net investment hedging relationships Cross currency swap agreements 4,264 3,189 — 90 (145) — Total derivatives designated as hedging instruments 9,699 9,048 46 125 (334) (309) Derivatives not designated as hedging instruments Foreign currency exchange contracts 8,198 9,679 7 74 (5) (3) Total derivatives at fair value $ 17,897 $ 18,727 $ 53 $ 199 $ (339) $ (312) All Derivative assets are presented in Other current assets or Other assets. All Derivative liabilities are presented in Accrued liabilities or Other liabilities. In addition to the foreign currency derivative contracts designated as net investment hedges, certain of the Company's foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was $6,099 million and $3,836 million as of December 31, 2023, and 2022, respectively. Interest rate swap agreements are designated as hedge relationships with gains or losses on the derivative recognized in Interest and other financial charges offsetting the gains and losses on the underlying debt being hedged. Gains and losses on interest rate swap agreements recognized in earnings were $121 million of income, $347 million of expense, and $135 million of expense for the years ended December 31, 2023, 2022, and 2021, respectively. Gains and losses are fully offset by losses and gains on the underlying debt being hedged. The following table sets forth the amounts recorded in the Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges: Carrying Amount Cumulative Amount of December 31, 2023 December 31, 2022 December 31, 2023 December 31, 2022 Long-term debt $ 4,551 $ 4,696 $ (166) $ (287) The following tables summarize the location and impact to the Consolidated Statement of Operations related to derivative instruments: Year Ended December 31, 2023 Net Sales Cost of Cost of Selling, General and Administrative Expenses Other (Income) Expense Interest and Other $ 36,662 $ 16,977 $ 6,018 $ 5,127 $ (840) $ 765 Gain or (loss) on cash flow hedges Foreign currency exchange contracts Amount reclassified from accumulated other comprehensive income (loss) into income 15 28 10 10 — — Gain or (loss) on fair value hedges Interest rate swap agreements Hedged items — — — — — (121) Derivatives designated as hedges — — — — — 121 Gain or (loss) on derivatives not designated as hedging instruments Foreign currency exchange contracts — — — — (116) — Year Ended December 31, 2022 Net Sales Cost of Cost of Services Sold Selling, General and Administrative Expenses Other (Income) Expense Interest and Other $ 35,466 $ 16,955 $ 5,392 $ 5,214 $ (366) $ 414 Gain or (loss) on cash flow hedges Foreign currency exchange contracts Amount reclassified from accumulated other comprehensive income (loss) into income 13 50 14 (3) — — Commodity Contracts Amount reclassified from accumulated other comprehensive income (loss) into income — (2) — — — — Gain or (loss) on fair value hedges Interest rate swap agreements Hedged items — — — — — 347 Derivatives designated as hedges — — — — — (347) Gain or (loss) on net investment hedges Foreign currency exchange contracts Amount excluded from effectiveness testing recognized in earnings using an amortization approach — — — — — 13 Gain or (loss) on derivatives not designated as hedging instruments Foreign currency exchange contracts — — — — 351 — Year Ended December 31, 2021 Net Sales Cost of Cost of Services Sold Selling, General and Administrative Expenses Other (Income) Expense Interest and Other $ 34,392 $ 17,082 $ 4,979 $ 4,798 $ (1,378) $ 343 Gain or (loss) on cash flow hedges Foreign currency exchange contracts Amount reclassified from accumulated other comprehensive income (loss) into income 5 8 2 9 — — Gain or (loss) on fair value hedges Interest rate swap agreements Hedged items — — — — — 135 Derivatives designated as hedges — — — — — (135) Gain or (loss) on net investment hedges Foreign currency exchange contracts Amount excluded from effectiveness testing recognized in earnings using an amortization approach — — — — — 16 Gain or (loss) on derivatives not designated as hedging instruments Foreign currency exchange contracts — — — — 195 — As of December 31, 2023, the Company estimates that approximately $24 million of net derivative gains related to its cash flow hedges included in Accumulated other comprehensive income (loss) will be reclassified into earnings within the next 12 months. The following table summarizes the amount of gain or (loss) on net investment hedges recognized in Accumulated other comprehensive income (loss): Years Ended December 31, 2023 2022 Euro-denominated long-term debt $ (84) $ 196 Euro-denominated commercial paper (42) 39 Cross currency swap agreements (193) (65) Foreign currency exchange contracts — 34

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS The accounting guidance for fair value measurements and disclosures establishes a three-level fair value hierarchy: • Level 1 - Inputs are based on quoted prices in active markets for identical assets and liabilities. • Level 2 - Inputs are based on observable inputs other than quoted prices in active markets for identical or similar assets and liabilities. • Level 3 - One or more inputs are unobservable and significant. Financial and nonfinancial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The following table sets forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis: December 31, 2023 December 31, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets Foreign currency exchange contracts $ — $ 35 $ — $ 35 $ — $ 93 $ — $ 93 Available for sale investments 63 217 — 280 87 559 — 646 Interest rate swap agreements — 18 — 18 — 16 — 16 Cross currency swap agreements — — — — — 90 — 90 Investments in equity securities 22 — — 22 22 32 — 54 Right to HWI Net Sale Proceeds — — 9 9 — — 295 295 Total assets $ 85 $ 270 $ 9 $ 364 $ 109 $ 790 $ 295 $ 1,194 Liabilities Foreign currency exchange contracts $ — $ 9 — $ 9 $ — $ 8 — $ 8 Interest rate swap agreements — 184 — 184 — 303 — 303 Commodity contracts — 1 — 1 — 1 — 1 Cross currency swap agreements — 145 — 145 — — — — Total liabilities $ — $ 339 $ — $ 339 $ — $ 312 $ — $ 312 The Company values foreign currency exchange contracts, interest rate swap agreements, cross currency swap agreements, and commodity contracts using broker quotations, or market transactions in either the listed or over-the-counter markets. As such, these derivative instruments are classified within level 2. The Company also holds investments in commercial paper, certificates of deposits, time deposits, and corporate debt securities that are designated as available for sale. These investments are valued using published prices based on observable market data. As such, these investments are classified within level 2. The Company holds certain available for sale investments in U.S. government securities and investments in equity securities. The Company values these investments utilizing published prices based on quoted market pricing, which are classified within level 1. The carrying value of cash and cash equivalents, trade accounts and notes receivables, payables, commercial paper, and other short-term borrowings contained in the Consolidated Balance Sheet approximates fair value. As part of the NARCO Buyout (see Note 19 Commitments and Contingencies for definition), Honeywell holds a right to proceeds from the definitive sale agreement pursuant to which HarbisonWalker International Holdings, Inc. (HWI), the reorganized and renamed entity that emerged from the NARCO Bankruptcy, was acquired by an affiliate of Platinum Equity, LLC (HWI Sale). The right to these proceeds is considered a financial instrument. The significant input for the valuation of this right is unobservable, and as such, is classified within level 3. The HWI Sale closed on February 16, 2023. During the twelve months ended December 31, 2023, Honeywell received $275 million of proceeds from the HWI Sale (HWI Net Sale Proceeds), of which $256 million was received during the first quarter of 2023 and $19 million during the second quarter of 2023. Additionally, during the second quarter of 2023, the Company recorded a fair value adjustment for the HWI Net Sale Proceeds and reduced the estimate by $11 million. The fair value of the remaining HWI Net Sale Proceeds as of December 31, 2023, represents contingent consideration to be paid in future periods if certain conditions under the definitive sale agreement for the HWI Sale are met. The following table sets forth a reconciliation of beginning and ending balances of assets and liabilities that were accounted for at fair value using level 3 measurements: Years Ended December 31, 2023 2022 Balance at beginning of period $ 295 $ — Recognition of right to HWI Net Sale Proceeds — 295 Receipt of HWI Net Sale Proceeds (275) — Fair value adjustment of HWI Net Sale Proceeds (11) — Balance at end of period $ 9 $ 295 The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value: December 31, 2023 December 31, 2022 Carrying Fair Carrying Fair Assets Long-term receivables $ 232 $ 173 $ 229 $ 183 Liabilities Long-term debt and related current maturities 18,358 17,706 16,853 15,856 The Company determined the fair value of the long-term receivables by utilizing transactions in the listed markets for identical or similar assets. As such, the fair value of these receivables is considered level 2.

ACCRUED LIABILITIES

ACCRUED LIABILITIES	12 Months Ended
	Dec. 31, 2023
Accrued Liabilities, Current [Abstract]
ACCRUED LIABILITIES	ACCRUED LIABILITIES December 31, 2023 2022 Customer advances and deferred income $ 3,499 $ 3,555 Compensation, benefit and other employee related 1,322 1,218 Repositioning 279 309 Asbestos-related liabilities 154 110 Income taxes 680 549 Other taxes 176 174 Environmental costs 227 222 Operating lease liabilities 196 192 Product warranties and performance guarantees 182 175 Insurance 69 68 Accrued interest 217 122 NARCO Buyout accrual — 1,325 Other (primarily operating expenses) 808 1,143 Total Accrued liabilities $ 7,809 $ 9,162

OTHER LIABILITIES

OTHER LIABILITIES	12 Months Ended
	Dec. 31, 2023
Other Liabilities Disclosure [Abstract]
OTHER LIABILITIES	OTHER LIABILITIES December 31, 2023 2022 Income taxes $ 1,742 $ 1,939 Pension and other employee related 1,342 1,306 Deferred income 1,171 1,334 Operating lease liabilities 897 775 Environmental costs 414 393 Insurance 248 289 Product warranties and performance guarantees 37 38 Asset retirement obligations 17 24 Other 397 371 Total Other liabilities $ 6,265 $ 6,469

STOCK-BASED COMPENSATION PLANS

STOCK-BASED COMPENSATION PLANS	12 Months Ended
	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION PLANS	STOCK-BASED COMPENSATION PLANS The 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates (2016 Plan) and 2016 Stock Plan for Non-Employee Directors of Honeywell International Inc. (2016 Directors Plan) were both approved by the shareowners at the Annual Meeting of Shareowners effective on April 25, 2016. At December 31, 2023, there were 28,946,133 and 781,768 shares of Honeywell common stock available for future grants under terms of the 2016 Plan and 2016 Directors Plan, respectively. STOCK OPTIONS The exercise price, term, and other conditions applicable to each option granted under the Company's stock plans are generally determined by the Management Development and Compensation Committee of the Board of Directors. The exercise price of stock options is set on the grant date and may not be less than the fair market value per share of the Company's stock on that date. The fair value is recognized as an expense over the employee’s requisite service period (generally the vesting period of the award). Options generally vest over a four-year period and expire after ten years. The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model. Expected volatility is based on implied volatilities from traded options on our common stock and historical volatility of the Company's common stock. The Company used a Monte Carlo simulation model to derive an expected term which represents an estimate of the time options are expected to remain outstanding. Such model uses historical data to estimate option exercise activity and post-vest termination behavior. The risk-free rate for periods within the contractual life of the option is based on the U.S. treasury yield curve in effect at the time of grant. The following table summarizes the impact to the Consolidated Statement of Operations from stock options: Years Ended December 31, 2023 2022 2021 Compensation expense $ 48 $ 45 $ 55 Future income tax benefit recognized 11 10 11 The following table sets forth fair value per share information, including related weighted average assumptions, used to determine compensation cost: Years Ended December 31, 2023 2022 2021 Weighted average fair value per share of options granted during the year 1 $ 38.84 $ 31.22 $ 32.42 Assumptions Expected annual dividend yield 2.50 % 2.58 % 2.31 % Expected volatility 22.42 % 23.05 % 24.69 % Risk-free rate of return 3.94 % 1.97 % 0.48 % Expected option term (years) 4.86 4.74 4.54 1 Estimated on date of grant using Black-Scholes option-pricing model. The following table summarizes information about stock option activity for the three years ended December 31, 2023: Number of Weighted Average Outstanding at December 31, 2020 16,568,529 $ 125.75 Granted 2,065,574 204.99 Exercised (2,016,489) 113.01 Lapsed or canceled (764,675) 175.42 Outstanding at December 31, 2021 15,852,939 135.31 Granted 2,150,910 189.53 Exercised (3,046,107) 103.89 Lapsed or canceled (905,454) 186.35 Outstanding at December 31, 2022 14,052,288 147.14 Granted 1,573,520 195.27 Exercised (1,640,952) 123.12 Lapsed or canceled (548,842) 192.22 Outstanding at December 31, 2023 13,436,014 $ 153.86 Vested and expected to vest at December 31, 2023 1 12,420,005 $ 150.58 Exercisable at December 31, 2023 9,593,986 $ 138.24 1 Represents the sum of vested options of 9.6 million and expected to vest options of 2.8 million. Expected to vest options are derived by applying the pre-vesting forfeiture rate assumption to total outstanding unvested options of 3.8 million. The following table summarizes information about stock options outstanding and exercisable at December 31, 2023: Range of Exercise Prices Options Outstanding Options Exercisable Number Weighted Average Life 1 Weighted Average Exercise Price Per Share Aggregate Number Weighted Average Exercise Price Per Share Aggregate $65.00–$89.99 687,158 0.16 $ 89.46 $ 83 687,158 $ 89.46 $ 83 $90.00–$99.99 2,285,249 1.52 98.79 253 2,285,249 98.79 253 $100.00–$134.99 1,814,529 3.02 119.30 164 1,787,835 119.15 163 $135.00–$189.99 5,737,860 5.83 170.92 222 4,078,279 164.61 209 $190.00–$232.60 2,911,218 8.02 200.23 30 755,465 204.77 22 13,436,014 4.90 $ 153.86 $ 752 9,593,986 $ 138.24 $ 730 1 Average remaining contractual life in years. There were 9,509,606 and 10,664,625 options exercisable at weighted average exercise prices of $127.99 and $113.30 at December 31, 2022, and 2021, respectively. The following table summarizes the financial statement impact from stock options exercised: Years Ended December 31, 2023 2022 2021 Intrinsic value 1 $ 122 $ 310 $ 219 Tax benefit realized 27 71 48 1 Represents the amount by which the stock price exceeded the exercise price of the options on the date of exercise. At December 31, 2023, there was $96 million of total unrecognized compensation cost related to non-vested stock option awards which is expected to be recognized over a weighted average period of 2.49 years. The total fair value of options vested for the years ended December 31, 2023, 2022, and 2021 was $48 million, $49 million, and $52 million, respectively. RESTRICTED STOCK UNITS Restricted stock unit (RSU) awards entitle the holder to receive one share of common stock for each unit when the units vest. RSUs are issued to certain key employees and directors as compensation at fair market value at the date of grant. RSUs generally become fully vested over periods ranging from three The following table summarizes information about RSU activity for the three years ended December 31, 2023: Number of Weighted Non-vested at December 31, 2020 3,396,523 $ 148.23 Granted 992,854 214.61 Vested (1,123,547) 144.34 Forfeited (308,293) 156.74 Non-vested at December 31, 2021 2,957,536 171.73 Granted 1,056,869 186.48 Vested (864,944) 157.21 Forfeited (441,453) 177.38 Non-vested at December 31, 2022 2,708,008 181.10 Granted 1,109,307 194.81 Vested (919,496) 171.92 Forfeited (290,982) 187.13 Non-vested at December 31, 2023 2,606,837 $ 189.18 As of December 31, 2023, there was approximately $250 million of total unrecognized compensation cost related to non-vested RSUs granted under the Company's stock plans which is expected to be recognized over a weighted average period of 1.91 years. The following table summarizes the impact to the Consolidated Statement of Operations from RSUs: Years Ended December 31, 2023 2022 2021 Compensation expense $ 154 $ 143 $ 162 Future income tax benefit recognized 32 29 23

EARNINGS PER SHARE

EARNINGS PER SHARE	12 Months Ended
	Dec. 31, 2023
Earnings Per Share [Abstract]
EARNINGS PER SHARE	EARNINGS PER SHARE The details of the earnings per share calculations for the years ended December 31, 2023, 2022, and 2021, are as follows (shares in millions): Basic Years Ended December 31, 2023 2022 2021 Net income attributable to Honeywell $ 5,658 $ 4,966 $ 5,542 Weighted average shares outstanding 663.0 677.1 692.3 Earnings per share of common stock—basic $ 8.53 $ 7.33 $ 8.01 Assuming Dilution Years Ended December 31, 2023 2022 2021 Net income attributable to Honeywell $ 5,658 $ 4,966 $ 5,542 Average shares Weighted average shares outstanding 663.0 677.1 692.3 Dilutive securities issuable—stock plans 5.2 6.0 8.1 Total weighted average diluted shares outstanding 668.2 683.1 700.4 Earnings per share of common stock—assuming dilution $ 8.47 $ 7.27 $ 7.91 The diluted earnings per share calculations exclude the effect of stock options when the cost to exercise an option exceeds the average market price of the common shares during the period. In 2023, 2022, and 2021, the weighted average number of stock options excluded from the computations was 4.5 million, 3.5 million, and 1.7 million, respectively. These stock options were outstanding at the end of each of the respective periods. As of December 31, 2023, and 2022, the total shares outstanding were 651.8 million and 667.6 million, respectively, and as of December 31, 2023, and 2022, total shares issued were 957.6 million.

ACCUMULATED OTHER COMPREHENSIVE

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	12 Months Ended
	Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) The changes in Accumulated other comprehensive income (loss) are provided in the tables below. Comprehensive income (loss) attributable to noncontrolling interest consists predominantly of net income. Pre-tax Tax After-Tax Year Ended December 31, 2023 Foreign exchange translation adjustment $ (269) $ — $ (269) Pension and other postretirement benefit adjustments (538) 131 (407) Changes in fair value of available for sale investments 5 — 5 Changes in fair value of cash flow hedges 17 (6) 11 Total net current period other comprehensive income (loss) $ (785) $ 125 $ (660) Year Ended December 31, 2022 Foreign exchange translation adjustment $ (354) $ — $ (354) Pension and other postretirement benefit adjustments (280) 47 (233) Changes in fair value of available for sale investments (8) — (8) Changes in fair value of cash flow hedges 9 6 15 Total net current period other comprehensive income (loss) $ (633) $ 53 $ (580) Year Ended December 31, 2021 Foreign exchange translation adjustment $ 302 $ — $ 302 Pension and other postretirement benefit adjustments 245 (59) 186 Changes in fair value of available for sale investments (3) — (3) Changes in fair value of cash flow hedges (4) 1 (3) Total net current period other comprehensive income (loss) $ 540 $ (58) $ 482 COMPONENTS OF ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) December 31, 2023 2022 Cumulative foreign exchange translation adjustment $ (3,101) $ (2,832) Pension and other postretirement benefit adjustments (1,055) (648) Fair value adjustments of available for sale investments (2) (7) Fair value adjustments of cash flow hedges 23 12 Total Accumulated other comprehensive income (loss) $ (4,135) $ (3,475) CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) BY COMPONENT Foreign Pension Changes in Changes in Total Balance at December 31, 2020 $ (2,780) $ (601) $ 4 $ — $ (3,377) Other comprehensive income (loss) before reclassifications 314 268 (3) 17 596 Amounts reclassified from accumulated other comprehensive income (loss) (12) (82) — (20) (114) Net current period other comprehensive income (loss) 302 186 (3) (3) 482 Balance at December 31, 2021 (2,478) (415) 1 (3) (2,895) Other comprehensive income (loss) before reclassifications (344) (623) (8) 71 (904) Amounts reclassified from accumulated other comprehensive income (loss) (10) 390 — (56) 324 Net current period other comprehensive income (loss) (354) (233) (8) 15 (580) Balance at December 31, 2022 (2,832) (648) (7) 12 (3,475) Other comprehensive income (loss) before reclassifications (269) (477) 5 60 (681) Amounts reclassified from accumulated other comprehensive income (loss) — 70 — (49) 21 Net current period other comprehensive income (loss) (269) (407) 5 11 (660) Balance at December 31, 2023 $ (3,101) $ (1,055) $ (2) $ 23 $ (4,135) RECLASSIFICATIONS OUT OF ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Year Ended December 31, 2023 Affected Line in the Consolidated Statement of Operations Net Sales Cost of Products Sold Cost of Services Sold Selling, General and Administrative Expenses Other (Income) Expense Interest and Other Financial Charges Total Amortization of pension and other postretirement benefit items Actuarial losses recognized $ — $ — $ — $ — $ 141 $ — $ 141 Prior service (credit) recognized — — — — (63) — (63) Losses (gains) on cash flow hedges (15) (28) (10) (10) — — (63) Losses (gains) on excluded component of net investment hedges — — — — — — — Total before tax $ (15) $ (28) $ (10) $ (10) $ 78 $ — $ 15 Tax (expense) benefit 6 Total reclassifications for the period, net of tax $ 21 Year Ended December 31, 2022 Affected Line in the Consolidated Statement of Operations Net Sales Cost of Products Sold Cost of Services Sold Selling, General and Administrative Expenses Other (Income) Expense Interest and Other Financial Charges Total Amortization of pension and other postretirement benefit items Actuarial losses recognized $ — $ — $ — $ — $ 516 $ — $ 516 Prior service (credit) recognized — — — — (84) — (84) Losses (gains) on cash flow hedges (13) (48) (14) 3 — — (72) Losses (gains) on excluded component of net investment hedges — — — — — (13) (13) Total before tax $ (13) $ (48) $ (14) $ 3 $ 432 $ (13) $ 347 Tax (expense) benefit (23) Total reclassifications for the period, net of tax $ 324 Year Ended December 31, 2021 Affected Line in the Consolidated Statement of Operations Net Sales Cost of Products Sold Cost of Services Sold Selling, General and Administrative Expenses Other (Income) Expense Interest and Other Financial Charges Total Amortization of pension and other postretirement benefit items Actuarial losses recognized $ — $ — $ — $ — $ 7 $ — $ 7 Prior service (credit) recognized — — — — (116) — (116) Losses (gains) on cash flow hedges (5) (8) (2) (9) — — (24) Losses (gains) on excluded component of net investment hedges — — — — — (16) (16) Total before tax $ (5) $ (8) $ (2) $ (9) $ (109) $ (16) $ (149) Tax (expense) benefit 35 Total reclassifications for the period, net of tax $ (114)

CAPITAL STOCK

CAPITAL STOCK	12 Months Ended
	Dec. 31, 2023
Class of Stock Disclosures [Abstract]
CAPITAL STOCK	CAPITAL STOCK The Company is authorized to issue up to 2,000,000,000 shares of common stock, with a par value of $1. Common shareowners are entitled to receive such dividends as may be declared by the Board of Directors, are entitled to one vote per share, and are entitled, in the event of liquidation, to share ratably in all the assets of the Company which are available for distribution to the common shareowners. Common shareowners do not have preemptive or conversion rights. Shares of common stock issued and outstanding or held in treasury are not liable to further calls or assessments. There are no restrictions on the Company relative to dividends or the repurchase or redemption of common stock. On April 24, 2023, the Board of Directors authorized the repurchase of up to a total of $10 billion of Honeywell common stock, including approximately $2.1 billion of remaining availability under the previously announced $10 billion share repurchase authorization. Approximately $7.1 billion and $2.9 billion remained available as of December 31, 2023, and 2022, respectively, for additional share repurchases. Honeywell repurchased approximately 19.2 million and 21.9 million shares of its common stock during the years ended December 31, 2023, and 2022, for $3.7 billion and $4.2 billion, respectively. The Company is authorized to issue up to 40,000,000 shares of preferred stock, without par value, and can determine the number of shares of each series, and the rights, preferences, and limitations of each series. At December 31, 2023, there was no preferred stock outstanding.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES ENVIRONMENTAL MATTERS The Company is subject to various federal, state, local, and foreign government requirements relating to the protection of the environment. The Company believes that, as a general matter, the Company's policies, practices, and procedures are properly designed to prevent unreasonable risk of environmental damage and personal injury and that the handling, manufacture, use, and disposal of hazardous substances are in accordance with environmental and safety laws and regulations. However, mainly because of past operations and operations of predecessor companies, the Company, like other companies engaged in similar businesses, incurred remedial response and voluntary cleanup costs for site contamination and is a party to lawsuits and claims associated with environmental and safety matters, including past production of products containing hazardous substances. Additional lawsuits, claims, and costs involving environmental matters are likely to continue to arise in the future. With respect to environmental matters involving site contamination, the Company continually conducts studies, individually or jointly with other potentially responsible parties, to determine the feasibility of various remedial techniques. It is the Company's policy to record appropriate liabilities for environmental matters when remedial efforts or damage claim payments are probable and the costs can be reasonably estimated. Such liabilities are based on our best estimate of the undiscounted future costs required to complete the remedial work. The recorded liabilities are adjusted periodically as remediation efforts progress or as additional technical, regulatory, or legal information becomes available. Given the uncertainties regarding the status of laws, regulations, enforcement policies, the impact of other potentially responsible parties, technology, and information related to individual sites, the Company does not believe it is possible to develop an estimate of the range of reasonably possible environmental loss in excess of the Company's recorded liabilities. The Company expects to fund expenditures for these matters from operating cash flows. The timing of cash expenditures depends on a number of factors, including the timing of remedial investigations and feasibility studies, the timing of litigation and settlements of remediation liability, personal injury and property damage claims, regulatory approval of cleanup projects, remedial techniques to be utilized, and agreements with other parties. The following table summarizes information concerning the Company's recorded liabilities for environmental costs: Years Ended December 31, 2023 2022 2021 Beginning of year $ 615 $ 618 $ 660 Accruals for environmental matters deemed probable and reasonably estimable 222 186 168 Environmental liability payments (196) (211) (210) Other — 22 — End of year $ 641 $ 615 $ 618 Environmental liabilities are included in the following balance sheet accounts: December 31, 2023 2022 Accrued liabilities $ 227 $ 222 Other liabilities 414 393 Total environmental liabilities $ 641 $ 615 The Company does not currently possess sufficient information to reasonably estimate the amounts of environmental liabilities to be recorded upon future completion of studies, litigation, or settlements, and neither the timing nor the amount of the ultimate costs associated with environmental matters can be determined, although they could be material to the Company's consolidated results of operations and operating cash flows in the periods recognized or paid. However, considering the Company's past experience and existing reserves, the Company does not expect that environmental matters will have a material adverse effect on its consolidated financial position. In conjunction with the Resideo spin-off, the Company entered into an indemnification and reimbursement agreement with a Resideo subsidiary, pursuant to which Resideo’s subsidiary has an ongoing obligation to make cash payments to Honeywell in amounts equal to 90% of Honeywell’s annual net spending for environmental matters at certain sites as defined in the agreement. The amount payable to Honeywell in any given year is subject to a cap of $140 million, and the obligation will continue until the earlier of December 31, 2043, or December 31 of the third consecutive year during which the annual payment obligation is less than $25 million. Reimbursements associated with this agreement are collected from Resideo quarterly and were $140 million in both 2023 and 2022 and offset operating cash outflows incurred by the Company. As the Company incurs costs for environmental matters deemed probable and reasonably estimable related to the sites covered by the indemnification and reimbursement agreement, a corresponding receivable from Resideo for 90% of such costs is also recorded. This receivable amount recorded in 2023 and 2022 was $187 million and $157 million, respectively. As of December 31, 2023, Other current assets and Other assets included $140 million and $521 million, res pectively, for the short-term and long-term portion of the receivable amount due from Resideo under the indemnification and reimbursement agreement. As of December 31, 2022, Other current assets and Other assets included $140 million and $474 million, respectively, for the short-term and long-term portion of the receivable amount due from Resideo under the indemnification and reimbursement agreement. ASBESTOS MATTERS Honeywell is named in asbestos-related personal injury claims related to NARCO, which was sold in 1986, and the Bendix Friction Materials (Bendix) business, which was sold in 2014. The following tables summarize information concerning NARCO and Bendix asbestos-related balances: ASBESTOS-RELATED LIABILITIES Year Ended December 31, 2023 Year Ended December 31, 2022 Year Ended December 31, 2021 Bendix NARCO Total Bendix NARCO Total Bendix NARCO Total Beginning of year $ 1,291 $ 1,325 $ 2,616 $ 1,372 $ 689 $ 2,061 $ 1,441 $ 779 $ 2,220 Accrual for update to estimated liability 43 5 48 93 (634) (541) 64 31 95 Change in estimated cost of future claims 423 — 423 41 — 41 29 — 29 Update of expected resolution values for pending claims 56 — 56 1 — 1 3 — 3 Asbestos-related liability payments (169) (5) (174) (216) (55) (271) (165) (121) (286) NARCO Buyout — (1,325) (1,325) — 1,325 1,325 — — — End of year $ 1,644 $ — $ 1,644 $ 1,291 $ 1,325 $ 2,616 $ 1,372 $ 689 $ 2,061 INSURANCE RECOVERIES FOR ASBESTOS-RELATED LIABILITIES Year Ended December 31, 2023 Year Ended December 31, 2022 Year Ended December 31, 2021 Bendix NARCO Total Bendix NARCO Total Bendix NARCO Total Beginning of year $ 130 $ 135 $ 265 $ 142 $ 221 $ 363 $ 148 $ 254 $ 402 Probable insurance recoveries related to estimated liability 11 — 11 5 2 7 7 — 7 Insurance receipts for asbestos-related liabilities (18) (21) (39) (17) (20) (37) (13) (33) (46) Insurance receivables settlements and write-offs — (26) (26) — (68) (68) — — — End of year $ 123 $ 88 $ 211 $ 130 $ 135 $ 265 $ 142 $ 221 $ 363 NARCO and Bendix asbestos-related balances are included in the following balance sheet accounts: December 31, 2023 2022 Other current assets $ 41 $ 41 Insurance recoveries for asbestos-related liabilities 170 224 Total insurance recoveries for asbestos-related liabilities $ 211 $ 265 Accrued liabilities $ 154 $ 1,436 Asbestos-related liabilities 1,490 1,180 Total asbestos-related liabilities 1 $ 1,644 $ 2,616 1 As of December 31, 2022, Accrued liabilities included the Buyout Amount, as described and defined below, agreed upon between Honeywell and the Trust. The Buyout Amount does not represent an asbestos-related liability. NARCO Products – NARCO manufactured high-grade, heat-resistant, refractory products for various industries. Honeywell’s predecessor, Allied Corporation, owned NARCO from 1979 to 1986. Allied Corporation sold the NARCO business in 1986 and entered into a cross-indemnity agreement which included an obligation to indemnify the purchaser for asbestos claims, arising primarily from alleged occupational exposure to asbestos-containing refractory brick and mortar for high-temperature applications. NARCO ceased manufacturing these products in 1980 and filed for bankruptcy in January 2002, at which point in time all then current and future NARCO asbestos claims were stayed against both NARCO and Honeywell pending the reorganization of NARCO. The Company established its initial liability for NARCO asbestos claims in 2002. NARCO emerged from bankruptcy in April 2013, at which time a federally authorized 524(g) trust was established to evaluate and resolve all existing NARCO asbestos claims (the Trust). Both Honeywell and NARCO are protected by a permanent channeling injunction barring all present and future individual actions in state or federal courts and requiring all asbestos-related claims based on exposure to NARCO asbestos-containing products to be made against the Trust (Channeling Injunction). The NARCO Trust Agreement (TA) and the NARCO Trust Distribution Procedures (TDP) set forth the structure and operating rules of the Trust, and established Honeywell’s evergreen funding obligations. The operating rules per the TDP define criteria claimants must meet for a claim to be considered valid and paid. Once operational in 2014, the Trust began to receive, process, and pay claims. In September 2021, Honeywell filed suit against the Trust in the United States Bankruptcy Court for the Western District of Pennsylvania (Bankruptcy Court) alleging that the Trust breached its duties in managing the Trust, including breaches of certain provisions of the TA and TDP. Honeywell's lawsuit sought appropriate relief preventing the Trust from continuing these practices. The Trust also filed suit against Honeywell, alleging Honeywell breached its obligations under the Trust's governing documents. Honeywell moved to dismiss the Trust’s suit, and on December 15, 2021, the Bankruptcy Court granted Honeywell’s motion to dismiss subject to granting the Trust leave to file an amended complaint. On December 28, 2021, the Trust filed an answer with counterclaims in response to Honeywell’s complaint and in lieu of filing an amended complaint. The Bankruptcy Court conducted a trial on these matters during May 2022; following the trial, the Company and the Trust began discussing a potential settlement of Honeywell’s remaining obligations to the Trust. On November 18, 2022, Honeywell entered into a definitive agreement (Buyout Agreement) with the Trust, and on November 20, 2022, in exchange for the NARCO Trust Advisory Committee (TAC) and Lawrence Fitzpatrick, in his capacity as the NARCO Asbestos Future Claimants Representative (FCR), becoming parties to the Buyout Agreement, Honeywell, the Trust, the TAC, and the FCR entered into an Amended and Restated Buyout Agreement (Amended Buyout Agreement). Pursuant to the terms of the Amended Buyout Agreement, Honeywell agreed to make a one-time, lump sum payment in the amount of $1.325 billion to the Trust (Buyout Amount), subject to certain deductions as described in the Amended Buyout Agreement and in exchange for the release by the Trust of Honeywell from all further and future obligations of any kind related to the Trust and/or any claimants who were exposed to asbestos-containing products manufactured, sold, or distributed by NARCO or its predecessors, including Honeywell’s ongoing evergreen obligation to fund (i) claims against the Trust, which comprise Honeywell’s NARCO asbestos-related claims liability, and (ii) the Trust’s annual operating expenses, which are expensed as incurred, including its legal fees (which operating expenses, for reference, were approximately $30 million in 2022) (such evergreen obligations referred to in (i) and (ii), Honeywell Obligations) (the NARCO Buyout). On December 8, 2022, the Bankruptcy Court issued an order that (A) approved the Amended Buyout Agreement, and (B) declared that the NARCO Channeling Injunction (which bars all past, present, and future individual actions in state or federal courts based on exposure to NARCO asbestos-containing products and requires all such claims to be made against the Trust) will remain in full force and effect without modification, dissolution, or termination (Order). On December 14, 2022, HWI, the reorganized and renamed entity that emerged from the NARCO bankruptcy, entered into a definitive agreement (Sale Agreement) pursuant to which an affiliate of Platinum Equity, LLC agreed to acquire HWI (HWI Sale) subject to the terms set forth in the Sale Agreement, including customary conditions to closing set forth therein. In accordance with the Amended Buyout Agreement, the economic rights of the Trust in respect of the net proceeds from the HWI Sale inure to the benefit of Honeywell. On January 30, 2023, the Company paid the Buyout Amount to the Trust, the parties closed the transactions contemplated in the Amended Buyout Agreement (Closing), and Honeywell was released from the Honeywell Obligations. Honeywell continues to have the right to collect proceeds in connection with its NARCO asbestos-related insurance policies. With the issuance of the Order, the Company derecognized the NARCO asbestos-related liability of $688 million from the Consolidated Balance Sheet and recognized a charge of $1.325 billion in the Consolidated Statement of Operations and accrued a corresponding liability in the Consolidated Balance Sheet for the Buyout Amount. In addition, the Company recognized a benefit of $295 million in the Consolidated Statement of Operations and corresponding asset in Other current assets in the Consolidated Balance Sheet for Honeywell's rights to the proceeds from the HWI Sale. The benefit of $295 million offset the charge for the Buyout Amount. On February 16, 2023, the HWI Sale closed. Pursuant to the Amended Buyout Agreement, during 2023, Honeywell received $275 million of proceeds from the HWI sale. See Note 12 Fair Value Measurements for further information on the related proceeds and remaining amount under the Amended Buyout Agreement. Bendix Products – Bendix manufactured automotive brake linings that contained chrysotile asbestos in an encapsulated form. Claimants consist largely of individuals who allege exposure to asbestos from brakes from either performing or being in the vicinity of individuals who performed brake replacements. The following tables present information regarding Bendix-related asbestos claims activity: Years Ended December 31, 2023 2022 Claims unresolved at the beginning of year 5,608 6,401 Claims filed 1,803 2,014 Claims resolved (1,894) (2,807) Claims unresolved at the end of year 5,517 5,608 Disease Distribution of Unresolved Claims Years Ended December 31, 2023 2022 Mesothelioma and other cancer claims 3,244 3,283 Nonmalignant claims 2,273 2,325 Total claims 5,517 5,608 Honeywell has experienced average resolution values per claim excluding legal costs as follows: Years Ended December 31, 2023 2022 2021 2020 2019 (in whole dollars) Mesothelioma and other cancer claims $ 66,200 $ 59,200 $ 56,000 $ 61,500 $ 50,200 Nonmalignant claims 1,730 520 400 550 3,900 The Consolidated Financial Statements reflect an estimated liability for resolution of asserted (claims filed as of the financial statement date) and unasserted Bendix-related asbestos claims, which exclude the Company’s ongoing legal fees to defend such asbestos claims which will continue to be expensed as they are incurred. The Company reflects the inclusion of all years of epidemiological disease projection through 2059 when estimating the liability for unasserted Bendix-related asbestos claims. Such liability for unasserted Bendix-related asbestos claims is based on historic and anticipated claims filing experience and dismissal rates, disease classifications, and average resolution values in the tort system over a defined look-back period. The Company historically valued Bendix asserted and unasserted claims using a five-year look-back period. The Company reviews the valuation assumptions and average resolution values used to estimate the cost of Bendix asserted and unasserted claims during the fourth quarter each year. The Company experienced fluctuations in average resolution values year-over-year in each of the past five years with no well-established trends in either direction. In 2023, the Company observed two consecutive years of increasing average resolution values (2023 and 2022), with more volatility in the earlier years of the five-year period (2019 through 2021). Based on these observations, the Company, during its annual review in the fourth quarter of 2023, reevaluated its valuation methodology and elected to give more weight to the two most recent years by shortening the look-back period from five years to two years (2023 and 2022). The Company believes that the average resolution values in the last two consecutive years are likely more representative of expected resolution values in future periods. It is not possible to predict whether such resolution values will increase, decrease, or stabilize in the future, given recent litigation trends within the tort system and the inherent uncertainty in predicting the outcome of such trends. The Company will continue to monitor Bendix claim resolution values and other trends within the tort system to assess the appropriate look-back period for determining average resolution values going forward. In 2023, the Company recognized a $522 million expense and corresponding adjustment to its estimated liability for Bendix asbestos-related claims. This amount includes $434 million attributable primarily to shortening the look-back period to the two most recent years, and to a lesser extent to increasing expected resolution values for a subset of asserted claims to adjust for higher claim values in that subset than in the modelled two-year data set. The Company's insurance receivable corresponding to the liability for settlement of asserted and unasserted Bendix asbestos claims reflects coverage which is provided by a large number of insurance policies written by dozens of insurance companies in both the domestic insurance market and the London excess market. Based on the Company's ongoing analysis of the probable insurance recovery, insurance receivables are recorded in the financial statements simultaneous with the recording of the estimated liability for the underlying asbestos claims. This determination is based on the Company's analysis of the underlying insurance policies, historical experience with insurers, ongoing review of the solvency of insurers, judicial determinations relevant to insurance programs, and consideration of the impacts of any settlements reached with the Company's insurers. On October 31, 2018, David Kanefsky (Plaintiff), a Honeywell shareholder, filed a putative class action complaint in the U.S. District Court for the District of New Jersey (the Court) alleging violations of the Securities Exchange Act of 1934 and Rule 10b-5 related to the prior accounting for Bendix asbestos claims. An Amended Complaint was filed on December 30, 2019, and on February 7, 2020, the Company filed a Motion to Dismiss. On May 18, 2020, the Court denied the Motion to Dismiss. On December 7, 2021, the parties filed a Stipulation of Settlement (Settlement Agreement) and Plaintiff filed a motion for preliminary approval of the Settlement Agreement, which included payment by Honeywell of $10 million to settle the claims in dispute. On January 18, 2022, the Court approved the motion for preliminary approval of the Settlement Agreement. On May 3, 2022, the Court entered a final judgment and order approving the Settlement Agreement and dismissed the action. Honeywell continues to believe the claims lacked merit and has denied wrongdoing as well as any liability for the claims made against Honeywell in the action. GARRETT LITIGATION AND BANKRUPTCY PROCEEDINGS In conjunction with the Garrett spin-off, the Company entered into a binding indemnification and reimbursement agreement (Garrett Indemnity) and a binding tax matters agreement (Tax Matters Agreement) with Garrett and a Garrett subsidiary. On December 2, 2019, Garrett and Garrett ASASCO Inc. filed a Summons with Notice and commenced a lawsuit in the Commercial Division of the Supreme Court of the State of New York, County of New York (the State Court), seeking to invalidate the Garrett Indemnity. Garrett sought damages and a declaratory judgment based on various claims set forth in the Summons with Notice. On July 17, 2020, the Company received a notice from Garrett asserting that the Company had caused material breaches of the Tax Matters Agreement and that the Tax Matters Agreement was unenforceable. On September 20, 2020, Garrett and 36 of its affiliates filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York (the Bankruptcy Court). On September 24, 2020, Garrett moved the existing State Court litigation against Honeywell to the Bankruptcy Court. For the year ended December 31, 2020, the Company reviewed the aggregate carrying value of the receivable amounts due in connection with the Garrett Indemnity and Tax Matters Agreement and reduced the aggregate carrying value of the receivable by $509 million to reflect the present value of the amounts owed to the Company over the full term of these agreements. On April 26, 2021, the Bankruptcy Court confirmed Garrett’s amended Chapter 11 plan of reorganization (the Confirmed Plan), and on April 30, 2021 (the Effective Date), Garrett emerged from bankruptcy. On the Effective Date, and in accordance with the Confirmed Plan, (i) the Company received from Garrett an initial payment of $375 million and 834.8 million shares of Garrett's Series B Preferred Stock in full and final satisfaction of the Garrett Indemnity and Tax Matters Agreement, (ii) the Garrett Indemnity and Tax Matters Agreement were terminated, (iii) the Company and Garrett mutually released each other from the claims asserted in all pending legal actions related to the Garrett Indemnity and Tax Matters Agreement, and (iv) all pending litigation between the Company and Garrett in connection with those agreements was resolved. The original Series B Preferred Stock Certificate of Designation provided for mandatory redemptions by Garrett of $35 million in 2022 and $100 million per year from 2023 to 2030 (inclusive) at the anniversary of the Effective Date, unless (i) Garrett’s consolidated EBITDA as of the end of the most recently completed fiscal year was less than $425 million, or (ii) Garrett did not have sufficient funds available to pay the redemption, at which point the redemption amounts past due would accrue interest. The Series B Preferred Stock Certificate of Designation also included rights which allowed (a) the Company to put the Series B Preferred Stock to Garrett if certain EBITDA conditions were met, and (b) Garrett to call the Series B Preferred Stock in whole or in part if certain EBITDA conditions were met. On September 30, 2021, Garrett filed an Amended and Restated Series B Preferred Stock Certificate of Designation (Amendment) with the Secretary of State of Delaware. The Amendment required Garrett to partially redeem a portion of the Series B Preferred Stock on or before March 31, 2022, such that the present value of remaining outstanding shares of the Series B Preferred Stock would be $400 million (First Partial Redemption), subject to applicable law, including that Garrett had funds legally available for the partial redemption. The First Partial Redemption would be applied to the latest scheduled redemption dates, beginning with the shares to be redeemed in 2030. The Amendment also provided that the Company could not exercise its right to put the Series B Preferred Stock to Garrett until after December 31, 2022, subject to the EBITDA conditions described in the above section, unless the partial redemption did not occur on or before March 31, 2022. All other material terms and conditions in the Amendment were unchanged from the original Series B Preferred Stock Certificate of Designation. On December 16, 2021, Garrett filed a Second Amended and Restated Series B Preferred Stock Certificate of Designation (Second Amendment) with the Secretary of State of Delaware. The Second Amendment accelerated the First Partial Redemption from March 31, 2022, to December 30, 2021, and allowed Garrett to partially redeem an additional portion of the Series B Preferred Stock on or before March 31, 2022, such that the present value of remaining outstanding shares of the Series B Preferred Stock would be $207 million (Second Partial Redemption). The Second Partial Redemption is subject to similar terms as the First Partial Redemption, including that Garrett had funds legally available for the partial redemption. However, the Second Partial Redemption was also contingent upon Garrett completing the First Partial Redemption and either (i) increasing their revolving credit facility, or (ii) the Garrett Board of Directors determining that Garrett otherwise had sufficient liquidity to effect the Second Partial Redemption. The Second Partial Redemption would be applied to the earliest scheduled redemptions beginning with the shares to be redeemed on April 30, 2022. On December 17, 2021, Garrett announced their intention to effect the First Partial Redemption on December 28, 2021, in the amount of $211 million. On December 28, 2021, Garrett paid $211 million for the amount due as the First Partial Redemption. On February 18, 2022, Garrett early redeemed $197 million of the Series B Preferred Stock, pursuant to the terms and conditions of the Second Amended and Restated Series B Preferred Stock Certificate of Designation. Immediately following the early redemption, the fair value of the Series B Preferred Stock was $207 million. On June 28, 2022, Garrett early redeemed all remaining shares of the Series B Preferred Stock in the amount of $212 million, pursuant to the terms and conditions of the Second Amended and Restated Series B Preferred Stock Certificate of Designation. Following the redemption, the Series B Preferred Stock were no longer outstanding. The Company recorded the Series B Preferred Stock at fair value at the Effective Date. See Note 12 Fair Value Measurements for additional information on the fair value leveling of the Series B Preferred Stock. PETROBRAS AND UNAOIL MATTERS On December 19, 2022, the Company reached a comprehensive resolution to the investigations by the U.S. Department of Justice (DOJ), the Securities and Exchange Commission (SEC), and certain Brazilian authorities (Brazilian Authorities) relating to the Company's use of third parties who previously worked for the Company's UOP business in Brazil in relation to a project awarded in 2010 for Petróleo Brasileiro S.A. (Petrobras). The investigations focused on the Company’s compliance with the U.S. Foreign Corrupt Practices Act and similar Brazilian laws (UOP Matters). The comprehensive resolution also resolves DOJ and SEC investigations relating to a matter involving a foreign subsidiary’s prior contract with Unaoil S.A.M. in Algeria executed in 2011 (the Unaoil Matter). In connection with the comprehensive resolution, (i) the Company agreed to pay a total equivalent of $202.7 million, which payment occurred in January 2023, to the DOJ, the SEC, and the Brazilian Authorities, collectively, in penalties, disgorgement, and prejudgment interest, (ii) the Company’s subsidiary, UOP, LLC (UOP), entered into a three-year Deferred Prosecution Agreement (DPA) with the DOJ for charges related to the UOP Matters, (iii) UOP entered into leniency agreements with the Brazilian authorities related to the UOP Matter in Brazil, and (iv) the Company entered into an agreement with the SEC that resolves allegations relating to the UOP Matters and the Unaoil Matter. Pursuant to these agreements, the Company agreed to undertake certain compliance measures and compliance reporting obligations. These agreements entirely resolve the Petrobras and Unaoil investigations. OTHER MATTERS The Company is subject to a number of other lawsuits, investigations, and disputes (some of which involve substantial amounts claimed) arising out of the conduct of the Company's business, including matters relating to commercial transactions, government contracts, product liability, prior acquisitions and divestitures, employee benefit plans, intellectual property, and environmental, health, and safety matters. The Company recognizes liabilities for any contingency that is probable of occurrence and reasonably estimable. The Company continually assesses the likelihood of adverse judgments or outcomes in such matters, as well as potential ranges of probable losses (taking into consideration any insurance recoveries), based on a careful analysis of each matter with the assistance of outside legal counsel and, if applicable, other experts. Given the uncertainty inherent in litigation and investigations, the Company does not believe it is possible to develop estimates of reasonably possible loss (or a range of possible loss) in excess of current accruals for commitment and contingency matters, including those discussed in this Note 19. Considering the Company's past experience and existing accruals, the Company does not expect the outcome of such matters, either individually or in the aggregate, to have a material adverse effect on the Company's consolidated financial position. Because most contingencies are resolved over long periods of time, potential liabilities are subject to change due to new developments, changes in settlement strategy or the impact of evidentiary requirements, which could cause the Company to pay damage awards or settlements (or become subject to equitable remedies) that could have a material adverse effect on the Company's consolidated results of operations or operating cash flows in the periods recognized or paid. WARRANTIES AND GUARANTEES In the normal course of business, the Company issues product warranties and product performance guarantees. The Company accrues for the estimated cost of product warranties and performance guarantees based on contract terms and historical experience at the time of sale. Adjustments to initial obligations for warranties and guarantees are made as changes to the obligations become reasonably estimable. The following table summarizes information concerning the Company's recorded obligations for product warranties and product performance guarantees: Years Ended December 31, 2023 2022 2021 Beginning of year $ 213 $ 223 $ 243 Accruals for warranties/guarantees issued during the year 139 117 146 Adjustment of pre-existing warranties/guarantees (27) (12) (7) Settlement of warranty/guarantee claims (106) (115) (159) End of year $ 219 $ 213 $ 223 Product warranties and product performance guarantees are included in the following balance sheet accounts: December 31, 2023 2022 Accrued liabilities $ 182 $ 175 Other liabilities 37 38 Total obligations for product warranties and product performance guarantees $ 219 $ 213

PENSION AND OTHER POSTRETIREMEN

PENSION AND OTHER POSTRETIREMENT BENEFITS	12 Months Ended
	Dec. 31, 2023
Retirement Benefits [Abstract]
PENSION AND OTHER POSTRETIREMENT BENEFITS	PENSION AND OTHER POSTRETIREMENT BENEFITS The Company sponsors a number of both funded and unfunded U.S. and non-U.S. defined benefit pension plans. Pension benefits for many of the Company's U.S. employees are provided through non-contributory, qualified, and non-qualified defined benefit plans. All non-union hourly and salaried employees joining Honeywell for the first time after December 31, 2012, are not eligible to participate in Honeywell’s U.S. defined benefit pension plans. The Company also sponsors defined benefit pension plans which cover non-U.S. employees who are not U.S. citizens, in certain jurisdictions, principally the UK, Netherlands, Germany, and Canada. Other pension plans outside of the U.S. are not material to the Company either individually or in the aggregate. The Company sponsors postretirement benefit plans that provide health care benefits and life insurance coverage mainly to U.S. eligible retirees. None of Honeywell’s U.S. employees are eligible for a retiree medical subsidy from the Company. In addition, the vast majority of Honeywell’s U.S. retirees either have no Company subsidy or have a fixed-dollar subsidy amount. This significantly limits the Company's exposure to the impact of future health care cost increases. The retiree medical and life insurance plans are not funded. Claims and expenses are paid from the Company's cash flows from operations. The following tables summarize the balance sheet impact, including the benefit obligations, assets, and funded status associated with the Company's significant pension and other postretirement benefit plans: Pension Benefits U.S. Plans Non-U.S. Plans 2023 2022 2023 2022 Change in benefit obligation Benefit obligation at beginning of year $ 13,290 $ 17,391 $ 4,400 $ 6,999 Service cost 29 86 11 19 Interest cost 645 380 200 103 Plan amendments — — — — Actuarial (gains) losses 1 337 (3,135) 191 (1,929) Benefits paid (1,509) (1,421) (250) (261) Settlements and curtailments — (13) — — Foreign currency translation — — 165 (533) Other — 2 1 2 Benefit obligation at end of year 12,792 13,290 4,718 4,400 Change in plan assets Fair value of plan assets at beginning of year 17,005 20,560 5,304 8,396 Actual return on plan assets 1,070 (2,161) 267 (2,187) Company contributions 28 37 22 17 Benefits paid (1,509) (1,421) (250) (261) Settlements and curtailments — (13) — — Foreign currency translation — — 205 (664) Other — 3 1 3 Fair value of plan assets at end of year 16,594 17,005 5,549 5,304 Funded status of plans $ 3,802 $ 3,715 $ 831 $ 904 Amounts recognized in the Consolidated Balance Sheet consist of Prepaid pension benefit cost 2 $ 4,052 $ 3,970 $ 1,335 $ 1,356 Accrued pension liabilities—current 3 (26) (28) (15) (14) Accrued pension liabilities—noncurrent 4 (224) (227) (489) (438) Net amount recognized $ 3,802 $ 3,715 $ 831 $ 904 1 The actuarial losses incurred in 2023 related to the Company's U.S. plans are primarily the result of a decrease in the discount rate assumption, as well as changes in demographic experience and demographic assumptions used to estimate the benefit obligations as of December 31, 2023, compared to December 31, 2022. Actuarial losses incurred in 2023 related to the Company's non-U.S. plans are primarily the result of a decrease in the discount rate assumption, partially offset by inflation related assumptions used to estimate the benefit obligations as of December 31, 2023, compared to December 31, 2022. Actuarial gains incurred in 2022 related to the Company's U.S. plans are primarily the result of an increase in the discount rate assumption, partially offset by changes in demographic experience and demographic assumptions used to estimate the benefit obligations as of December 31, 2022, compared to December 31, 2021. Actuarial gains incurred in 2022 related to the Company's non-U.S. plans are primarily the result of an increase in the discount rate assumption, partially offset by inflation related assumptions used to estimate the benefit obligations as of December 31, 2022, compared to December 31, 2021. 2 Included in Other assets in the Consolidated Balance Sheet. 3 Included in Accrued liabilities in the Consolidated Balance Sheet. 4 Included in Other liabilities in the Consolidated Balance Sheet. Other 2023 2022 Change in benefit obligation Benefit obligation at beginning of year $ 133 $ 196 Service cost — — Interest cost 6 5 Plan amendments — — Actuarial (gains) losses 3 (54) Benefits paid (26) (14) Benefit obligation at end of year 116 133 Change in plan assets Fair value of plan assets at beginning of year — — Actual return on plan assets — — Company contributions — — Benefits paid — — Fair value of plan assets at end of year — — Funded status of plans $ (116) $ (133) Amounts recognized in the Consolidated Balance Sheet consist of Accrued liabilities $ (12) $ (21) Postretirement benefit obligations other than pensions 1 (104) (112) Net amount recognized $ (116) $ (133) 1 Excludes non-U.S. plan of $30 million and $34 million as of December 31, 2023, and 2022, respectively. Amounts recognized in Accumulated other comprehensive (income) loss associated with the Company's significant pension and other postretirement benefit plans at December 31, 2023, and 2022, are as follows: Pension Benefits U.S. Plans Non-U.S. Plans 2023 2022 2023 2022 Prior service (credit) cost $ (7) $ (50) $ 18 $ 18 Net actuarial (gain) loss 1,191 814 422 360 Net amount recognized $ 1,184 $ 764 $ 440 $ 378 Other 2023 2022 Prior service (credit) cost $ (30) $ (50) Net actuarial (gain) loss (68) (84) Net amount recognized $ (98) $ (134) Net periodic benefit (income) cost and other amounts recognized in Other comprehensive (income) loss for the Company's significant pension and other postretirement benefit plans include the following components: Pension Benefits U.S. Plans Non-U.S. Plans 2023 2022 2021 2023 2022 2021 Service cost $ 29 $ 86 $ 105 $ 11 $ 19 $ 26 Interest cost 645 380 306 200 103 77 Expected return on plan assets (1,111) (1,281) (1,220) (274) (278) (348) Amortization of prior service (credit) cost (42) (42) (42) — — — Recognition of actuarial (gains) losses — (14) 31 153 537 9 Settlements and curtailments — (2) — — — — Net periodic benefit (income) cost $ (479) $ (873) $ (820) $ 90 $ 381 $ (236) U.S. Plans Non-U.S. Plans 2023 2022 2021 2023 2022 2021 Actuarial (gains) losses $ 378 $ 307 $ (14) $ 198 $ 294 $ (221) Prior service (credit) cost — — — — — (3) Prior service credit recognized during year 42 43 43 — (1) (1) Actuarial (gains) losses recognized during year — 15 — (153) (537) (9) Foreign currency translation — — — 17 204 (1) Total recognized in Other comprehensive (income) loss $ 420 $ 365 $ 29 $ 62 $ (40) $ (235) Total recognized in net periodic benefit (income) cost and Other comprehensive (income) loss $ (59) $ (508) $ (791) $ 152 $ 341 $ (471) Other Postretirement Benefits Years Ended December 31, 2023 2022 2021 Service cost $ — $ — $ — Interest cost 6 5 5 Amortization of prior service (credit) cost (20) (42) (74) Recognition of actuarial (gains) losses (13) (4) (2) Net periodic benefit (income) cost $ (27) $ (41) $ (71) Years Ended December 31, 2023 2022 2021 Actuarial (gains) losses $ 3 $ (54) $ (8) Prior service (credit) cost — — — Prior service credit recognized during year 20 42 74 Actuarial (gains) losses recognized during year 13 4 2 Total recognized in other comprehensive (income) loss 36 (8) 68 Total recognized in net periodic benefit (income) cost and Other comprehensive (income) loss $ 9 $ (49) $ (3) Major actuarial assumptions used in determining the benefit obligations and net periodic benefit (income) cost for the Company's significant benefit plans are presented in the following table as weighted averages: Pension Benefits U.S. Plans Non-U.S. Plans 2023 2022 2021 2023 2022 2021 Actuarial assumptions used to determine benefit obligations as of December 31 Discount rate 4.97 % 5.17 % 2.87 % 4.15 % 4.50 % 1.79 % Expected annual rate of compensation increase 3.25 % 3.25 % 3.25 % 2.68 % 2.69 % 2.56 % Actuarial assumptions used to determine net periodic benefit (income) cost for years ended December 31 Discount rate—benefit obligation 5.17 % 2.87 % 2.50 % 4.49 % 1.77 % 1.24 % Discount rate—service cost 5.26 % 2.98 % 2.68 % 3.81 % 1.48 % 1.00 % Discount rate—interest cost 5.07 % 2.26 % 1.76 % 4.56 % 1.59 % 1.00 % Expected rate of return on plan assets 6.75 % 6.40 % 6.15 % 5.15 % 3.61 % 4.03 % Expected annual rate of compensation increase 3.25 % 3.25 % 3.25 % 2.68 % 2.56 % 2.43 % Other Postretirement Benefits 2023 2022 2021 Actuarial assumptions used to determine benefit obligations as of December 31 Discount rate 5.00 % 5.32 % 2.66 % Actuarial assumptions used to determine net periodic benefit cost for years ended December 31 Discount rate 5.32 % 2.66 % 2.20 % The discount rate for the Company's U.S. pension and other postretirement benefit plans reflects the current rate at which the associated liabilities could be settled at the measurement date of December 31. To determine discount rates for the Company's U.S. pension and other postretirement benefit plans, the Company uses a modeling process that involves matching the expected cash outflows of the Company's benefit plans to a yield curve constructed from a portfolio of high-quality, fixed income debt instruments. The Company uses the single weighted average yield of this hypothetical portfolio as a discount rate benchmark. The Company utilizes a full yield curve approach in the estimation of the service and interest cost components of net periodic pension benefit (income) for the Company's significant pension plans. This approach applies the specific spot rates along the yield curve used in the determination of the pension benefit obligation to their underlying projected cash flows and provides a more precise measurement of service and interest costs by improving the correlation between projected cash flows and their corresponding spot rates. For the Company's U.S. pension plans, the single weighted average spot rates used to determine service and interest costs for 2024 are 5.06% and 4.89%, respectively. The discount rate used to determine the other postretirement benefit obligation is higher principally due to a shorter expected duration of other postretirement plan obligations as compared to pension plan obligations. The Company plans to use an expected rate of return on U.S. plan assets of 7.00% for 2024, which represents an increase from the 6.75% assumption used for 2023. The Company's asset return assumption is based on historical plan asset returns over varying long-term periods combined with current market conditions and broad asset mix considerations with a focus on long-term trends rather than short-term market conditions. The Company reviews the expected rate of return on an annual basis and revises it as appropriate. For non-U.S. benefit plans, actuarial assumptions reflect economic and market factors relevant to each country. PENSION BENEFITS The following amounts relate to the Company's significant pension plans with accumulated benefit obligations exceeding the fair value of plan assets: December 31, U.S. Plans Non-U.S. Plans 2023 2022 2023 2022 Projected benefit obligation $ 251 $ 255 $ 753 $ 682 Accumulated benefit obligation 249 253 736 664 Fair value of plan assets — — 249 230 The accumulated benefit obligation for the Company's U.S. defined benefit pension plans was $12.8 billion and $13.3 billion and for the Company's non-U.S. defined benefit pension plans was $4.7 billion and $4.4 billion at December 31, 2023, and 2022, respectively. The Company's asset investment strategy for its U.S. pension plans focuses on maintaining a diversified portfolio using various asset classes in order to achieve the Company's long-term investment objectives on a risk adjusted basis. The Company's long-term target allocations are as follows: 45%-65% fixed income securities and cash, 25%-40% equity securities, 5%-10% real estate investments, and 10%-20% other types of investments. Equity securities include publicly-traded stock of companies located inside the United States. Fixed income securities include corporate bonds of companies from diversified industries, mortgage-backed securities, and U.S. Treasuries. Real estate investments include direct investments in commercial properties and investments in real estate funds. Other types of investments include investments in private equity that follow several different strategies. The Company reviews its assets on a regular basis to ensure that the Company is within the targeted asset allocation ranges and, if necessary, asset balances are adjusted back within target allocations. The Company's non-U.S. pension assets are typically managed by decentralized fiduciary committees with the Honeywell Corporate Investments group providing investment guidance. The Company's non-U.S. investment policies are different for each country as local regulations and financial and tax considerations are part of the funding and investment allocation process in each country. In accordance with Accounting Standards Codification “Fair Value Measurement (Topic 820)”, certain investments that are measured at fair value using the net asset value (NAV) per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in the following tables are intended to permit reconciliation of the fair value hierarchy to the amounts presented for the total pension benefits plan assets. The fair values of both the Company's U.S. and non-U.S. pension plans assets by asset category are as follows: U.S. Plans December 31, 2023 Total Level 1 Level 2 Level 3 Equities Honeywell common stock $ 3,049 $ 3,049 $ — $ — U.S. equities — — — — Fixed income Short-term investments 2,942 283 2,659 — Government securities 532 — 532 — Corporate bonds 5,733 — 5,733 — Mortgage/Asset-backed securities 676 — 676 — Insurance contracts 7 — 7 — Direct investments Direct private investments 1,293 — — 1,293 Real estate properties 977 — — 977 Total $ 15,209 $ 3,332 $ 9,607 $ 2,270 Investments measured at NAV Private funds 1,265 Real estate funds 8 Commingled funds 112 Total assets at fair value $ 16,594 U.S. Plans December 31, 2022 Total Level 1 Level 2 Level 3 Equities Honeywell common stock $ 3,336 $ 3,336 $ — $ — U.S. equities 6 6 — — Fixed income Short-term investments 855 855 — — Government securities 1,492 — 1,492 — Corporate bonds 6,632 — 6,632 — Mortgage/Asset-backed securities 1,119 — 1,119 — Insurance contracts 8 — 8 — Direct investments Direct private investments 1,284 — — 1,284 Real estate properties 1,005 — — 1,005 Total $ 15,737 $ 4,197 $ 9,251 $ 2,289 Investments measured at NAV Private funds 1,258 Real estate funds 10 Commingled funds — Total assets at fair value $ 17,005 Non-U.S. Plans December 31, 2023 Total Level 1 Level 2 Level 3 Equities U.S. equities $ 195 $ — $ 195 $ — Non-U.S. equities 365 — 365 — Fixed income Short-term investments 387 168 219 — Government securities 1,635 — 1,635 — Corporate bonds 1,103 — 1,103 — Mortgage/Asset-backed securities 10 — 10 — Insurance contracts 108 — 108 — Insurance buy-in contracts 1,605 — — 1,605 Investments in private funds Private funds 115 — 41 74 Real estate funds 16 — — 16 Total $ 5,539 $ 168 $ 3,676 $ 1,695 Investments measured at NAV Private funds 8 Real estate funds 2 Total assets at fair value $ 5,549 Non-U.S. Plans December 31, 2022 Total Level 1 Level 2 Level 3 Equities U.S. equities $ 144 $ 2 $ 142 $ — Non-U.S. equities 374 — 374 — Fixed income Short-term investments 341 341 — — Government securities 2,045 — 2,045 — Corporate bonds 1,031 — 1,031 — Mortgage/Asset-backed securities 31 — 31 — Insurance contracts 115 — 115 — Insurance buy-in contracts 950 — — 950 Investments in private funds Private funds 90 — 54 36 Real estate funds 130 — — 130 Total $ 5,251 $ 343 $ 3,792 $ 1,116 Investments measured at NAV Private funds 10 Real estate funds 43 Total assets at fair value $ 5,304 The following table summarizes changes in the fair value of level 3 assets for both U.S. and non-U.S. plans: U.S. Plans Non-U.S. Plans Direct Private Investments Real Estate Properties Private Funds Real Estate Funds Insurance Buy-in Contracts Balance at December 31, 2021 $ 1,336 $ 843 $ 33 $ 163 $ 691 Actual return on plan assets Relating to assets still held at year-end (66) 88 11 (33) (477) Relating to assets sold during the year 98 (24) — 1 — Purchases 75 148 — — 736 Sales and settlements (159) (50) (8) (1) — Balance at December 31, 2022 1,284 1,005 36 130 950 Actual return on plan assets Relating to assets still held at year-end (34) (115) 3 — 68 Relating to assets sold during the year 159 — 1 (3) — Purchases 131 88 39 — 587 Sales and settlements (247) (1) (5) (111) — Balance at December 31, 2023 $ 1,293 $ 977 $ 74 $ 16 $ 1,605 The Company enters into futures contracts to gain exposure to certain markets. Sufficient cash or cash equivalents are held by the Company's pension plans to cover the notional value of the futures contracts. At December 31, 2023, and 2022, the Company's U.S. plans had contracts with notional amounts of $4,025 million and $2,567 million, respectively. At December 31, 2023, and 2022, the Company's non-U.S. plans had contracts with notional amounts of $124 million and $120 million, respectively. In both the Company's U.S. and non-U.S. pension plans, the notional derivative exposure is related to outstanding equity and fixed income futures contracts. Common stocks, preferred stocks, real estate investment trusts, and short-term investments are valued at the closing price reported in the active market in which the individual securities are traded. Corporate bonds, mortgage/asset-backed securities, and government securities are valued either by using pricing models, bids provided by brokers or dealers, quoted prices of securities with similar characteristics, or discounted cash flows, and as such, include adjustments for certain risks that may not be observable such as credit and liquidity risks. Certain securities are held in collective trust funds which are valued using net asset values provided by the administrators of the funds. Investments in private equity, debt, real estate and hedge funds, and direct private investments are valued at estimated fair value based on quarterly financial information received from the investment advisor and/or general partner. Investments in real estate properties are valued on a quarterly basis using the income approach. Valuation estimates are periodically supplemented by third party appraisals. The insurance buy-in contracts represent policies held by the Honeywell UK Pension Scheme, whereby the cost of providing pension benefits to plan participants is funded by the policies. The cash flows from the policies are intended to match the pension benefits. The fair value of these policies is based on an estimate of the policies' exit price. The Company's funding policy for qualified defined benefit pension plans is to contribute amounts at least sufficient to satisfy regulatory funding standards. In 2023, 2022, and 2021, the Company was not required to make contributions to the U.S. pension plans and no contributions were made. The Company is not required to make any contributions to the U.S. pension plans in 2024. In 2023, contributions of $12 million were made to the non-U.S. pension plans to satisfy regulatory funding requirements. In 2024, the Company expects to make contributions of cash and/or marketable securities of approximately $12 million to the non-U.S. pension plans to satisfy regulatory funding standards. Contributions for both the U.S. and non-U.S. pension plans do not reflect benefits paid directly from Company assets. Benefit payments, including amounts to be paid from Company assets, and reflecting expected future service, as appropriate, are expected to be paid as follows: U.S. Plans Non-U.S. Plans 2024 $ 1,094 $ 257 2025 1,077 253 2026 1,062 260 2027 1,044 266 2028 1,022 268 2029-2033 4,699 1,270 During the twelve months ended December 31, 2023, the Company repurchased $200 million of outstanding Honeywell shares of common stock from the Honeywell U.S. Pension Plan Master Trust. The Company completed no repurchases of outstanding Honeywell shares of common stock from the Honeywell U.S. Pension Plan Master Trust during 2022. OTHER POSTRETIREMENT BENEFITS December 31, 2023 2022 Assumed health care cost trend rate Health care cost trend rate assumed for next year 7.00 % 7.50 % Rate that the cost trend rate gradually declines to 5.00 % 5.00 % Year that the rate reaches the rate it is assumed to remain at 2031 2031 Benefit payments reflecting expected future service, as appropriate, are expected to be paid as follows: Without Impact of Net of 2024 $ 13 $ 12 2025 12 12 2026 12 11 2027 11 11 2028 11 10 2029-2033 46 44

OTHER (INCOME) EXPENSE

OTHER (INCOME) EXPENSE	12 Months Ended
	Dec. 31, 2023
Other Income and Expenses [Abstract]
OTHER (INCOME) EXPENSE	OTHER (INCOME) EXPENSE Years Ended December 31, 2023 2022 2021 Interest income $ (321) $ (138) $ (102) Pension ongoing income—non-service (441) (602) (1,202) Other postretirement income—non-service (29) (41) (71) Equity income of affiliated companies (100) (61) (67) Gain on sale of non-strategic businesses and assets (5) (22) (102) Foreign exchange (gain) loss 9 48 25 Expense related to UOP Matters — 45 160 Expense (benefit) related to Russia-Ukraine conflict (3) 45 — Net expense related to the NARCO Buyout and HWI Sale 11 342 — Other, net 39 18 (19) Total Other (income) expense $ (840) $ (366) $ (1,378) See Note 19 Commitments and Contingencies for more information on the UOP Matters, NARCO Buyout, and HWI Sale. See Note 4 Repositioning and Other Charges for further discussion of the expense related to the Russia-Ukraine conflict. See Note 2 Acquisitions and Divestitures for further discussion on the gain on sale of non-strategic businesses and assets.

SEGMENT FINANCIAL DATA

SEGMENT FINANCIAL DATA	12 Months Ended
	Dec. 31, 2023
Segment Reporting [Abstract]
SEGMENT FINANCIAL DATA	SEGMENT FINANCIAL DATA Honeywell globally manages its business operations through four reportable business segments. Segment information is consistent with how management reviews the businesses, makes investing and resource allocation decisions, and assesses operating performance. Honeywell’s senior management evaluates segment performance based on segment profit. Each segment’s profit is measured as segment income (loss) before taxes excluding general corporate unallocated expense, interest and other financial charges, stock compensation expense, pension and other postretirement income (expense), repositioning and other charges, and other items within Other (income) expense. Effective during the first quarter of 2024, the Company realigned certain of its business units comprising its historical Performance Materials and Technologies, and Safety and Productivity Solutions reportable business segments by forming two new reportable business segments: Industrial Automation, and Energy and Sustainability Solutions. Industrial Automation includes Sensing and Safety Technologies, Productivity Solutions and Services, and Warehouse and Workflow Solutions, previously included in Safety and Productivity Solutions, in addition to Process Solutions, previously included in Performance Materials and Technologies. Energy and Sustainability Solutions includes UOP and Advanced Materials, previously included in Performance Materials and Technologies. Further, as part of the realignment, the Company renamed its historical Aerospace and Honeywell Building Technologies reportable business segments to Aerospace Technologies and Building Automation, respectively. This realignment had no impact on the Company’s historical consolidated financial position, results of operations, or cash flows. Prior period amounts have been recast. Years Ended December 31, 2023 2022 2021 Net sales Aerospace Technologies Products $ 7,316 $ 6,330 $ 6,158 Services 6,308 5,497 4,868 Net Aerospace Technologies sales 13,624 11,827 11,026 Industrial Automation Products 8,176 9,439 10,403 Services 2,580 2,199 2,022 Net Industrial Automation sales 10,756 11,638 12,425 Building Automation Products 4,599 4,591 4,098 Services 1,432 1,409 1,441 Net Building Automation sales 6,031 6,000 5,539 Energy and Sustainability Solutions Products 5,682 5,600 4,984 Services 557 396 418 Net Energy and Sustainability Solutions sales 6,239 5,996 5,402 Corporate and All Other Services 12 5 — Net Corporate and All Other sales 12 5 — Net sales $ 36,662 $ 35,466 $ 34,392 Depreciation and amortization Aerospace Technologies $ 267 $ 285 $ 278 Industrial Automation 386 422 439 Building Automation 107 92 67 Energy and Sustainability Solutions 253 247 252 Corporate and All Other 163 158 102 Total depreciation and amortization $ 1,176 $ 1,204 $ 1,138 Segment profit Aerospace Technologies $ 3,741 $ 3,228 $ 3,051 Industrial Automation 1,967 1,896 1,824 Building Automation 1,505 1,439 1,238 Energy and Sustainability Solutions 1,483 1,538 1,325 Corporate and All Other (392) (412) (226) Total segment profit $ 8,304 $ 7,689 $ 7,212 Years Ended December 31, 2023 2022 2021 Capital expenditures Aerospace Technologies $ 310 $ 246 $ 284 Industrial Automation 194 77 232 Building Automation 79 74 62 Energy and Sustainability Solutions 374 291 223 Corporate and All Other 82 78 94 Total capital expenditures $ 1,039 $ 766 $ 895 Years Ended December 31, 2023 2022 Total assets Aerospace Technologies $ 12,976 $ 12,189 Industrial Automation 22,026 21,337 Building Automation 6,723 6,599 Energy and Sustainability Solutions 8,048 7,442 Corporate and All Other 11,752 14,708 Total assets $ 61,525 $ 62,275 A reconciliation of segment profit to consolidated income before taxes are as follows: Years Ended December 31, 2023 2022 2021 Segment profit $ 8,304 $ 7,689 $ 7,212 Interest and other financial charges (765) (414) (343) Interest income 321 138 102 Stock compensation expense 1 (202) (188) (217) Pension ongoing income 2 528 993 1,083 Pension mark-to-market expense (153) (523) (40) Other postretirement income 2 29 41 71 Repositioning and other charges 3 (860) (1,266) (569) Other expense 4 (43) (91) (64) Income before taxes $ 7,159 $ 6,379 $ 7,235 1 Amounts included in Selling, general and administrative expenses. 2 Amounts included in Cost of products and services sold (service cost component), Selling, general and administrative expenses (service cost component), Research and development expenses (service cost component), and Other (income) expense (non-service cost component). 3 Amounts included in Cost of products and services sold, Selling, general and administrative expenses, and Other (income) expense. 4 Amounts include the other components of Other (income) expense not included within other categories in this reconciliation. Equity income of affiliated companies is included in segment profit.

GEOGRAPHIC AREAS - FINANCIAL DA

GEOGRAPHIC AREAS - FINANCIAL DATA	12 Months Ended
	Dec. 31, 2023
Geographic Areas, Revenues from External Customers [Abstract]
Geographic Areas - Financial Data	GEOGRAPHIC AREAS—FINANCIAL DATA Net Sales 1 Long-lived Assets 2 Years Ended December 31, Years Ended December 31, 2023 2022 2021 2023 2022 2021 United States $ 20,907 $ 21,262 $ 20,662 $ 4,107 $ 3,949 $ 3,964 Europe 8,052 6,840 6,800 555 537 566 Other international 7,703 7,364 6,930 998 985 1,032 Net sales $ 36,662 $ 35,466 $ 34,392 $ 5,660 $ 5,471 $ 5,562 1 Sales between geographic areas approximate market value and are not significant. Net sales are classified according to their country of origin. Included in United States Net sales are export sales of $4,708 million, $4,187 million, and $4,037 million for the years ended December 31, 2023, 2022, and 2021, respectively. 2 Long-lived assets consists of Property, plant and equipment—net.

SUPPLEMENTAL CASH FLOW INFORMAT

SUPPLEMENTAL CASH FLOW INFORMATION	12 Months Ended
	Dec. 31, 2023
Supplemental Cash Flow Information [Abstract]
SUPPLEMENTAL CASH FLOW INFORMATION	SUPPLEMENTAL CASH FLOW INFORMATION Years Ended December 31, 2023 2022 2021 Net payments for repositioning and other charges Severance and exit cost payments $ (294) $ (275) $ (382) Environmental payments (196) (211) (210) Reimbursement receipts 140 140 140 Insurance receipts for asbestos-related liabilities 39 37 46 Insurance receivables settlements and write-offs 26 68 — Asbestos-related liability payments (174) (271) (286) Total net payments for repositioning and other charges $ (459) $ (512) $ (692) Interest paid, net of amounts capitalized $ 649 $ 375 $ 339 Income taxes paid, net of refunds 1,581 1,324 1,202 Non-cash investing and financing activities Common stock contributed to savings plans 216 196 191 Marketable securities contributed to non-U.S. pension plans — — 81 Impact of Quantinuum contribution 1 — — 460 Noncontrolling interest non-cash contribution 1 — — 419 Loan in exchange for prepaid assets — — 25 Receipt of Garrett Series B Preferred Stock 2 — — 577 1 See Note 2 Acquisitions and Divestitures for additional information of non-cash amounts recognized related to the combination of Honeywell Quantum Solutions and Cambridge Quantum Computing to form Quantinuum, a newly formed entity, which Honeywell consolidates as the controlling majority-owner. 2 See Note 19 Commitments and Contingencies for additional information of non-cash amounts recognized related to the receipt of 834.8 million shares of Garrett Series B Preferred Stock in exchange for the full and final satisfaction of the Garrett Indemnity, Tax Matters Agreement, and pending litigation between the Company and Garrett. The non-cash amount reflects the fair value of the Garrett Series B Preferred Stock as of April 30, 2021, the date Garrett issued the Series B Preferred Stock to the Company.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Accounting Principles	ACCOUNTING PRINCIPLES The financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. The following is a description of Honeywell’s significant accounting policies.
Principles of Consolidation	PRINCIPLES OF CONSOLIDATION The Consolidated Financial Statements include the accounts of Honeywell International Inc. and all of its subsidiaries and entities in which a controlling interest is maintained. The Company's consolidation policy requires equity investments that the Company exercises significant influence over, but does not control the investee and are not the primary beneficiary of the investee’s activities, to be accounted for using the equity method. Investments through which the Company is not able to exercise significant influence over the investee and which the Company does not have readily determinable fair values are accounted for under the cost method. All intercompany transactions and balances are eliminated in consolidation.
Reclassifications	RECLASSIFICATIONS Certain prior year amounts are reclassified to conform to the current year presentation. Historically, the Company included Company-sponsored costs and costs that relate to contracts with customers for research and development projects as a component of Cost of products and services sold on the Consolidated Statement of Operations. Effective January 1, 2023, the Company began classifying Company-sponsored costs for research and development projects as a separate financial statement line item, titled Research and development expenses, on the Consolidated Statement of Operations and recast prior period results for this reclassification. This reclassification had no impact on the Company's net income, earnings per share, cash flows, segment reporting, or financial position. The Company revised historical periods to reflect this change in presentation.
Recent Accounting Pronouncements	RECENT ACCOUNTING PRONOUNCEMENTS The Company considers the applicability and impact of all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB). ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company's Consolidated Statement of Operations, Balance Sheet, and Cash Flows (Consolidated Financial Statements). In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Taxes Disclosures , which requires greater disaggregation of income tax disclosures. The new standard requires additional information to be disclosed with respect to the income tax rate reconciliation and income taxes paid disaggregated by jurisdiction. This ASU should be applied prospectively for fiscal years beginning after December 15, 2024, with retrospective application permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which requires companies to enhance the disclosures about segment expenses. The new standard requires the disclosure of the Company’s Chief Operating Decision Maker (CODM), expanded incremental line-item disclosures of significant segment expenses used by the CODM for decision-making, and the inclusion of previous annual only segment disclosure requirements on a quarterly basis. This ASU should be applied retrospectively for fiscal years beginning after December 15, 2023, and early adoption is permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements. In September 2022, the FASB issued ASU 2022-04, Liabilities—Supplier Finance Programs (Topic 405): Disclosure of Supplier Finance Program Obligations , to enhance the transparency of supplier finance programs. The new standard requires annual disclosure of the key terms of the program, a description of where in the financial statements amounts outstanding under the program are presented, a rollforward of such amounts, and interim disclosure of amounts outstanding as of the end of each period. The guidance does not affect recognition, measurement, or financial statement presentation of supplier finance programs. The ASU is effective on January 1, 2023, except for the rollforward, which is effective on January 1, 2024. The Company adopted this guidance on January 1, 2023, with the exception of the rollforward that is effective on January 1, 2024. The adoption of this standard does not have a material impact on the Company’s Consolidated Financial Statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805) : Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. This ASU should be applied prospectively to acquisitions occurring on or after the effective date of December 15, 2022, and early adoption was permitted. The Company adopted this guidance on January 1, 2022. The adoption of this standard does not have a material impact on the Company’s Consolidated Financial Statements. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by the transition away from reference rates expected to be discontinued to alternative reference rates. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope , to expand the scope of this guidance to include derivatives. The guidance was effective upon issuance and may be applied prospectively to contract modifications made and hedging relationships entered into on or before December 31, 2022. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 , which extends the period of time entities can utilize the reference rate reform relief guidance under ASU 2020-04 from December 31, 2022, to December 31, 2024. The Company will apply the guidance to impacted transactions during the transition period. The adoption of this standard does not have a material impact on the Company’s Consolidated Financial Statements.
Research and Development	RESEARCH AND DEVELOPMENT
Cash And Cash Equivalents	CASH AND CASH EQUIVALENTS Cash and cash equivalents include cash on hand and highly liquid investments having an original maturity of three months or less.
Inventories	INVENTORIES Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Carrying value adjustments for inventory obsolescence is equal to the difference between the cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.
Property, Plant and Equipment	PROPERTY, PLANT AND EQUIPMENT Property, plant and equipment are recorded at cost, including any asset retirement obligations, less accumulated depreciation. For financial reporting, the straight-line method of depreciation is used over the estimated useful lives of 10 to 50 years for buildings and improvements an d 3 to 16 years for machinery and equipment. Recognition of the fair value of obligations associated with the retirement of tangible long-lived assets is required when there is a legal obligation to incur such costs. Upon initial recognition of a liability, the cost is capitalized as part of the related long-lived asset and depreciated over the corresponding asset’s useful life.
Goodwill and Indefinite-Lived Intangible Assets	GOODWILL AND INDEFINITE-LIVED INTANGIBLE ASSETS Goodwill and indefinite-lived intangible assets are subject to impairment testing annually as of the first day of the fourth quarter, or if a triggering event occurs or changes in circumstances indicate that the carrying amount may not be fully recoverable. This testing compares carrying values to fair values and, when appropriate, the carrying value of these assets is reduced to fair value, not to exceed the carrying value of goodwill. The Company completed its annual goodwill impairment test as of the first day of the fourth quarter and determined there was no impairment as of that date. The Company is not aware of any additional triggering events. Prior to 2022, the Company performed its annual goodwill and intangible asset impairment test as of the last day of the first quarter. In 2022, the Company changed the date of its annual goodwill and intangible asset impairment assessment to the first day of the fourth quarter. The Company believes this change does not represent a material change in method of applying an accounting principle. This change has been applied prospectively as of the date of the change, as retrospective application is deemed impracticable due to the inability to objectively determine the assumptions used in earlier periods without the benefit of hindsight. This voluntary change is preferable under the circumstances as it results in better alignment with the timing of the Company’s forecasting process and reduces the time period between the assessment date and annual financial statements. This change in accounting principle does not delay, accelerate, or avoid an impairment of goodwill. In 2022, due to this change, the Company performed annual goodwill and intangible asset impairment tests as of the last day of the first quarter and the first day of the fourth quarter.
Definite-Lived Intangible Assets	DEFINITE-LIVED INTANGIBLE ASSETS Other intangible assets with definite lives consist of customer relationships, patents and technology, trademarks, and other intangibles and are amortized over their estimated u seful lives, ranging from 2 to 20 years.
Capitalized Software	CAPITALIZED SOFTWARE The Company capitalizes costs of software developed or obtained for internal use during the application development stage of a project and amortizes those costs using the straight-line method over the expected useful life of the software, not to exceed 7 years. Costs incurred during the preliminary and post-implementation stages are expensed as incurred. Development costs for software held for sale are capitalized once a project has reached the point of technological feasibility. Completed projects are amortized after reaching the point of general availability using the straight-line method based on the expected useful life, not to exceed 7 years. At each balance sheet date, or earlier if an indicator of an impairment exists, the Company evaluates the recoverability of unamortized capitalized software costs based on estimated future undiscounted revenues net of estimated related costs over the remaining amortization period. Capitalized software held for internal use and held for sale is included in Other assets in the Consolidated Balance Sheet.
Foreign Currency Translation	FOREIGN CURRENCY TRANSLATION Assets and liabilities of subsidiaries operating outside the United States with a functional currency other than the U.S. Dollar are translated into U.S. Dollars using year-end exchange rates. Sales, costs, and expenses are translated at the average exchange rates in effect during the year. Foreign currency translation gains and losses are included as a component of Accumulated other comprehensive income (loss). For subsidiaries operating in highly inflationary environments, inventories and property, plant and equipment, including related expenses, are remeasured at the exchange rate in effect on the date the assets were acquired, while monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these subsidiaries are included in earnings.
Derivative Financial Instruments	DERIVATIVE FINANCIAL INSTRUMENTS All derivative financial instruments are recorded on the balance sheet as assets or liabilities and measured at fair value. For derivatives designated as hedges of the fair value of assets or liabilities, the changes in fair values of both the derivatives and the hedged items are recorded in current earnings. For derivatives designated as cash flow hedges, the changes in fair value of the derivatives are recorded in Accumulated other comprehensive income (loss) and subsequently recognized in earnings when the hedged items impact earnings. Derivative financial instruments designated as hedges must be designated and effective as a hedge of the identified risk exposure at the inception of the contract. Changes in fair value of the derivative contract must be highly correlated with changes in fair value of the underlying hedged item at inception and over the life of the hedge contract. Cash flows of such derivative financial instruments are classified consistent with the underlying hedged item. The Company elected to exclude the time value of the derivatives (i.e., the forward points) from the assessment of hedge effectiveness and to recognize the initial value of the excluded component in earnings using the amortization approach. For derivative instruments that are designated and qualify as a net investment hedge, the gain or loss is reported as a component of Other comprehensive income (loss) and recorded in Accumulated other comprehensive income (loss). The gain or loss will be subsequently reclassified into earnings when the hedged net investment is either sold or substantially liquidated.
Leases	LEASES At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. The assessment is based on (i) whether the contract involves the use of a distinct identified asset, (ii) whether the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the period, and (iii) whether the Company has the right to direct the use of the asset. All significant lease arrangements are generally recognized at lease commencement. Operating lease right-of-use (ROU) assets and lease liabilities are recognized at commencement. A ROU asset and corresponding lease liability are not recorded for leases with an initial term of 12 months or less (short-term leases); however, lease expense for these leases is recognized as incurred over the lease term. ROU assets represent the Company's right to use an underlying asset during the reasonably certain lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Lease payments may be fixed or variable, however, only fixed payments or in-substance fixed payments are included in determining the lease liability. Variable lease payments are recognized in operating expenses in the period in which the obligation for those payments are incurred. The operating lease ROU asset also includes any lease payments related to initial direct costs and prepayments and excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are generally accounted for separately. The Company primarily uses its incremental borrowing rate, which is based on the information available at the lease commencement date, in determining the present value of the lease payments. In determining the borrowing rate, the Company considers the lease term, secured incremental borrowing rate, and for leases denominated in a currency different than the U.S. dollar, the collateralized borrowing rate in the foreign currency using the U.S. dollar and foreign currency swap spread, when available.
Pension Benefits	PENSION BENEFITS The Company presents net periodic pension costs by disaggregating the service cost component of such costs and reports those costs in the same line item or items in the Consolidated Statement of Operations as other compensation costs arising from services rendered by the pertinent employees during the period. The other non-service components of such costs are required to be presented separately from the service cost component. The Company records the service cost component of Pension ongoing (income) expense in Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. The remaining components of costs within Pension ongoing (income) expense, primarily interest costs and assumed return on plan assets, are recorded in Other (income) expense. The Company recognizes net actuarial gains or losses in excess of 10% of the greater of the fair value of plan assets or the plan's projected benefit obligation (the corridor) annually in the fourth quarter each year (MTM Adjustment). The MTM Adjustment is also reported in Other (income) expense.
Supply Chain Financing	SUPPLY CHAIN FINANCING The Company maintains agreements with third-party financial institutions that offer voluntary supply chain financing (SCF) programs to suppliers. The SCF programs enable suppliers, at their sole discretion, to sell their receivables to third-party financial institutions in order to receive payment on receivables earlier than the negotiated commercial terms between suppliers and the Company. Supplier sale of receivables to third-party financial institutions is on terms negotiated between the supplier and the respective third-party financial institution. The Company agrees on commercial terms for the goods and services procured from suppliers, including prices, quantities, and payment terms, which normally range between 60 and 120 days, regardless of whether the supplier elects to participate in the SCF programs. A suppliers’ voluntary participation in the SCF programs has no bearing on the Company's payment terms and the Company has no economic interest in a supplier’s decision to participate in the SCF programs. The Company agrees to pay participating third-party financial institutions the stated amounts of confirmed invoices from suppliers on the original maturity dates of the invoices.
Sales Recognition	SALES RECOGNITION Product and service sales are recognized when or as the Company transfers control of the promised products or services to its customers. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Service sales, principally representing repair, maintenance, and engineering activities, are recognized over the contractual period or as services are rendered. Sales under long-term contracts with performance obligations satisfied over time are recognized using either an input or output method. The Company recognizes revenue over time as the Company performs on these contracts because of the continuous transfer of control to the customer. With control transferring over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. The Company generally uses the cost-to-cost input method of progress for contracts because it best depicts the transfer of control to the customer that occurs as the Company incurs costs. Under the cost-to-cost input method, the extent of progress towards completion is measured based on the proportion of costs incurred to date to the total estimated costs at completion of the performance obligation. The Company reviews its cost estimates on significant contracts on a periodic basis, or when circumstances change and warrant a modification to a previous estimate. Cost estimates are largely based on negotiated or estimated purchase contract terms, historical performance trends, and other economic projections. Significant factors that influence these estimates include inflationary trends, technical and schedule risks, internal and subcontractor performance trends, business volume assumptions, asset utilization, and anticipated labor agreements. Provisions for anticipated losses on long-term contracts are recorded in full when such losses become evident, to the extent required. The customer funding for costs incurred for nonrecurring engineering and development activities of the Company's products under agreements with commercial customers is deferred and subsequently recognized as revenue as products are delivered to the customers. Additionally, expenses incurred, up to the customer agreed funded amount, are deferred as an asset and recognized as cost of sales when products are delivered to the customer. The deferred customer funding and costs result in recognition of deferred costs (asset) and deferred revenue (liability) within Other assets and Accrued liabilities, respectively, in the Consolidated Balance Sheet. Deferred contract fulfillment costs were approximately $1.2 billion and $1.3 billion as of December 31, 2023, and 2022, respectively. The amounts recognized as Cost of products and services sold were approximately $0.1 billion for the year ended December 31, 2023, and $0.2 billion and $0.1 billion for 2022 and 2021, respectively. Revenues for the Company's mechanical service programs are recognized as performance obligations that are satisfied over time, with recognition reflecting a series of distinct services using the output method. The terms of a contract or the historical business practice can give rise to variable consideration due to, but not limited to, cash-based incentives, rebates, performance awards, or credits. The Company estimates variable consideration at the most likely amount the Company will receive from customers. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The Company's estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company's anticipated performance and all information (historical, current and forecasted) that is reasonably available to the Company.
Stock-Based Compensation Plans	STOCK-BASED COMPENSATION PLANS The principal awards issued under the Company's stock-based compensation plans, which are described in Note 15 Stock-Based Compensation Plans, are non-qualified stock options and restricted stock units. The cost for such awards is measured at the grant date based on the fair value of the award. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods (generally the vesting period of the equity award) and is included in Selling, general and administrative expenses. Forfeitures are estimated at the time of grant to recognize expense for those awards expected to vest and are based on the Company's historical forfeiture rates.
Income Taxes	INCOME TAXES Significant judgment is required in evaluating tax positions. The Company establishes reserves for income taxes when, despite the belief that tax positions are fully supportable, certain positions remain that do not meet the minimum recognition threshold. The approach for evaluating certain and uncertain tax positions is defined by the authoritative guidance which determines when a tax position is more likely than not to be sustained upon examination by the applicable taxing authority. In the normal course of business, the Company and its subsidiaries are examined by various federal, state, and foreign tax authorities. The Company regularly assesses the potential outcomes of these examinations and any future examinations for the current or prior years in determining the adequacy of the Company's provision for income taxes. The Company continually assesses the likelihood and amount of potential adjustments and adjusts the income tax provision, the current tax liability, and deferred taxes in the period in which the facts that give rise to a change in estimate become known. See Note 5 Income Taxes for additional information.
Earnings Per Share	EARNINGS PER SHARE Basic earnings per share is based on the weighted average number of common shares outstanding. Diluted earnings per share is based on the weighted average number of common shares outstanding and all dilutive potential common shares outstanding.
Environmental	ENVIRONMENTAL The Company accrues costs related to environmental matters when it is probable that it has incurred a liability related to a contaminated site and the amount can be reasonably estimated. See Note 19 Commitments and Contingencies for additional information.
Reimbursement Receivables	REIMBURSEMENT RECEIVABLES In conjunction with the Resideo Technologies, Inc. (Resideo) spin-off, the Company entered into a reimbursement agreement under which Honeywell receives cash payments as reimbursement primarily related to net spending for environmental matters at certain sites as defined in the reimbursement agreement. Accordingly, the Company recorded receivables based on estimates of the underlying reimbursable Honeywell environmental spend, and the Company monitors the recoverability of such receivables, which are subject to the terms of applicable credit agreements and general ability to pay.
Asbestos Related Liabilities and Insurance Recoveries	ASBESTOS-RELATED LIABILITIES AND INSURANCE RECOVERIES The Company recognizes a liability for any asbestos-related contingency that is probable of occurrence and reasonably estimable. In connection with the recognition of liabilities for asbestos-related matters, the Company records asbestos-related insurance recoveries that are deemed probable. See Note 19 Commitments and Contingencies for additional information.
Revenue from Contract with Customer	Aerospace Technologies – A global supplier of products, software, and services for aircrafts that it sells to original equipment manufacturers (OEM) and other customers in a variety of end markets including: air transport, regional, business and general aviation aircraft, airlines, aircraft operators, and defense and space contractors. Aerospace Technologies products and services include auxiliary power units, propulsion engines, environmental control systems, integrated avionics, wireless connectivity services, electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, management and technical services, advanced systems and instruments, satellite and space components, aircraft wheels and brakes, and thermal systems. Aerospace Technologies also provides spare parts, repair, overhaul, and maintenance services (principally to aircraft operators), and sells licenses or intellectual property to other parties. Our Honeywell Forge solutions enable our customers to turn data into predictive maintenance and predictive analytics to enable better fleet management and make flight operations more efficient. Industrial Automation – A global provider of industrial automation solutions that deliver intelligent, sustainable, and secure operations for customers in oil and gas, petrochemicals, life sciences, metals and mining, and warehouse and logistics segments. With millions of installed assets, Industrial Automation deploys outcome-based solutions to increase asset utilization; improve operational efficiency and labor productivity; reduce carbon emissions with less energy consumption; and enhance cyber security for critical infrastructure and operational assets. Industrial Automation offerings include automation control and instrumentation products and services; smart energy products; sensing technologies with an array of custom-engineered sensors and services; gas detection technologies and personal protective equipment; and system design, advanced automation equipment, software and analytics for manufacturing, distribution and fulfillment operations. These products and services are combined with proprietary machine learning and artificial intelligence algorithms in products and projects which are digitally enabled through our industry leading industrial Internet of Things (IoT) platform, Honeywell Forge. Building Automation – A global provider of products, software, solutions, and technologies that enable building owners and occupants to ensure their facilities are safe, energy efficient, sustainable, and productive. Building Automation products and services include advanced software applications for building control and optimization; sensors, switches, control systems, and instruments for energy management; access control; video surveillance; fire products; and installation, maintenance, and upgrades of systems. Our Honeywell Forge solutions enable our customers to digitally manage buildings, connecting data from different assets to enable smart maintenance, improve building performance, and even protect from incoming security threats. Energy and Sustainability Solutions – A global provider of industry leading technology, processing, and licensing capabilities combined with material science capabilities and innovative chemistry to offer focused solutions that are integral to facilitating the world's energy transition. The reportable business segment is comprised of UOP and Advanced Materials business units. The UOP business provides sustainable aviation fuels, petrochemical & refining technologies, and carbon management solutions across multiple sectors through process technology solutions, products, including catalysts and adsorbents, equipment and aftermarket services. The Advanced Materials business provides customers with its Solstice lower global warming potential refrigeration and heating solutions, Spectra fibers for high end protective armor and medical applications, and leading-edge semiconductor materials. Our Honeywell Forge solutions serve customer asset productivity and efficiency needs by providing connectivity, data integration, and software solutions to generate a holistic view of their operations. Corporate and All Other – Corporate and All Other includes revenue from Honeywell's majority-owned investment in Quantinuum. Through Quantinuum, Honeywell provides a wide range of service offerings of fully integrated quantum computing hardware and software solutions. See Note 22 Segment Financial Data for a summary by disaggregated product and services sales for each reportable business segment. The Company tracks progress on satisfying performance obligations under contracts with customers. The related billings and cash collections are recorded in the Consolidated Balance Sheet in Accounts receivable—net and Other assets (unbilled receivables (contract assets) and billed receivables), and Accrued liabilities and Other liabilities (customer advances and deposits (contract liabilities)). Unbilled receivables arise when the timing of cash collected from customers differs from the timing of revenue recognition, such as when contract provisions require specific milestones to be met before a customer can be billed. Contract assets are recognized when the revenue associated with the contract is recognized prior to billing and derecognized when billed in accordance with the terms of the contract. Contract liabilities are recorded when customers remit contractual cash payments in advance of the Company satisfying performance obligations under contractual arrangements, including those with performance obligations to be satisfied over a period of time. Contract liabilities are derecognized when revenue is recorded, either when a milestone is met triggering the contractual right to bill or when the performance obligation is satisfied.

REVENUE RECOGNITION AND CONTR_2

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS (Tables)	12 Months Ended
	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation Of Revenue	See the following disaggregated revenue table and related discussions by reportable business segment for details: Years Ended December 31, 2023 2022 2021 Aerospace Technologies Commercial Aviation Original Equipment $ 2,397 $ 2,089 $ 1,720 Commercial Aviation Aftermarket 6,241 5,108 4,155 Defense and Space 4,986 4,630 5,151 Net Aerospace Technologies sales 13,624 11,827 11,026 Industrial Automation Sensing and Safety Technologies 2,733 2,860 3,123 Productivity Solutions and Services 1,313 1,739 1,778 Process Solutions 5,267 4,731 4,611 Warehouse and Workflow Solutions 1,443 2,308 2,913 Net Industrial Automation sales 10,756 11,638 12,425 Building Automation Products 3,583 3,638 3,173 Building Solutions 2,448 2,362 2,366 Net Building Automation sales 6,031 6,000 5,539 Energy and Sustainability Solutions UOP 2,586 2,404 2,348 Advanced Materials 3,653 3,592 3,054 Net Energy and Sustainability Solutions sales 6,239 5,996 5,402 Corporate and All Other 12 5 — Net sales $ 36,662 $ 35,466 $ 34,392 Years Ended December 31, 2023 2022 2021 Products, transferred point in time 58 % 59 % 58 % Products, transferred over time 12 14 17 Net product sales 70 73 75 Services, transferred point in time 10 8 8 Services, transferred over time 20 19 17 Net service sales 30 27 25 Net sales 100 % 100 % 100 %
Contract with Customer, Asset and Liability	The following table summarizes the Company's contract assets and liabilities balances: 2023 2022 Contract assets—January 1 $ 2,294 $ 2,060 Contract assets—December 31 2,013 2,294 Change in contract assets—increase (decrease) (281) 234 Contract liabilities—January 1 (4,583) (4,290) Contract liabilities—December 31 (4,326) (4,583) Change in contract liabilities—decrease (increase) 257 (293) Net change $ (24) $ (59)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction	The following table outlines the Company's remaining performance obligations disaggregated by reportable business segment: December 31, 2023 Aerospace Technologies $ 13,898 Industrial Automation 6,227 Building Automation 7,302 Energy and Sustainability Solutions 4,303 Corporate and All Other 1 47 Total performance obligations 2 $ 31,777 1 The remaining performance obligations within Corporate and All Other relate to the Quantinuum business. 2 Effective March 31, 2022, performance obligations exclude contracts with customers related to Russia as collectability is not reasonably assured.

REPOSITIONING AND OTHER CHARG_2

REPOSITIONING AND OTHER CHARGES (Tables)	12 Months Ended
	Dec. 31, 2023
Restructuring and Related Activities [Abstract]
Repositioning And Other Charges	A summary of net repositioning and other charges follows: Years Ended December 31, 2023 2022 2021 Severance $ 162 $ 122 $ 80 Asset impairments 41 176 117 Exit costs 139 122 134 Reserve adjustments (56) (56) (13) Total net repositioning charges 286 364 318 Asbestos-related charges, net of insurance and reimbursements 534 532 129 Probable and reasonably estimable environmental liabilities, net of reimbursements 44 28 22 Other charges (4) 342 100 Total net repositioning and other charges $ 860 $ 1,266 $ 569
Pretax Distribution Of Total Net Repositioning And Other Charges	The following table summarizes the pre-tax distribution of total net repositioning and other charges by classification in the Consolidated Statement of Operations: Years Ended December 31, 2023 2022 2021 Cost of products and services sold $ 680 $ 572 $ 457 Selling, general and administrative expenses 172 309 112 Other (income) expense 8 385 — Total net repositioning and other charges $ 860 $ 1,266 $ 569
Pretax Impact of Total Net Repositioning and Other Charges by Segment	The following table summarizes the pre-tax amount of total net repositioning and other charges by reportable business segment. These amounts are excluded from segment profit as described in Note 22 Segment Financial Data: Years Ended December 31, 2023 2022 2021 Aerospace Technologies $ 23 $ 41 $ 62 Industrial Automation 139 395 280 Building Automation 58 63 13 Energy and Sustainability Solutions 23 125 12 Corporate and All Other 617 642 202 Total net repositioning and other charges $ 860 $ 1,266 $ 569
Total Repositioning Reserves	The following table summarizes the status of the Company's total repositioning reserves: Severance Asset Exit Total Balance at December 31, 2020 $ 527 $ — $ 74 $ 601 Charges 80 117 134 331 Usage—cash (299) — (83) (382) Usage—noncash — (119) — (119) Divestitures — — — — Adjustments (14) 2 (1) (13) Foreign currency translation (5) — (2) (7) Balance at December 31, 2021 289 — 122 411 Charges 122 176 122 420 Usage—cash (135) — (140) (275) Usage—noncash — (168) (15) (183) Divestitures — — — — Adjustments (42) (8) (6) (56) Foreign currency translation 1 — (9) (8) Balance at December 31, 2022 235 — 74 309 Charges 162 41 139 342 Usage—cash (173) — (121) (294) Usage—noncash — (36) — (36) Divestitures — (4) (5) (9) Adjustments (42) (1) (13) (56) Foreign currency translation 6 — 17 23 Balance at December 31, 2023 $ 188 $ — $ 91 $ 279

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Income Before Taxes	Years Ended December 31, 2023 2022 2021 U.S. $ 2,368 $ 3,305 $ 3,955 Non-U.S. 4,791 3,074 3,280 Total Income before taxes $ 7,159 $ 6,379 $ 7,235
Tax Expense (Benefit)	Tax expense (benefit) consists of: Years Ended December 31, 2023 2022 2021 Current U.S. Federal $ 176 $ 653 $ 415 U.S. State 60 124 146 Non-U.S. 1,098 815 886 Total current tax expense (benefit) 1,334 1,592 1,447 Deferred U.S. Federal 27 (175) 173 U.S. State 11 (36) 37 Non-U.S. 115 32 (32) Total deferred tax expense (benefit) 153 (180) 178 Total Tax expense $ 1,487 $ 1,412 $ 1,625 The U.S. federal statutory income tax rate is reconciled to the effective income tax rate as follows: Years Ended December 31, 2023 2022 2021 U.S. federal statutory income tax rate 21.0 % 21.0 % 21.0 % Taxes on non-U.S. earnings 1,2,3 (2.0) (0.4) (1.4) U.S. state income taxes 1 0.5 1.4 1.5 Reserves for tax contingencies 3.4 1.1 2.2 Employee share-based payments (0.3) (0.9) (0.7) Restructuring — 0.7 (1.4) U.S. federal tax credits (1.6) (0.9) (0.6) U.S. valuation allowance (0.1) (0.2) 2.0 All other items—net (0.1) 0.3 (0.1) Effective income tax rate 20.8 % 22.1 % 22.5 % 1 Net of changes in valuation allowance. 2 Includes U.S. taxes on non-U.S. earnings, net of foreign tax credits. 3 2023 includes (3.6)% deferred tax benefit resulting from a non-U.S. legislative change, offset by 3.6% deferred tax expense resulting from a full valuation allowance.
Deferred Tax Assets (Liabilities)	The tax effects of temporary differences and tax carryforwards which give rise to future income tax benefits and payables are as follows: Deferred tax assets December 31, 2023 2022 Postretirement benefits other than pensions $ 55 $ 59 Asbestos and environmental 405 545 Capitalized research and development 582 — Employee compensation and benefits 148 142 Lease liabilities 258 233 Other accruals and reserves 196 363 Net operating losses 687 695 Capital loss limitation and carryover 385 126 Tax credit carryforwards and other attributes 420 163 Gross deferred tax assets 3,136 2,326 Valuation allowance (1,292) (812) Total deferred tax assets 1,844 1,514 Deferred tax liabilities Pension (1,132) (1,088) Property, plant and equipment (441) (233) Right-of-use asset (240) (212) Intangibles (817) (818) Unremitted earnings of foreign subsidiaries (542) (517) Other asset basis differences (369) (317) Other (5) (1) Total deferred tax liabilities (3,546) (3,186) Net deferred tax liability $ (1,702) $ (1,672)
Summary of Operating Loss Carryforwards	As of December 31, 2023, the Company's net operating loss, capital loss, tax credit carryforwards, and other attributes were as follows: Jurisdiction Net Operating Tax Credit Carryforwards and Other Attributes U.S. Federal $ 532 $ 96 U.S. State 675 25 Non-U.S. 3,720 304 Total $ 4,927 $ 425
Change in Unrecognized Tax Benefits	Many jurisdictions impose limitations on the timing and utilization of net operating loss and tax credit carryforwards. Approximately $3,140 million of the non-U.S. net operating loss has no expiration period. The U.S. federal capital loss carryforward of $502 million expires in 2026. The remaining net operating loss, capital loss and credit carryforwards, and other tax attributes have expiration periods through 2043. Years Ended December 31, 2023 2022 2021 Change in unrecognized tax benefits Balance at beginning of year $ 1,086 $ 1,061 $ 991 Gross increases related to current period tax positions 89 64 93 Gross increases related to prior periods tax positions 181 31 39 Gross decreases related to prior periods tax positions — (19) (27) Decrease related to resolutions of audits with tax authorities (132) (3) (1) Expiration of the statute of limitations for the assessment of taxes (3) (8) (12) Foreign currency translation 4 (40) (22) Balance at end of year $ 1,225 $ 1,086 $ 1,061
Summary of Income Tax Examinations	The following table summarizes tax years that remain subject to examination by major tax jurisdictions as of December 31, 2023: Jurisdiction Open Tax Years Examination in progress Examination not yet initiated U.S. Federal 2017-2021 2022-2023 U.S. State 2013-2021 2022-2023 China 2013-2022 2023 Germany 2013-2020 2021-2023 India 2013-2020 2021-2023 Puerto Rico N/A 2020-2023 Switzerland 2019-2020 2021-2023 United Kingdom 2013-2021 2022-2023

INVENTORIES (Tables)

INVENTORIES (Tables)	12 Months Ended
	Dec. 31, 2023
Inventory Disclosure [Abstract]
Inventories	December 31, 2023 2022 Raw materials $ 1,704 $ 1,407 Work in process 1,217 1,049 Finished products 3,257 3,082 Total Inventories $ 6,178 $ 5,538

PROPERTY, PLANT AND EQUIPMENT_2

PROPERTY, PLANT AND EQUIPMENT-NET (Tables)	12 Months Ended
	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment - Net	December 31, 2023 2022 Land and improvements $ 211 $ 216 Machinery and equipment 10,717 10,383 Buildings and improvements 3,528 3,394 Construction in progress 878 769 Total Property, plant and equipment 15,334 14,762 Less—Accumulated depreciation (9,674) (9,291) Total Property, plant and equipment—net $ 5,660 $ 5,471

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS-NET (Tables)	12 Months Ended
	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table summarizes the change in the carrying amount of goodwill for the years ended December 31, 2023, and 2022, by reportable business segment: December 31, 2022 Acquisitions/ Currency December 31, 2023 Aerospace Technologies $ 2,376 $ — $ 10 $ 2,386 Industrial Automation 9,183 392 75 9,650 Building Automation 3,338 — 42 3,380 Energy and Sustainability Solutions 1,726 — 1 1,727 Corporate and All Other 874 — 32 906 Total Goodwill $ 17,497 $ 392 $ 160 $ 18,049
Other Intangible Assets	Other intangible assets are comprised of: December 31, 2023 December 31, 2022 Gross Accumulated Net Gross Accumulated Net Definite-life intangibles Patents and technology $ 2,399 $ (1,837) $ 562 $ 2,313 $ (1,759) $ 554 Customer relationships 4,199 (2,601) 1,598 3,989 (2,397) 1,592 Trademarks 362 (284) 78 371 (273) 98 Other 299 (277) 22 299 (274) 25 Total definite-life intangibles—net 7,259 (4,999) 2,260 6,972 (4,703) 2,269 Indefinite-life intangibles Trademarks 971 — 971 953 — 953 Total Other intangible assets—net $ 8,230 $ (4,999) $ 3,231 $ 7,925 $ (4,703) $ 3,222

LONG-TERM DEBT AND CREDIT AGR_2

LONG-TERM DEBT AND CREDIT AGREEMENTS (Tables)	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Long-Term Debt and Credit Agreements	December 31, 2023 2022 1.30% Euro notes due 2023 $ — $ 1,334 3.35% notes due 2023 — 300 0.00% Euro notes due 2024 547 534 2.30% notes due 2024 750 750 4.85% notes due 2024 400 400 1.35% notes due 2025 1,250 1,250 2.50% notes due 2026 1,500 1,500 1.10% notes due 2027 1,000 1,000 3.50% Euro notes due 2027 711 — 4.95% notes due 2028 500 500 2.25% Euro notes due 2028 820 800 4.25% notes due 2029 750 — 2.70% notes due 2029 750 750 1.95% notes due 2030 1,000 1,000 1.75% notes due 2031 1,500 1,500 0.75% Euro notes due 2032 547 534 3.75% Euro notes due 2032 547 — 5.00% notes due 2033 1,100 1,100 4.50% notes due 2034 1,000 — 4.125% Euro notes due 2034 1,094 1,067 5.70% notes due 2036 441 441 5.70% notes due 2037 462 462 5.375% notes due 2041 417 417 3.812% notes due 2047 442 445 2.80% notes due 2050 750 750 Industrial development bond obligations, floating rate maturing at various dates through 2037 22 22 6.625% debentures due 2028 201 201 9.065% debentures due 2033 51 51 Other (including capitalized leases), 7.0% weighted average interest rate maturing at various dates through 2029 217 265 Fair value of hedging instruments (166) (287) Debt issuance costs (245) (233) Total Long-term debt and current related maturities 18,358 16,853 Less: Current maturities of long-term debt 1,796 1,730 Total Long-term debt $ 16,562 $ 15,123
Principal Payments on Long-Term Debt	The schedule of principal payments on long-term debt is as follows: December 31, 2023 2024 $ 1,796 2025 1,314 2026 1,528 2027 1,718 2028 1,527 Thereafter 10,475 Total Long-term debt and current related maturities 18,358 Less: Current maturities of long-term debt 1,796 Total Long-term debt $ 16,562

LEASES (Tables)

LEASES (Tables)	12 Months Ended
	Dec. 31, 2023
Leases [Abstract]
Schedule of Leases	Years Ended December 31, 2023 2022 Operating lease cost $ 239 $ 224 Variable lease cost 4 8 Short-term lease cost 13 18 Finance lease cost Amortization of right-of-use assets 74 72 Interest on lease liability 19 21 Total finance lease cost 93 93 Total lease cost $ 349 $ 343
Supplemental Cash Flow Information	Supplemental cash flow information related to leases was as follows: Years Ended December 31, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows for operating leases $ 237 $ 225 Operating cash flows for finance leases 19 21 Financing cash flows for finance leases 87 79 Right-of-use assets obtained in exchange for lease obligations Operating leases $ 339 $ 251 Finance leases 42 61
Supplemental Balance Sheet Information	Supplemental balance sheet information related to leases was as follows: December 31, 2023 2022 Operating leases Other assets $ 1,004 $ 881 Accrued liabilities 196 192 Other liabilities 897 775 Total operating lease liabilities $ 1,093 $ 967 Finance leases Property, plant and equipment $ 402 $ 383 Accumulated depreciation (204) (161) Property, plant and equipment—net $ 198 $ 222 Current maturities of long-term debt $ 86 $ 77 Long-term debt 99 145 Total finance lease liabilities $ 185 $ 222 Weighted average remaining lease term Operating leases 9 years 8 years Finance leases 3 years 4 years Weighted average discount rate Operating leases 3.0 % 2.1 % Finance leases 8.5 % 7.8 %
Maturities of Lease Liabilities	As of December 31, 2023, maturities of lease liabilities were as follows: Operating Leases Finance Leases 2024 $ 222 $ 98 2025 185 53 2026 155 24 2027 131 12 2028 105 11 Thereafter 443 7 Total lease payments 1,241 205 Less: Interest 148 20 Total maturities of lease liabilities $ 1,093 $ 185

DERIVATIVE INSTRUMENTS AND HE_2

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS (Tables)	12 Months Ended
	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The following table summarizes the notional amounts and fair values of the Company’s outstanding derivatives by risk category and instrument type within the Consolidated Balance Sheet: Notional Fair Value Asset Fair Value (Liability) December 31, 2023 December 31, 2022 December 31, 2023 December 31, 2022 December 31, 2023 December 31, 2022 Derivatives in fair value hedging relationships Interest rate swap agreements $ 4,717 $ 4,984 $ 18 $ 16 $ (184) $ (303) Derivatives in cash flow hedging relationships Foreign currency exchange contracts 712 866 28 19 (4) (5) Commodity contracts 6 9 — — (1) (1) Derivatives in net investment hedging relationships Cross currency swap agreements 4,264 3,189 — 90 (145) — Total derivatives designated as hedging instruments 9,699 9,048 46 125 (334) (309) Derivatives not designated as hedging instruments Foreign currency exchange contracts 8,198 9,679 7 74 (5) (3) Total derivatives at fair value $ 17,897 $ 18,727 $ 53 $ 199 $ (339) $ (312)
Schedule of Derivative Instruments	The following table sets forth the amounts recorded in the Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges: Carrying Amount Cumulative Amount of December 31, 2023 December 31, 2022 December 31, 2023 December 31, 2022 Long-term debt $ 4,551 $ 4,696 $ (166) $ (287)
Derivative Instruments, Gain (Loss)	The following tables summarize the location and impact to the Consolidated Statement of Operations related to derivative instruments: Year Ended December 31, 2023 Net Sales Cost of Cost of Selling, General and Administrative Expenses Other (Income) Expense Interest and Other $ 36,662 $ 16,977 $ 6,018 $ 5,127 $ (840) $ 765 Gain or (loss) on cash flow hedges Foreign currency exchange contracts Amount reclassified from accumulated other comprehensive income (loss) into income 15 28 10 10 — — Gain or (loss) on fair value hedges Interest rate swap agreements Hedged items — — — — — (121) Derivatives designated as hedges — — — — — 121 Gain or (loss) on derivatives not designated as hedging instruments Foreign currency exchange contracts — — — — (116) — Year Ended December 31, 2022 Net Sales Cost of Cost of Services Sold Selling, General and Administrative Expenses Other (Income) Expense Interest and Other $ 35,466 $ 16,955 $ 5,392 $ 5,214 $ (366) $ 414 Gain or (loss) on cash flow hedges Foreign currency exchange contracts Amount reclassified from accumulated other comprehensive income (loss) into income 13 50 14 (3) — — Commodity Contracts Amount reclassified from accumulated other comprehensive income (loss) into income — (2) — — — — Gain or (loss) on fair value hedges Interest rate swap agreements Hedged items — — — — — 347 Derivatives designated as hedges — — — — — (347) Gain or (loss) on net investment hedges Foreign currency exchange contracts Amount excluded from effectiveness testing recognized in earnings using an amortization approach — — — — — 13 Gain or (loss) on derivatives not designated as hedging instruments Foreign currency exchange contracts — — — — 351 — Year Ended December 31, 2021 Net Sales Cost of Cost of Services Sold Selling, General and Administrative Expenses Other (Income) Expense Interest and Other $ 34,392 $ 17,082 $ 4,979 $ 4,798 $ (1,378) $ 343 Gain or (loss) on cash flow hedges Foreign currency exchange contracts Amount reclassified from accumulated other comprehensive income (loss) into income 5 8 2 9 — — Gain or (loss) on fair value hedges Interest rate swap agreements Hedged items — — — — — 135 Derivatives designated as hedges — — — — — (135) Gain or (loss) on net investment hedges Foreign currency exchange contracts Amount excluded from effectiveness testing recognized in earnings using an amortization approach — — — — — 16 Gain or (loss) on derivatives not designated as hedging instruments Foreign currency exchange contracts — — — — 195 —
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)	The following table summarizes the amount of gain or (loss) on net investment hedges recognized in Accumulated other comprehensive income (loss): Years Ended December 31, 2023 2022 Euro-denominated long-term debt $ (84) $ 196 Euro-denominated commercial paper (42) 39 Cross currency swap agreements (193) (65) Foreign currency exchange contracts — 34

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis	The following table sets forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis: December 31, 2023 December 31, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets Foreign currency exchange contracts $ — $ 35 $ — $ 35 $ — $ 93 $ — $ 93 Available for sale investments 63 217 — 280 87 559 — 646 Interest rate swap agreements — 18 — 18 — 16 — 16 Cross currency swap agreements — — — — — 90 — 90 Investments in equity securities 22 — — 22 22 32 — 54 Right to HWI Net Sale Proceeds — — 9 9 — — 295 295 Total assets $ 85 $ 270 $ 9 $ 364 $ 109 $ 790 $ 295 $ 1,194 Liabilities Foreign currency exchange contracts $ — $ 9 — $ 9 $ — $ 8 — $ 8 Interest rate swap agreements — 184 — 184 — 303 — 303 Commodity contracts — 1 — 1 — 1 — 1 Cross currency swap agreements — 145 — 145 — — — — Total liabilities $ — $ 339 $ — $ 339 $ — $ 312 $ — $ 312
Schedule of Fair Value Using Level 3 Measurements	The following table sets forth a reconciliation of beginning and ending balances of assets and liabilities that were accounted for at fair value using level 3 measurements: Years Ended December 31, 2023 2022 Balance at beginning of period $ 295 $ — Recognition of right to HWI Net Sale Proceeds — 295 Receipt of HWI Net Sale Proceeds (275) — Fair value adjustment of HWI Net Sale Proceeds (11) — Balance at end of period $ 9 $ 295
Financial Assets and Liabilities That Were Not Carried at Fair Value	The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value: December 31, 2023 December 31, 2022 Carrying Fair Carrying Fair Assets Long-term receivables $ 232 $ 173 $ 229 $ 183 Liabilities Long-term debt and related current maturities 18,358 17,706 16,853 15,856

ACCRUED LIABILITIES (Tables)

ACCRUED LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2023
Accrued Liabilities, Current [Abstract]
Schedule of Accrued Liabilities	December 31, 2023 2022 Customer advances and deferred income $ 3,499 $ 3,555 Compensation, benefit and other employee related 1,322 1,218 Repositioning 279 309 Asbestos-related liabilities 154 110 Income taxes 680 549 Other taxes 176 174 Environmental costs 227 222 Operating lease liabilities 196 192 Product warranties and performance guarantees 182 175 Insurance 69 68 Accrued interest 217 122 NARCO Buyout accrual — 1,325 Other (primarily operating expenses) 808 1,143 Total Accrued liabilities $ 7,809 $ 9,162

OTHER LIABILITIES (Tables)

OTHER LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2023
Other Liabilities Disclosure [Abstract]
Other Liabilities	December 31, 2023 2022 Income taxes $ 1,742 $ 1,939 Pension and other employee related 1,342 1,306 Deferred income 1,171 1,334 Operating lease liabilities 897 775 Environmental costs 414 393 Insurance 248 289 Product warranties and performance guarantees 37 38 Asset retirement obligations 17 24 Other 397 371 Total Other liabilities $ 6,265 $ 6,469

STOCK-BASED COMPENSATION PLANS

STOCK-BASED COMPENSATION PLANS (Tables)	12 Months Ended
	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Income Statement Impact from Stock Options	The following table summarizes the impact to the Consolidated Statement of Operations from stock options: Years Ended December 31, 2023 2022 2021 Compensation expense $ 48 $ 45 $ 55 Future income tax benefit recognized 11 10 11
Share-based Compensation Fair Value Assumptions	The following table sets forth fair value per share information, including related weighted average assumptions, used to determine compensation cost: Years Ended December 31, 2023 2022 2021 Weighted average fair value per share of options granted during the year 1 $ 38.84 $ 31.22 $ 32.42 Assumptions Expected annual dividend yield 2.50 % 2.58 % 2.31 % Expected volatility 22.42 % 23.05 % 24.69 % Risk-free rate of return 3.94 % 1.97 % 0.48 % Expected option term (years) 4.86 4.74 4.54 1 Estimated on date of grant using Black-Scholes option-pricing model.
Stock Options Activity	The following table summarizes information about stock option activity for the three years ended December 31, 2023: Number of Weighted Average Outstanding at December 31, 2020 16,568,529 $ 125.75 Granted 2,065,574 204.99 Exercised (2,016,489) 113.01 Lapsed or canceled (764,675) 175.42 Outstanding at December 31, 2021 15,852,939 135.31 Granted 2,150,910 189.53 Exercised (3,046,107) 103.89 Lapsed or canceled (905,454) 186.35 Outstanding at December 31, 2022 14,052,288 147.14 Granted 1,573,520 195.27 Exercised (1,640,952) 123.12 Lapsed or canceled (548,842) 192.22 Outstanding at December 31, 2023 13,436,014 $ 153.86 Vested and expected to vest at December 31, 2023 1 12,420,005 $ 150.58 Exercisable at December 31, 2023 9,593,986 $ 138.24 1 Represents the sum of vested options of 9.6 million and expected to vest options of 2.8 million. Expected to vest options are derived by applying the pre-vesting forfeiture rate assumption to total outstanding unvested options of 3.8 million.
Schedule of Share Based Compensation by Price Ranges	The following table summarizes information about stock options outstanding and exercisable at December 31, 2023: Range of Exercise Prices Options Outstanding Options Exercisable Number Weighted Average Life 1 Weighted Average Exercise Price Per Share Aggregate Number Weighted Average Exercise Price Per Share Aggregate $65.00–$89.99 687,158 0.16 $ 89.46 $ 83 687,158 $ 89.46 $ 83 $90.00–$99.99 2,285,249 1.52 98.79 253 2,285,249 98.79 253 $100.00–$134.99 1,814,529 3.02 119.30 164 1,787,835 119.15 163 $135.00–$189.99 5,737,860 5.83 170.92 222 4,078,279 164.61 209 $190.00–$232.60 2,911,218 8.02 200.23 30 755,465 204.77 22 13,436,014 4.90 $ 153.86 $ 752 9,593,986 $ 138.24 $ 730 1 Average remaining contractual life in years.
Financial Statement Impact From Stock Options Exercised	The following table summarizes the financial statement impact from stock options exercised: Years Ended December 31, 2023 2022 2021 Intrinsic value 1 $ 122 $ 310 $ 219 Tax benefit realized 27 71 48 1 Represents the amount by which the stock price exceeded the exercise price of the options on the date of exercise.
Restricted Stock Units Activity	The following table summarizes information about RSU activity for the three years ended December 31, 2023: Number of Weighted Non-vested at December 31, 2020 3,396,523 $ 148.23 Granted 992,854 214.61 Vested (1,123,547) 144.34 Forfeited (308,293) 156.74 Non-vested at December 31, 2021 2,957,536 171.73 Granted 1,056,869 186.48 Vested (864,944) 157.21 Forfeited (441,453) 177.38 Non-vested at December 31, 2022 2,708,008 181.10 Granted 1,109,307 194.81 Vested (919,496) 171.92 Forfeited (290,982) 187.13 Non-vested at December 31, 2023 2,606,837 $ 189.18
Income Statement Impact from RSUs	The following table summarizes the impact to the Consolidated Statement of Operations from RSUs: Years Ended December 31, 2023 2022 2021 Compensation expense $ 154 $ 143 $ 162 Future income tax benefit recognized 32 29 23

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2023
Earnings Per Share [Abstract]
Earnings Per Share Basic	The details of the earnings per share calculations for the years ended December 31, 2023, 2022, and 2021, are as follows (shares in millions): Basic Years Ended December 31, 2023 2022 2021 Net income attributable to Honeywell $ 5,658 $ 4,966 $ 5,542 Weighted average shares outstanding 663.0 677.1 692.3 Earnings per share of common stock—basic $ 8.53 $ 7.33 $ 8.01
Earnings Per Share Diluted	Assuming Dilution Years Ended December 31, 2023 2022 2021 Net income attributable to Honeywell $ 5,658 $ 4,966 $ 5,542 Average shares Weighted average shares outstanding 663.0 677.1 692.3 Dilutive securities issuable—stock plans 5.2 6.0 8.1 Total weighted average diluted shares outstanding 668.2 683.1 700.4 Earnings per share of common stock—assuming dilution $ 8.47 $ 7.27 $ 7.91

ACCUMULATED OTHER COMPREHENSI_2

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)	12 Months Ended
	Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The changes in Accumulated other comprehensive income (loss) are provided in the tables below. Comprehensive income (loss) attributable to noncontrolling interest consists predominantly of net income. Pre-tax Tax After-Tax Year Ended December 31, 2023 Foreign exchange translation adjustment $ (269) $ — $ (269) Pension and other postretirement benefit adjustments (538) 131 (407) Changes in fair value of available for sale investments 5 — 5 Changes in fair value of cash flow hedges 17 (6) 11 Total net current period other comprehensive income (loss) $ (785) $ 125 $ (660) Year Ended December 31, 2022 Foreign exchange translation adjustment $ (354) $ — $ (354) Pension and other postretirement benefit adjustments (280) 47 (233) Changes in fair value of available for sale investments (8) — (8) Changes in fair value of cash flow hedges 9 6 15 Total net current period other comprehensive income (loss) $ (633) $ 53 $ (580) Year Ended December 31, 2021 Foreign exchange translation adjustment $ 302 $ — $ 302 Pension and other postretirement benefit adjustments 245 (59) 186 Changes in fair value of available for sale investments (3) — (3) Changes in fair value of cash flow hedges (4) 1 (3) Total net current period other comprehensive income (loss) $ 540 $ (58) $ 482
Components Of Accumulated Other Comprehensive Income (Loss)	COMPONENTS OF ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) December 31, 2023 2022 Cumulative foreign exchange translation adjustment $ (3,101) $ (2,832) Pension and other postretirement benefit adjustments (1,055) (648) Fair value adjustments of available for sale investments (2) (7) Fair value adjustments of cash flow hedges 23 12 Total Accumulated other comprehensive income (loss) $ (4,135) $ (3,475)
Change In Accumulated Other Comprehensive Income (Loss) By Component	CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) BY COMPONENT Foreign Pension Changes in Changes in Total Balance at December 31, 2020 $ (2,780) $ (601) $ 4 $ — $ (3,377) Other comprehensive income (loss) before reclassifications 314 268 (3) 17 596 Amounts reclassified from accumulated other comprehensive income (loss) (12) (82) — (20) (114) Net current period other comprehensive income (loss) 302 186 (3) (3) 482 Balance at December 31, 2021 (2,478) (415) 1 (3) (2,895) Other comprehensive income (loss) before reclassifications (344) (623) (8) 71 (904) Amounts reclassified from accumulated other comprehensive income (loss) (10) 390 — (56) 324 Net current period other comprehensive income (loss) (354) (233) (8) 15 (580) Balance at December 31, 2022 (2,832) (648) (7) 12 (3,475) Other comprehensive income (loss) before reclassifications (269) (477) 5 60 (681) Amounts reclassified from accumulated other comprehensive income (loss) — 70 — (49) 21 Net current period other comprehensive income (loss) (269) (407) 5 11 (660) Balance at December 31, 2023 $ (3,101) $ (1,055) $ (2) $ 23 $ (4,135)
Reclassifications Out Of Accumulated Other Comprehensive Income (Loss)	RECLASSIFICATIONS OUT OF ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Year Ended December 31, 2023 Affected Line in the Consolidated Statement of Operations Net Sales Cost of Products Sold Cost of Services Sold Selling, General and Administrative Expenses Other (Income) Expense Interest and Other Financial Charges Total Amortization of pension and other postretirement benefit items Actuarial losses recognized $ — $ — $ — $ — $ 141 $ — $ 141 Prior service (credit) recognized — — — — (63) — (63) Losses (gains) on cash flow hedges (15) (28) (10) (10) — — (63) Losses (gains) on excluded component of net investment hedges — — — — — — — Total before tax $ (15) $ (28) $ (10) $ (10) $ 78 $ — $ 15 Tax (expense) benefit 6 Total reclassifications for the period, net of tax $ 21 Year Ended December 31, 2022 Affected Line in the Consolidated Statement of Operations Net Sales Cost of Products Sold Cost of Services Sold Selling, General and Administrative Expenses Other (Income) Expense Interest and Other Financial Charges Total Amortization of pension and other postretirement benefit items Actuarial losses recognized $ — $ — $ — $ — $ 516 $ — $ 516 Prior service (credit) recognized — — — — (84) — (84) Losses (gains) on cash flow hedges (13) (48) (14) 3 — — (72) Losses (gains) on excluded component of net investment hedges — — — — — (13) (13) Total before tax $ (13) $ (48) $ (14) $ 3 $ 432 $ (13) $ 347 Tax (expense) benefit (23) Total reclassifications for the period, net of tax $ 324 Year Ended December 31, 2021 Affected Line in the Consolidated Statement of Operations Net Sales Cost of Products Sold Cost of Services Sold Selling, General and Administrative Expenses Other (Income) Expense Interest and Other Financial Charges Total Amortization of pension and other postretirement benefit items Actuarial losses recognized $ — $ — $ — $ — $ 7 $ — $ 7 Prior service (credit) recognized — — — — (116) — (116) Losses (gains) on cash flow hedges (5) (8) (2) (9) — — (24) Losses (gains) on excluded component of net investment hedges — — — — — (16) (16) Total before tax $ (5) $ (8) $ (2) $ (9) $ (109) $ (16) $ (149) Tax (expense) benefit 35 Total reclassifications for the period, net of tax $ (114)

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Loss Contingency	The following table summarizes information concerning the Company's recorded liabilities for environmental costs: Years Ended December 31, 2023 2022 2021 Beginning of year $ 615 $ 618 $ 660 Accruals for environmental matters deemed probable and reasonably estimable 222 186 168 Environmental liability payments (196) (211) (210) Other — 22 — End of year $ 641 $ 615 $ 618
Environmental Liabilities	Environmental liabilities are included in the following balance sheet accounts: December 31, 2023 2022 Accrued liabilities $ 227 $ 222 Other liabilities 414 393 Total environmental liabilities $ 641 $ 615
Asbestos Related Liabilities	Year Ended December 31, 2023 Year Ended December 31, 2022 Year Ended December 31, 2021 Bendix NARCO Total Bendix NARCO Total Bendix NARCO Total Beginning of year $ 1,291 $ 1,325 $ 2,616 $ 1,372 $ 689 $ 2,061 $ 1,441 $ 779 $ 2,220 Accrual for update to estimated liability 43 5 48 93 (634) (541) 64 31 95 Change in estimated cost of future claims 423 — 423 41 — 41 29 — 29 Update of expected resolution values for pending claims 56 — 56 1 — 1 3 — 3 Asbestos-related liability payments (169) (5) (174) (216) (55) (271) (165) (121) (286) NARCO Buyout — (1,325) (1,325) — 1,325 1,325 — — — End of year $ 1,644 $ — $ 1,644 $ 1,291 $ 1,325 $ 2,616 $ 1,372 $ 689 $ 2,061
Insurance Recoveries for Asbestos Related Liabilities	Year Ended December 31, 2023 Year Ended December 31, 2022 Year Ended December 31, 2021 Bendix NARCO Total Bendix NARCO Total Bendix NARCO Total Beginning of year $ 130 $ 135 $ 265 $ 142 $ 221 $ 363 $ 148 $ 254 $ 402 Probable insurance recoveries related to estimated liability 11 — 11 5 2 7 7 — 7 Insurance receipts for asbestos-related liabilities (18) (21) (39) (17) (20) (37) (13) (33) (46) Insurance receivables settlements and write-offs — (26) (26) — (68) (68) — — — End of year $ 123 $ 88 $ 211 $ 130 $ 135 $ 265 $ 142 $ 221 $ 363
NARCO and Bendix Asbestos Related Balances	NARCO and Bendix asbestos-related balances are included in the following balance sheet accounts: December 31, 2023 2022 Other current assets $ 41 $ 41 Insurance recoveries for asbestos-related liabilities 170 224 Total insurance recoveries for asbestos-related liabilities $ 211 $ 265 Accrued liabilities $ 154 $ 1,436 Asbestos-related liabilities 1,490 1,180 Total asbestos-related liabilities 1 $ 1,644 $ 2,616 1 As of December 31, 2022, Accrued liabilities included the Buyout Amount, as described and defined below, agreed upon between Honeywell and the Trust. The Buyout Amount does not represent an asbestos-related liability.
Schedule Of Bendix Loss Contingencies Litigation Claims Activity	The following tables present information regarding Bendix-related asbestos claims activity: Years Ended December 31, 2023 2022 Claims unresolved at the beginning of year 5,608 6,401 Claims filed 1,803 2,014 Claims resolved (1,894) (2,807) Claims unresolved at the end of year 5,517 5,608
Schedule of Bendix Loss Contingencies Disease Distribution	Disease Distribution of Unresolved Claims Years Ended December 31, 2023 2022 Mesothelioma and other cancer claims 3,244 3,283 Nonmalignant claims 2,273 2,325 Total claims 5,517 5,608
Average Resolution Values Per Claim Excluding Legal Costs	Honeywell has experienced average resolution values per claim excluding legal costs as follows: Years Ended December 31, 2023 2022 2021 2020 2019 (in whole dollars) Mesothelioma and other cancer claims $ 66,200 $ 59,200 $ 56,000 $ 61,500 $ 50,200 Nonmalignant claims 1,730 520 400 550 3,900
Movement In Standard Product Warranty Rollforward And Balances	The following table summarizes information concerning the Company's recorded obligations for product warranties and product performance guarantees: Years Ended December 31, 2023 2022 2021 Beginning of year $ 213 $ 223 $ 243 Accruals for warranties/guarantees issued during the year 139 117 146 Adjustment of pre-existing warranties/guarantees (27) (12) (7) Settlement of warranty/guarantee claims (106) (115) (159) End of year $ 219 $ 213 $ 223 Product warranties and product performance guarantees are included in the following balance sheet accounts: December 31, 2023 2022 Accrued liabilities $ 182 $ 175 Other liabilities 37 38 Total obligations for product warranties and product performance guarantees $ 219 $ 213

PENSION AND OTHER POSTRETIREM_2

PENSION AND OTHER POSTRETIREMENT BENEFITS (Tables)	12 Months Ended
	Dec. 31, 2023
Retirement Benefits [Abstract]
Defined Benefit Plans Disclosure	The following tables summarize the balance sheet impact, including the benefit obligations, assets, and funded status associated with the Company's significant pension and other postretirement benefit plans: Pension Benefits U.S. Plans Non-U.S. Plans 2023 2022 2023 2022 Change in benefit obligation Benefit obligation at beginning of year $ 13,290 $ 17,391 $ 4,400 $ 6,999 Service cost 29 86 11 19 Interest cost 645 380 200 103 Plan amendments — — — — Actuarial (gains) losses 1 337 (3,135) 191 (1,929) Benefits paid (1,509) (1,421) (250) (261) Settlements and curtailments — (13) — — Foreign currency translation — — 165 (533) Other — 2 1 2 Benefit obligation at end of year 12,792 13,290 4,718 4,400 Change in plan assets Fair value of plan assets at beginning of year 17,005 20,560 5,304 8,396 Actual return on plan assets 1,070 (2,161) 267 (2,187) Company contributions 28 37 22 17 Benefits paid (1,509) (1,421) (250) (261) Settlements and curtailments — (13) — — Foreign currency translation — — 205 (664) Other — 3 1 3 Fair value of plan assets at end of year 16,594 17,005 5,549 5,304 Funded status of plans $ 3,802 $ 3,715 $ 831 $ 904 Amounts recognized in the Consolidated Balance Sheet consist of Prepaid pension benefit cost 2 $ 4,052 $ 3,970 $ 1,335 $ 1,356 Accrued pension liabilities—current 3 (26) (28) (15) (14) Accrued pension liabilities—noncurrent 4 (224) (227) (489) (438) Net amount recognized $ 3,802 $ 3,715 $ 831 $ 904 1 The actuarial losses incurred in 2023 related to the Company's U.S. plans are primarily the result of a decrease in the discount rate assumption, as well as changes in demographic experience and demographic assumptions used to estimate the benefit obligations as of December 31, 2023, compared to December 31, 2022. Actuarial losses incurred in 2023 related to the Company's non-U.S. plans are primarily the result of a decrease in the discount rate assumption, partially offset by inflation related assumptions used to estimate the benefit obligations as of December 31, 2023, compared to December 31, 2022. Actuarial gains incurred in 2022 related to the Company's U.S. plans are primarily the result of an increase in the discount rate assumption, partially offset by changes in demographic experience and demographic assumptions used to estimate the benefit obligations as of December 31, 2022, compared to December 31, 2021. Actuarial gains incurred in 2022 related to the Company's non-U.S. plans are primarily the result of an increase in the discount rate assumption, partially offset by inflation related assumptions used to estimate the benefit obligations as of December 31, 2022, compared to December 31, 2021. 2 Included in Other assets in the Consolidated Balance Sheet. 3 Included in Accrued liabilities in the Consolidated Balance Sheet. 4 Included in Other liabilities in the Consolidated Balance Sheet. Other 2023 2022 Change in benefit obligation Benefit obligation at beginning of year $ 133 $ 196 Service cost — — Interest cost 6 5 Plan amendments — — Actuarial (gains) losses 3 (54) Benefits paid (26) (14) Benefit obligation at end of year 116 133 Change in plan assets Fair value of plan assets at beginning of year — — Actual return on plan assets — — Company contributions — — Benefits paid — — Fair value of plan assets at end of year — — Funded status of plans $ (116) $ (133) Amounts recognized in the Consolidated Balance Sheet consist of Accrued liabilities $ (12) $ (21) Postretirement benefit obligations other than pensions 1 (104) (112) Net amount recognized $ (116) $ (133) 1 Excludes non-U.S. plan of $30 million and $34 million as of December 31, 2023, and 2022, respectively.
Other Changes in Plan Assets Recognized in Other Comprehensive Income	Amounts recognized in Accumulated other comprehensive (income) loss associated with the Company's significant pension and other postretirement benefit plans at December 31, 2023, and 2022, are as follows: Pension Benefits U.S. Plans Non-U.S. Plans 2023 2022 2023 2022 Prior service (credit) cost $ (7) $ (50) $ 18 $ 18 Net actuarial (gain) loss 1,191 814 422 360 Net amount recognized $ 1,184 $ 764 $ 440 $ 378 Other 2023 2022 Prior service (credit) cost $ (30) $ (50) Net actuarial (gain) loss (68) (84) Net amount recognized $ (98) $ (134)
Net Periodic Benefit Cost	Net periodic benefit (income) cost and other amounts recognized in Other comprehensive (income) loss for the Company's significant pension and other postretirement benefit plans include the following components: Pension Benefits U.S. Plans Non-U.S. Plans 2023 2022 2021 2023 2022 2021 Service cost $ 29 $ 86 $ 105 $ 11 $ 19 $ 26 Interest cost 645 380 306 200 103 77 Expected return on plan assets (1,111) (1,281) (1,220) (274) (278) (348) Amortization of prior service (credit) cost (42) (42) (42) — — — Recognition of actuarial (gains) losses — (14) 31 153 537 9 Settlements and curtailments — (2) — — — — Net periodic benefit (income) cost $ (479) $ (873) $ (820) $ 90 $ 381 $ (236) U.S. Plans Non-U.S. Plans 2023 2022 2021 2023 2022 2021 Actuarial (gains) losses $ 378 $ 307 $ (14) $ 198 $ 294 $ (221) Prior service (credit) cost — — — — — (3) Prior service credit recognized during year 42 43 43 — (1) (1) Actuarial (gains) losses recognized during year — 15 — (153) (537) (9) Foreign currency translation — — — 17 204 (1) Total recognized in Other comprehensive (income) loss $ 420 $ 365 $ 29 $ 62 $ (40) $ (235) Total recognized in net periodic benefit (income) cost and Other comprehensive (income) loss $ (59) $ (508) $ (791) $ 152 $ 341 $ (471) Other Postretirement Benefits Years Ended December 31, 2023 2022 2021 Service cost $ — $ — $ — Interest cost 6 5 5 Amortization of prior service (credit) cost (20) (42) (74) Recognition of actuarial (gains) losses (13) (4) (2) Net periodic benefit (income) cost $ (27) $ (41) $ (71) Years Ended December 31, 2023 2022 2021 Actuarial (gains) losses $ 3 $ (54) $ (8) Prior service (credit) cost — — — Prior service credit recognized during year 20 42 74 Actuarial (gains) losses recognized during year 13 4 2 Total recognized in other comprehensive (income) loss 36 (8) 68 Total recognized in net periodic benefit (income) cost and Other comprehensive (income) loss $ 9 $ (49) $ (3)
Assumptions Used in Calculations	Major actuarial assumptions used in determining the benefit obligations and net periodic benefit (income) cost for the Company's significant benefit plans are presented in the following table as weighted averages: Pension Benefits U.S. Plans Non-U.S. Plans 2023 2022 2021 2023 2022 2021 Actuarial assumptions used to determine benefit obligations as of December 31 Discount rate 4.97 % 5.17 % 2.87 % 4.15 % 4.50 % 1.79 % Expected annual rate of compensation increase 3.25 % 3.25 % 3.25 % 2.68 % 2.69 % 2.56 % Actuarial assumptions used to determine net periodic benefit (income) cost for years ended December 31 Discount rate—benefit obligation 5.17 % 2.87 % 2.50 % 4.49 % 1.77 % 1.24 % Discount rate—service cost 5.26 % 2.98 % 2.68 % 3.81 % 1.48 % 1.00 % Discount rate—interest cost 5.07 % 2.26 % 1.76 % 4.56 % 1.59 % 1.00 % Expected rate of return on plan assets 6.75 % 6.40 % 6.15 % 5.15 % 3.61 % 4.03 % Expected annual rate of compensation increase 3.25 % 3.25 % 3.25 % 2.68 % 2.56 % 2.43 % Other Postretirement Benefits 2023 2022 2021 Actuarial assumptions used to determine benefit obligations as of December 31 Discount rate 5.00 % 5.32 % 2.66 % Actuarial assumptions used to determine net periodic benefit cost for years ended December 31 Discount rate 5.32 % 2.66 % 2.20 %
Accumulated Benefit Obligations in Excess of Plan Assets	The following amounts relate to the Company's significant pension plans with accumulated benefit obligations exceeding the fair value of plan assets: December 31, U.S. Plans Non-U.S. Plans 2023 2022 2023 2022 Projected benefit obligation $ 251 $ 255 $ 753 $ 682 Accumulated benefit obligation 249 253 736 664 Fair value of plan assets — — 249 230
Fair Value of Plan Assets	The fair values of both the Company's U.S. and non-U.S. pension plans assets by asset category are as follows: U.S. Plans December 31, 2023 Total Level 1 Level 2 Level 3 Equities Honeywell common stock $ 3,049 $ 3,049 $ — $ — U.S. equities — — — — Fixed income Short-term investments 2,942 283 2,659 — Government securities 532 — 532 — Corporate bonds 5,733 — 5,733 — Mortgage/Asset-backed securities 676 — 676 — Insurance contracts 7 — 7 — Direct investments Direct private investments 1,293 — — 1,293 Real estate properties 977 — — 977 Total $ 15,209 $ 3,332 $ 9,607 $ 2,270 Investments measured at NAV Private funds 1,265 Real estate funds 8 Commingled funds 112 Total assets at fair value $ 16,594 U.S. Plans December 31, 2022 Total Level 1 Level 2 Level 3 Equities Honeywell common stock $ 3,336 $ 3,336 $ — $ — U.S. equities 6 6 — — Fixed income Short-term investments 855 855 — — Government securities 1,492 — 1,492 — Corporate bonds 6,632 — 6,632 — Mortgage/Asset-backed securities 1,119 — 1,119 — Insurance contracts 8 — 8 — Direct investments Direct private investments 1,284 — — 1,284 Real estate properties 1,005 — — 1,005 Total $ 15,737 $ 4,197 $ 9,251 $ 2,289 Investments measured at NAV Private funds 1,258 Real estate funds 10 Commingled funds — Total assets at fair value $ 17,005 Non-U.S. Plans December 31, 2023 Total Level 1 Level 2 Level 3 Equities U.S. equities $ 195 $ — $ 195 $ — Non-U.S. equities 365 — 365 — Fixed income Short-term investments 387 168 219 — Government securities 1,635 — 1,635 — Corporate bonds 1,103 — 1,103 — Mortgage/Asset-backed securities 10 — 10 — Insurance contracts 108 — 108 — Insurance buy-in contracts 1,605 — — 1,605 Investments in private funds Private funds 115 — 41 74 Real estate funds 16 — — 16 Total $ 5,539 $ 168 $ 3,676 $ 1,695 Investments measured at NAV Private funds 8 Real estate funds 2 Total assets at fair value $ 5,549 Non-U.S. Plans December 31, 2022 Total Level 1 Level 2 Level 3 Equities U.S. equities $ 144 $ 2 $ 142 $ — Non-U.S. equities 374 — 374 — Fixed income Short-term investments 341 341 — — Government securities 2,045 — 2,045 — Corporate bonds 1,031 — 1,031 — Mortgage/Asset-backed securities 31 — 31 — Insurance contracts 115 — 115 — Insurance buy-in contracts 950 — — 950 Investments in private funds Private funds 90 — 54 36 Real estate funds 130 — — 130 Total $ 5,251 $ 343 $ 3,792 $ 1,116 Investments measured at NAV Private funds 10 Real estate funds 43 Total assets at fair value $ 5,304
Changes in Fair Value of Level 3 Plan Assets	The following table summarizes changes in the fair value of level 3 assets for both U.S. and non-U.S. plans: U.S. Plans Non-U.S. Plans Direct Private Investments Real Estate Properties Private Funds Real Estate Funds Insurance Buy-in Contracts Balance at December 31, 2021 $ 1,336 $ 843 $ 33 $ 163 $ 691 Actual return on plan assets Relating to assets still held at year-end (66) 88 11 (33) (477) Relating to assets sold during the year 98 (24) — 1 — Purchases 75 148 — — 736 Sales and settlements (159) (50) (8) (1) — Balance at December 31, 2022 1,284 1,005 36 130 950 Actual return on plan assets Relating to assets still held at year-end (34) (115) 3 — 68 Relating to assets sold during the year 159 — 1 (3) — Purchases 131 88 39 — 587 Sales and settlements (247) (1) (5) (111) — Balance at December 31, 2023 $ 1,293 $ 977 $ 74 $ 16 $ 1,605
Estimated Future Benefit Payments	Benefit payments, including amounts to be paid from Company assets, and reflecting expected future service, as appropriate, are expected to be paid as follows: U.S. Plans Non-U.S. Plans 2024 $ 1,094 $ 257 2025 1,077 253 2026 1,062 260 2027 1,044 266 2028 1,022 268 2029-2033 4,699 1,270
Assumed Health Care Cost Trend Rates	December 31, 2023 2022 Assumed health care cost trend rate Health care cost trend rate assumed for next year 7.00 % 7.50 % Rate that the cost trend rate gradually declines to 5.00 % 5.00 % Year that the rate reaches the rate it is assumed to remain at 2031 2031
Schedule Of Benefit Payments Reflecting Expected Future Service	Benefit payments reflecting expected future service, as appropriate, are expected to be paid as follows: Without Impact of Net of 2024 $ 13 $ 12 2025 12 12 2026 12 11 2027 11 11 2028 11 10 2029-2033 46 44

OTHER (INCOME) EXPENSE (Tables)

OTHER (INCOME) EXPENSE (Tables)	12 Months Ended
	Dec. 31, 2023
Other Income and Expenses [Abstract]
Other (Income) Expense	Years Ended December 31, 2023 2022 2021 Interest income $ (321) $ (138) $ (102) Pension ongoing income—non-service (441) (602) (1,202) Other postretirement income—non-service (29) (41) (71) Equity income of affiliated companies (100) (61) (67) Gain on sale of non-strategic businesses and assets (5) (22) (102) Foreign exchange (gain) loss 9 48 25 Expense related to UOP Matters — 45 160 Expense (benefit) related to Russia-Ukraine conflict (3) 45 — Net expense related to the NARCO Buyout and HWI Sale 11 342 — Other, net 39 18 (19) Total Other (income) expense $ (840) $ (366) $ (1,378)

SEGMENT FINANCIAL DATA (Tables)

SEGMENT FINANCIAL DATA (Tables)	12 Months Ended
	Dec. 31, 2023
Segment Reporting [Abstract]
Segment Financial Data	Years Ended December 31, 2023 2022 2021 Net sales Aerospace Technologies Products $ 7,316 $ 6,330 $ 6,158 Services 6,308 5,497 4,868 Net Aerospace Technologies sales 13,624 11,827 11,026 Industrial Automation Products 8,176 9,439 10,403 Services 2,580 2,199 2,022 Net Industrial Automation sales 10,756 11,638 12,425 Building Automation Products 4,599 4,591 4,098 Services 1,432 1,409 1,441 Net Building Automation sales 6,031 6,000 5,539 Energy and Sustainability Solutions Products 5,682 5,600 4,984 Services 557 396 418 Net Energy and Sustainability Solutions sales 6,239 5,996 5,402 Corporate and All Other Services 12 5 — Net Corporate and All Other sales 12 5 — Net sales $ 36,662 $ 35,466 $ 34,392 Depreciation and amortization Aerospace Technologies $ 267 $ 285 $ 278 Industrial Automation 386 422 439 Building Automation 107 92 67 Energy and Sustainability Solutions 253 247 252 Corporate and All Other 163 158 102 Total depreciation and amortization $ 1,176 $ 1,204 $ 1,138 Segment profit Aerospace Technologies $ 3,741 $ 3,228 $ 3,051 Industrial Automation 1,967 1,896 1,824 Building Automation 1,505 1,439 1,238 Energy and Sustainability Solutions 1,483 1,538 1,325 Corporate and All Other (392) (412) (226) Total segment profit $ 8,304 $ 7,689 $ 7,212 Years Ended December 31, 2023 2022 2021 Capital expenditures Aerospace Technologies $ 310 $ 246 $ 284 Industrial Automation 194 77 232 Building Automation 79 74 62 Energy and Sustainability Solutions 374 291 223 Corporate and All Other 82 78 94 Total capital expenditures $ 1,039 $ 766 $ 895 Years Ended December 31, 2023 2022 Total assets Aerospace Technologies $ 12,976 $ 12,189 Industrial Automation 22,026 21,337 Building Automation 6,723 6,599 Energy and Sustainability Solutions 8,048 7,442 Corporate and All Other 11,752 14,708 Total assets $ 61,525 $ 62,275
Reconciliation of Operating Profit Loss From Segments to Consolidated	A reconciliation of segment profit to consolidated income before taxes are as follows: Years Ended December 31, 2023 2022 2021 Segment profit $ 8,304 $ 7,689 $ 7,212 Interest and other financial charges (765) (414) (343) Interest income 321 138 102 Stock compensation expense 1 (202) (188) (217) Pension ongoing income 2 528 993 1,083 Pension mark-to-market expense (153) (523) (40) Other postretirement income 2 29 41 71 Repositioning and other charges 3 (860) (1,266) (569) Other expense 4 (43) (91) (64) Income before taxes $ 7,159 $ 6,379 $ 7,235 1 Amounts included in Selling, general and administrative expenses. 2 Amounts included in Cost of products and services sold (service cost component), Selling, general and administrative expenses (service cost component), Research and development expenses (service cost component), and Other (income) expense (non-service cost component). 3 Amounts included in Cost of products and services sold, Selling, general and administrative expenses, and Other (income) expense. 4 Amounts include the other components of Other (income) expense not included within other categories in this reconciliation. Equity income of affiliated companies is included in segment profit.

GEOGRAPHIC AREAS - FINANCIAL _2

GEOGRAPHIC AREAS - FINANCIAL DATA (Tables)	12 Months Ended
	Dec. 31, 2023
Geographic Areas, Revenues from External Customers [Abstract]
Geographic Areas - Financial Data	Net Sales 1 Long-lived Assets 2 Years Ended December 31, Years Ended December 31, 2023 2022 2021 2023 2022 2021 United States $ 20,907 $ 21,262 $ 20,662 $ 4,107 $ 3,949 $ 3,964 Europe 8,052 6,840 6,800 555 537 566 Other international 7,703 7,364 6,930 998 985 1,032 Net sales $ 36,662 $ 35,466 $ 34,392 $ 5,660 $ 5,471 $ 5,562 1 Sales between geographic areas approximate market value and are not significant. Net sales are classified according to their country of origin. Included in United States Net sales are export sales of $4,708 million, $4,187 million, and $4,037 million for the years ended December 31, 2023, 2022, and 2021, respectively. 2 Long-lived assets consists of Property, plant and equipment—net.

SUPPLEMENTAL CASH FLOW INFORM_2

SUPPLEMENTAL CASH FLOW INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2023
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information	Years Ended December 31, 2023 2022 2021 Net payments for repositioning and other charges Severance and exit cost payments $ (294) $ (275) $ (382) Environmental payments (196) (211) (210) Reimbursement receipts 140 140 140 Insurance receipts for asbestos-related liabilities 39 37 46 Insurance receivables settlements and write-offs 26 68 — Asbestos-related liability payments (174) (271) (286) Total net payments for repositioning and other charges $ (459) $ (512) $ (692) Interest paid, net of amounts capitalized $ 649 $ 375 $ 339 Income taxes paid, net of refunds 1,581 1,324 1,202 Non-cash investing and financing activities Common stock contributed to savings plans 216 196 191 Marketable securities contributed to non-U.S. pension plans — — 81 Impact of Quantinuum contribution 1 — — 460 Noncontrolling interest non-cash contribution 1 — — 419 Loan in exchange for prepaid assets — — 25 Receipt of Garrett Series B Preferred Stock 2 — — 577 1 See Note 2 Acquisitions and Divestitures for additional information of non-cash amounts recognized related to the combination of Honeywell Quantum Solutions and Cambridge Quantum Computing to form Quantinuum, a newly formed entity, which Honeywell consolidates as the controlling majority-owner. 2 See Note 19 Commitments and Contingencies for additional information of non-cash amounts recognized related to the receipt of 834.8 million shares of Garrett Series B Preferred Stock in exchange for the full and final satisfaction of the Garrett Indemnity, Tax Matters Agreement, and pending litigation between the Company and Garrett. The non-cash amount reflects the fair value of the Garrett Series B Preferred Stock as of April 30, 2021, the date Garrett issued the Series B Preferred Stock to the Company.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Product Information [Line Items]
Research and development expenses	$ 1,456	$ 1,478	$ 1,333
Customer-sponsored research and development	1,303	1,336	1,284
Accounts payable	6,849	6,329
Capitalized contract fulfillment costs	1,200	1,300
Capitalized contract amounts recognized as cost of products and services sold	$ 100	200	$ 100
Minimum
Product Information [Line Items]
Finite lived intangible assets estimated useful lives	2 years
Minimum | Building and Building Improvements
Product Information [Line Items]
Property, plant and equipment, useful life	10 years
Minimum | Machinery and equipment
Product Information [Line Items]
Property, plant and equipment, useful life	3 years
Maximum
Product Information [Line Items]
Finite lived intangible assets estimated useful lives	20 years
Maximum | Software and Software Development Costs
Product Information [Line Items]
Finite lived intangible assets estimated useful lives	7 years
Maximum | Building and Building Improvements
Product Information [Line Items]
Property, plant and equipment, useful life	50 years
Maximum | Machinery and equipment
Product Information [Line Items]
Property, plant and equipment, useful life	16 years
Suppliers Utilizing Third Party Services Sold Through To Financial Institutions
Product Information [Line Items]
Accounts payable	$ 1,112	$ 992

ACQUISITIONS AND DIVESTITURES -

ACQUISITIONS AND DIVESTITURES - Narrative (Details) $ in Millions						1 Months Ended	3 Months Ended	12 Months Ended
	Aug. 25, 2023 USD ($)	Jun. 30, 2023 USD ($)	Jan. 18, 2022 USD ($)	Nov. 29, 2021 USD ($)	Mar. 15, 2021 USD ($)	Dec. 31, 2021 USD ($)	Sep. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) entity	Dec. 31, 2021 USD ($)	Feb. 12, 2021 USD ($)
Business Acquisition [Line Items]
Goodwill								$ 18,049	$ 17,497
Impact of Quantinuum contribution								0	0	$ 460
Noncontrolling interest non-cash contribution						$ 419		0	0	419
Proceeds from sales of businesses, net of fees paid								$ 4	$ 0	203
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Russian Domiciled Entities
Business Acquisition [Line Items]
Divestiture, number of business entities sold | entity									3
Proceeds from sales of businesses, net of fees paid									$ 1
Pretax gain on disposition of business									22
Retail Footwear
Business Acquisition [Line Items]
Proceeds from sales of businesses, net of fees paid					$ 230
Gain (loss) on sale of nonstrategic business and assets										95
Customer relationships
Business Acquisition [Line Items]
Finite lived intangible assets estimated useful lives								15 years
SCADAfence
Business Acquisition [Line Items]
Percent acquired	100%
Consideration amount	$ 52
Intangible assets acquired								$ 17
Goodwill								42
Compressor Controls Corporation
Business Acquisition [Line Items]
Percent acquired		100%
Consideration amount		$ 673
Intangible assets acquired								282
Goodwill								350
US Digital Design, Inc.
Business Acquisition [Line Items]
Percent acquired			100%
Consideration amount			$ 186
Intangible assets acquired								53
Goodwill								$ 129
Quantinuum
Business Acquisition [Line Items]
Goodwill									945
Payments to acquire interest in joint venture				$ 270
Controlling interest ownership percentage by parent				54%
Impact of Quantinuum contribution				$ 460
Fair value adjustment of initial ownership interest in acquired entity				$ 22
Intangible Assets									$ 90
Quantinuum | Honeywell International
Business Acquisition [Line Items]
Noncontrolling interest, ownership percentage				4.20%
Quantinuum | Cambridge Quantum Computing
Business Acquisition [Line Items]
Payments to acquire interest in joint venture						12
Noncontrolling interest non-cash contribution				$ 419
Sparta Systems
Business Acquisition [Line Items]
Goodwill						1,011				1,011
Controlling interest ownership percentage by parent											100%
Intangible Assets						$ 383				$ 383
Purchase price											$ 1,303
Carrier Global Corporation | Forecast
Business Acquisition [Line Items]
Payments to acquire businesses, gross							$ 5,000

REVENUE RECOGNITION AND CONTR_3

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Net Sales	$ 36,662	$ 35,466	$ 34,392
Disaggregation of revenue, timing of recognition - percentage	100%	100%	100%
Product
Disaggregation of Revenue [Line Items]
Net Sales	$ 25,773	$ 25,960	$ 25,643
Disaggregation of revenue, timing of recognition - percentage	70%	73%	75%
Product | Transferred at Point in Time
Disaggregation of Revenue [Line Items]
Disaggregation of revenue, timing of recognition - percentage	58%	59%	58%
Product | Transferred over Time
Disaggregation of Revenue [Line Items]
Disaggregation of revenue, timing of recognition - percentage	12%	14%	17%
Service
Disaggregation of Revenue [Line Items]
Net Sales	$ 10,889	$ 9,506	$ 8,749
Disaggregation of revenue, timing of recognition - percentage	30%	27%	25%
Service | Transferred at Point in Time
Disaggregation of Revenue [Line Items]
Disaggregation of revenue, timing of recognition - percentage	10%	8%	8%
Service | Transferred over Time
Disaggregation of Revenue [Line Items]
Disaggregation of revenue, timing of recognition - percentage	20%	19%	17%
Operating Segments
Disaggregation of Revenue [Line Items]
Net Sales	$ 36,662	$ 35,466	$ 34,392
Corporate and All Other
Disaggregation of Revenue [Line Items]
Net Sales	12	5	0
Aerospace Technologies | Operating Segments
Disaggregation of Revenue [Line Items]
Net Sales	13,624	11,827	11,026
Aerospace Technologies | Operating Segments | Commercial Aviation Original Equipment
Disaggregation of Revenue [Line Items]
Net Sales	2,397	2,089	1,720
Aerospace Technologies | Operating Segments | Commercial Aviation Aftermarket
Disaggregation of Revenue [Line Items]
Net Sales	6,241	5,108	4,155
Aerospace Technologies | Operating Segments | Defense and Space
Disaggregation of Revenue [Line Items]
Net Sales	4,986	4,630	5,151
Industrial Automation | Operating Segments
Disaggregation of Revenue [Line Items]
Net Sales	10,756	11,638	12,425
Industrial Automation | Operating Segments | Sensing and Safety Technologies
Disaggregation of Revenue [Line Items]
Net Sales	2,733	2,860	3,123
Industrial Automation | Operating Segments | Productivity Products [Member]
Disaggregation of Revenue [Line Items]
Net Sales	1,313	1,739	1,778
Industrial Automation | Operating Segments | Process Solutions [Member]
Disaggregation of Revenue [Line Items]
Net Sales	5,267	4,731	4,611
Industrial Automation | Operating Segments | Warehouse and Workflow Solutions
Disaggregation of Revenue [Line Items]
Net Sales	1,443	2,308	2,913
Building Automation | Operating Segments
Disaggregation of Revenue [Line Items]
Net Sales	6,031	6,000	5,539
Building Automation | Operating Segments | Products
Disaggregation of Revenue [Line Items]
Net Sales	3,583	3,638	3,173
Building Automation | Operating Segments | Building Solutions
Disaggregation of Revenue [Line Items]
Net Sales	2,448	2,362	2,366
Energy and Sustainability Solutions | Operating Segments
Disaggregation of Revenue [Line Items]
Net Sales	6,239	5,996	5,402
Energy and Sustainability Solutions | Operating Segments | UOP
Disaggregation of Revenue [Line Items]
Net Sales	2,586	2,404	2,348
Energy and Sustainability Solutions | Operating Segments | Advanced Materials
Disaggregation of Revenue [Line Items]
Net Sales	$ 3,653	$ 3,592	$ 3,054

REVENUE RECOGNITION AND CONTR_4

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS - Contract Balances (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Change in Contract Balances [Roll Forward]
Contract assets	$ 2,013	$ 2,294	$ 2,060
Change in contract assets—increase (decrease)	(281)	234
Contract liability	(4,326)	(4,583)	$ (4,290)
Change in contract liabilities—decrease (increase)	257	(293)
Net change	(24)	(59)
Contract with customer liability revenue recognized	2,070	1,838
Unbilled contracts receivable	$ 1,949	$ 2,265

REVENUE RECOGNITION AND CONTR_5

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS - Performance Obligations (Details) $ in Millions	Dec. 31, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation - amount	$ 31,777
Within One Year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	60%
Greater Than One Year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	40%
Corporate and All Other
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation - amount	$ 47
Aerospace Technologies
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation - amount	13,898
Building Automation
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation - amount	7,302
Energy and Sustainability Solutions
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation - amount	4,303
Safety And Productivity Solutions [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation - amount	$ 6,227

REPOSITIONING AND OTHER CHARG_3

REPOSITIONING AND OTHER CHARGES - Repositioning and Other Charges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Component of Operating Other Cost and Expense [Abstract]
Total net repositioning charges	$ 286	$ 364	$ 318
Asbestos-related charges, net of insurance and reimbursements	534	532	129
Probable and reasonably estimable environmental liabilities, net of reimbursements	44	28	22
Other charges	(4)	342	100
Total net repositioning and other charges	860	1,266	569
Severance
Component of Operating Other Cost and Expense [Abstract]
Total net repositioning charges	162	122	80
Asset impairments
Component of Operating Other Cost and Expense [Abstract]
Total net repositioning charges	41	176	117
Exit costs
Component of Operating Other Cost and Expense [Abstract]
Total net repositioning charges	139	122	134
Reserve adjustments
Component of Operating Other Cost and Expense [Abstract]
Total net repositioning charges	$ (56)	$ (56)	$ (13)

REPOSITIONING AND OTHER CHARG_4

REPOSITIONING AND OTHER CHARGES - Pretax Distribution of Total Net Repositioning (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Restructuring Reserve Disclosures [Line Items]
Total net repositioning charges	$ 860	$ 1,266	$ 569
Cost of products and services sold
Restructuring Reserve Disclosures [Line Items]
Total net repositioning charges	680	572	457
Selling, general and administrative expenses
Restructuring Reserve Disclosures [Line Items]
Total net repositioning charges	172	309	112
Other (income) expense
Restructuring Reserve Disclosures [Line Items]
Total net repositioning charges	$ 8	$ 385	$ 0

REPOSITIONING AND OTHER CHARG_5

REPOSITIONING AND OTHER CHARGES - Pretax Impact of Total Net Repositioning and Other Charges by Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	$ 860	$ 1,266	$ 569
Corporate and All Other
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	617	642	202
Aerospace Technologies | Operating Segments
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	23	41	62
Building Automation | Operating Segments
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	139	395	280
Energy and Sustainability Solutions | Operating Segments
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	58	63	13
Safety And Productivity Solutions [Member] | Operating Segments
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	$ 23	$ 125	$ 12

REPOSITIONING AND OTHER CHARG_6

REPOSITIONING AND OTHER CHARGES - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) employee	Dec. 31, 2022 USD ($) employee	Dec. 31, 2021 USD ($) employee
Net Repositioning And Other Charges [Line Items]
Charges	$ 342	$ 420	$ 331
Restructuring and related cost, incurred cost	$ 286	$ 364	$ 318
Number of employees severed | employee	5,854	4,345	6,432
Other (Income) Expense	$ (840)	$ (366)	$ (1,378)
Cost of products and services sold	22,995	22,347	22,061
Selling, general and administrative expenses	5,127	5,214	4,798
Foreign currency transaction gain (loss), before tax	(9)	(48)	(25)
Other charges	4	(342)	(100)
Russia And Ukraine Conflict
Net Repositioning And Other Charges [Line Items]
Other (Income) Expense		295
Cost of products and services sold		65
Foreign currency transaction gain (loss), before tax		(45)
Russia And Ukraine Conflict | Other (income) expense
Net Repositioning And Other Charges [Line Items]
Tax valuation allowance adjustment		(2)
Severance
Net Repositioning And Other Charges [Line Items]
Charges	162	122	80
Restructuring and related cost, incurred cost	162	122	80
Asset impairments
Net Repositioning And Other Charges [Line Items]
Charges	41	176	117
Restructuring and related cost, incurred cost	41	176	117
Exit costs
Net Repositioning And Other Charges [Line Items]
Charges	139	122	134
Restructuring and related cost, incurred cost	139	122	134
Restructuring and related cost, cost incurred to date	62	63	45
Reserve adjustments
Net Repositioning And Other Charges [Line Items]
Restructuring and related cost, incurred cost	$ (56)	(56)	(13)
COVID-19 Related
Net Repositioning And Other Charges [Line Items]
Other charges		41	$ 105
Contract Adjustments, Impairment Of Other Assets And Employee Severance | Russia And Ukraine Conflict
Net Repositioning And Other Charges [Line Items]
Selling, general and administrative expenses		$ (185)

REPOSITIONING AND OTHER CHARG_7

REPOSITIONING AND OTHER CHARGES - Repositioning Reserves (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Restructuring Reserve [Roll Forward]
Beginning balance	$ 309	$ 411	$ 601
Charges	342	420	331
Usage—cash	(294)	(275)	(382)
Usage—noncash	(36)	(183)	(119)
Divestitures	(9)	0	0
Adjustments	(56)	(56)	(13)
Foreign currency translation	23	(8)	(7)
Ending balance	279	309	411
Severance
Restructuring Reserve [Roll Forward]
Beginning balance	235	289	527
Charges	162	122	80
Usage—cash	(173)	(135)	(299)
Usage—noncash	0	0	0
Divestitures	0	0	0
Adjustments	(42)	(42)	(14)
Foreign currency translation	6	1	(5)
Ending balance	188	235	289
Asset impairments
Restructuring Reserve [Roll Forward]
Beginning balance	0	0	0
Charges	41	176	117
Usage—cash	0	0	0
Usage—noncash	(36)	(168)	(119)
Divestitures	(4)	0	0
Adjustments	(1)	(8)	2
Foreign currency translation	0	0	0
Ending balance	0	0	0
Exit costs
Restructuring Reserve [Roll Forward]
Beginning balance	74	122	74
Charges	139	122	134
Usage—cash	(121)	(140)	(83)
Usage—noncash	0	(15)	0
Divestitures	(5)	0	0
Adjustments	(13)	(6)	(1)
Foreign currency translation	17	(9)	(2)
Ending balance	$ 91	$ 74	$ 122

INCOME TAXES - Income Before Ta

INCOME TAXES - Income Before Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income before taxes
U.S.	$ 2,368	$ 3,305	$ 3,955
Non-U.S.	4,791	3,074	3,280
Total Income before taxes	7,159	6,379	7,235
Tax expense (benefit) consists of
U.S. Federal	176	653	415
U.S. State	60	124	146
Non-U.S.	1,098	815	886
Total current tax expense (benefit)	1,334	1,592	1,447
Deferred
U.S. Federal	27	(175)	173
U.S. State	11	(36)	37
Non-U.S.	115	32	(32)
Total deferred tax expense (benefit)	153	(180)	178
Tax expense	$ 1,487	$ 1,412	$ 1,625

INCOME TAXES - Tax Expense (Ben

INCOME TAXES - Tax Expense (Benefit) (Details)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
U.S. federal statutory income tax rate	21%	21%	21%
Taxes on non-U.S. earnings	(2.00%)	(0.40%)	(1.40%)
U.S. state income taxes	0.50%	1.40%	1.50%
Reserves for tax contingencies	3.40%	1.10%	2.20%
Employee share-based payments	(0.30%)	(0.90%)	(0.70%)
Restructuring	0%	0.70%	(1.40%)
U.S. federal tax credits	(1.60%)	(0.90%)	(0.60%)
U.S. valuation allowance	(0.10%)	(0.20%)	2%
All other items—net	(0.10%)	0.30%	(0.10%)
Effective income tax rate	20.80%	22.10%	22.50%
Effective income tax rate reconciliation, tax benefit from foreign legislative change, percent	(3.60%)
Effective income tax rate reconciliation, tax expense, valuation allowance, percent	3.60%

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Examination [Line Items]
Net (decrease) increase in the effective tax rate from prior period	(130.00%)	(0.40%)
Non-U.S. effective income tax rate	25.30%	27.50%
Net (decrease) increase in non-U.S. income tax rate	(220.00%)	1.50%
Gross deferred tax assets	$ 3,136	$ 2,326
Valuation allowance	1,292	812
Valuation allowance impact to tax expense	458	(8)	$ 124
Deferred tax asset, foreign tax legislation change	257
Deferred tax assets, other tax carryforwards	201
Tax charge on earnings of foreign subsidiaries	542	517
Undistributed earnings and profits of foreign affiliates	15,000
Unrecognized tax benefits	1,225	1,086	1,061	$ 991
Income tax examination unrecognized tax benefits from examination	803	640	592
Income tax examination estimated interest and penalties from examination	74	5	79
Income tax examination accrued interest and penalties from examination	612	$ 557	$ 580
Uncertainty Of Realizability Of Deferred Tax Asset
Income Tax Examination [Line Items]
Valuation allowance	257
Non-U.S.
Income Tax Examination [Line Items]
Gross deferred tax assets	1,378
Valuation allowance	1,176
Domestic Tax Authority
Income Tax Examination [Line Items]
Valuation allowance	$ 116

INCOME TAXES - Deferred Tax Ass

INCOME TAXES - Deferred Tax Assets (Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Deferred tax assets
Postretirement benefits other than pensions	$ 55	$ 59
Asbestos and environmental	405	545
Capitalized research and development	582	0
Employee compensation and benefits	148	142
Lease liabilities	258	233
Other accruals and reserves	196	363
Net operating losses	687	695
Capital loss limitation and carryover	385	126
Tax credit carryforwards and other attributes	420	163
Gross deferred tax assets	3,136	2,326
Valuation allowance	(1,292)	(812)
Total deferred tax assets	1,844	1,514
Deferred tax liabilities
Pension	(1,132)	(1,088)
Property, plant and equipment	(441)	(233)
Right-of-use asset	(240)	(212)
Intangibles	(817)	(818)
Unremitted earnings of foreign subsidiaries	(542)	(517)
Other asset basis differences	(369)	(317)
Other	(5)	(1)
Total deferred tax liabilities	(3,546)	(3,186)
Net deferred tax liability	$ (1,702)	$ (1,672)

INCOME TAXES - Operating Loss C

INCOME TAXES - Operating Loss Carryforwards (Details) $ in Millions	Dec. 31, 2023 USD ($)
Operating Loss Carryforwards [Line Items]
Net Operating and Capital Loss Carryforwards	$ 4,927
Tax Credit Carryforwards and Other Attributes	425
U.S. Federal
Operating Loss Carryforwards [Line Items]
Net Operating and Capital Loss Carryforwards	532
Tax Credit Carryforwards and Other Attributes	96
U.S. State
Operating Loss Carryforwards [Line Items]
Net Operating and Capital Loss Carryforwards	675
Tax Credit Carryforwards and Other Attributes	25
Non-U.S.
Operating Loss Carryforwards [Line Items]
Net Operating and Capital Loss Carryforwards	3,720
Tax Credit Carryforwards and Other Attributes	$ 304

INCOME TAXES - Change in Unreco

INCOME TAXES - Change in Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Operating loss carryforward, not subject to expiration	$ 3,140
Operating loss carryforwards, subject to expiration	502
Change in unrecognized tax benefits
Beginning balance	1,086	$ 1,061	$ 991
Gross increases related to current period tax positions	89	64	93
Gross increases related to prior periods tax positions	181	31	39
Gross decreases related to prior periods tax positions	0	(19)	(27)
Decrease related to resolutions of audits with tax authorities	(132)	(3)	(1)
Expiration of the statute of limitations for the assessment of taxes	(3)	(8)	(12)
Foreign currency translation	4	(40)	(22)
Ending balance	$ 1,225	$ 1,086	$ 1,061

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 1,704	$ 1,407
Work in process	1,217	1,049
Finished products	3,257	3,082
Total Inventories	$ 6,178	$ 5,538

PROPERTY, PLANT AND EQUIPMENT_3

PROPERTY, PLANT AND EQUIPMENT-NET (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Total Property, plant and equipment	$ 15,334	$ 14,762
Less—Accumulated depreciation	(9,674)	(9,291)
Property, plant and equipment—net	5,660	5,471
Depreciation	659	657	$ 674
Land and improvements
Property, Plant and Equipment [Line Items]
Total Property, plant and equipment	211	216
Machinery and equipment
Property, Plant and Equipment [Line Items]
Total Property, plant and equipment	10,717	10,383
Buildings and improvements
Property, Plant and Equipment [Line Items]
Total Property, plant and equipment	3,528	3,394
Construction in progress
Property, Plant and Equipment [Line Items]
Total Property, plant and equipment	$ 878	$ 769

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS-NET - Schedule of Goodwill (Details) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 17,497
Acquisitions/ Divestitures	392
Currency Translation Adjustment	160
Ending balance	18,049
Corporate and All Other
Goodwill [Roll Forward]
Beginning balance	874
Acquisitions/ Divestitures	0
Currency Translation Adjustment	32
Ending balance	906
Aerospace Technologies
Goodwill [Roll Forward]
Beginning balance	2,376
Acquisitions/ Divestitures	0
Currency Translation Adjustment	10
Ending balance	2,386
Building Automation
Goodwill [Roll Forward]
Beginning balance	3,338
Acquisitions/ Divestitures	0
Currency Translation Adjustment	42
Ending balance	3,380
Energy and Sustainability Solutions
Goodwill [Roll Forward]
Beginning balance	1,726
Acquisitions/ Divestitures	0
Currency Translation Adjustment	1
Ending balance	1,727
Safety And Productivity Solutions [Member]
Goodwill [Roll Forward]
Beginning balance	9,183
Acquisitions/ Divestitures	392
Currency Translation Adjustment	75
Ending balance	$ 9,650

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS-NET - Other Intangible Assets (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	$ 7,259	$ 6,972
Finite-lived intangible assets, accumulated amortization	(4,999)	(4,703)
Net Carrying Amount	2,260	2,269
Indefinite-life intangibles
Trademarks with indefinite lives	971	953
Gross carrying amount	8,230	7,925
Net carrying amount	3,231	3,222
Patents and technology
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	2,399	2,313
Finite-lived intangible assets, accumulated amortization	(1,837)	(1,759)
Net Carrying Amount	562	554
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	4,199	3,989
Finite-lived intangible assets, accumulated amortization	(2,601)	(2,397)
Net Carrying Amount	1,598	1,592
Trademarks
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	362	371
Finite-lived intangible assets, accumulated amortization	(284)	(273)
Net Carrying Amount	78	98
Other
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	299	299
Finite-lived intangible assets, accumulated amortization	(277)	(274)
Net Carrying Amount	$ 22	$ 25

GOODWILL AND OTHER INTANGIBLE_5

GOODWILL AND OTHER INTANGIBLE ASSETS-NET - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 292	$ 333	$ 465
Future amortization expense - 2024	287
Future amortization expense - 2025	262
Future amortization expense - 2026	257
Future amortization expense - 2027	247
Future amortization expense - 2028	$ 249

LONG-TERM DEBT AND CREDIT AGR_3

LONG-TERM DEBT AND CREDIT AGREEMENTS - Schedule of Long-Term Debt and Credit Agreements (Details) € in Millions, $ in Millions	Dec. 31, 2023 USD ($)	Dec. 01, 2023	May 17, 2023 USD ($)	May 17, 2023 EUR (€)	Feb. 22, 2023	Dec. 31, 2022 USD ($)	Nov. 02, 2022 USD ($)	Nov. 02, 2022 EUR (€)
Debt Instrument [Line Items]
Debt issuance costs	$ (245)					$ (233)
Total Long-term debt and current related maturities	18,358					16,853
Less: Current maturities of long-term debt	1,796					1,730
Total Long-term debt	16,562					15,123
Fair value of hedging instruments | Fair value of hedging instruments
Debt Instrument [Line Items]
Fair value of hedging instruments	$ (166)					(287)
1.30% Euro notes due 2023
Debt Instrument [Line Items]
Various interest rates	1.30%				1.30%
Senior notes	$ 0					1,334
3.35% notes due 2023
Debt Instrument [Line Items]
Various interest rates	3.35%	3.35%
Senior notes	$ 0					300
0.00% Euro notes due 2024
Debt Instrument [Line Items]
Various interest rates	0%
Senior notes	$ 547					534
2.30% notes due 2024
Debt Instrument [Line Items]
Various interest rates	2.30%
Senior notes	$ 750					750
4.85% notes due 2024
Debt Instrument [Line Items]
Various interest rates	4.85%						4.85%	4.85%
Senior notes	$ 400					400	$ 400
1.35% notes due 2025
Debt Instrument [Line Items]
Various interest rates	1.35%
Senior notes	$ 1,250					1,250
2.50% notes due 2026
Debt Instrument [Line Items]
Various interest rates	2.50%
Senior notes	$ 1,500					1,500
1.10% notes due 2027
Debt Instrument [Line Items]
Various interest rates	1.10%
Senior notes	$ 1,000					1,000
3.500% Senior Notes due 2027
Debt Instrument [Line Items]
Various interest rates	3.50%		3.50%	3.50%
Senior notes	$ 711			€ 650		0
4.95% notes due 2028
Debt Instrument [Line Items]
Various interest rates	4.95%						4.95%	4.95%
Senior notes	$ 500					500	$ 500
2.25% Euro notes due 2028
Debt Instrument [Line Items]
Various interest rates	2.25%
Senior notes	$ 820					800
4.25% notes due 2029
Debt Instrument [Line Items]
Various interest rates	4.25%		4.25%	4.25%
Senior notes	$ 750		$ 750			0
2.70% notes due 2029
Debt Instrument [Line Items]
Various interest rates	2.70%
Senior notes	$ 750					750
1.95% notes due 2030
Debt Instrument [Line Items]
Various interest rates	1.95%
Senior notes	$ 1,000					1,000
1.75% notes due 2031
Debt Instrument [Line Items]
Various interest rates	1.75%
Senior notes	$ 1,500					1,500
0.75% Euro notes due 2032
Debt Instrument [Line Items]
Various interest rates	0.75%
Senior notes	$ 547					534
3.750% Senior Notes due 2032
Debt Instrument [Line Items]
Various interest rates	3.75%		3.75%	3.75%
Senior notes	$ 547			€ 500		0
5.00% notes due 2033
Debt Instrument [Line Items]
Various interest rates	5%						5%	5%
Senior notes	$ 1,100					1,100	$ 1,100
4.50% notes due 2034
Debt Instrument [Line Items]
Various interest rates	4.50%		4.50%	4.50%
Senior notes	$ 1,000		$ 1,000			0
4.125% Euro notes due 2034
Debt Instrument [Line Items]
Various interest rates	4.125%						4.125%	4.125%
Senior notes	$ 1,094					1,067		€ 1,000
5.70% notes due 2036
Debt Instrument [Line Items]
Various interest rates	5.70%
Senior notes	$ 441					441
5.70% notes due 2037
Debt Instrument [Line Items]
Various interest rates	5.70%
Senior notes	$ 462					462
5.375% notes due 2041
Debt Instrument [Line Items]
Various interest rates	5.375%
Senior notes	$ 417					417
3.812% notes due 2047
Debt Instrument [Line Items]
Various interest rates	3.812%
Senior notes	$ 442					445
2.80% notes due 2050
Debt Instrument [Line Items]
Various interest rates	2.80%
Senior notes	$ 750					750
Industrial development bond obligations, floating rate maturing at various dates through 2037
Debt Instrument [Line Items]
Industrial development bond obligations, floating rate maturing at various dates through 2037	$ 22					22
6.625% debentures due 2028
Debt Instrument [Line Items]
Various interest rates	6.625%
Debentures	$ 201					201
9.065% debentures due 2033
Debt Instrument [Line Items]
Various interest rates	9.065%
Debentures	$ 51					51
Other (including capitalized leases), 7.0% weighted average interest rate maturing at various dates through 2029
Debt Instrument [Line Items]
Debt, weighted average interest rate	7%
Other (including capitalized leases), 7.0% weighted average interest rate maturing at various dates through 2029	$ 217					$ 265

LONG-TERM DEBT AND CREDIT AGR_4

LONG-TERM DEBT AND CREDIT AGREEMENTS - Principal Payments on Long-Term Debt (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
2024	$ 1,796
2025	1,314
2026	1,528
2027	1,718
2028	1,527
Thereafter	10,475
Total Long-term debt and current related maturities	18,358	$ 16,853
Less: Current maturities of long-term debt	1,796	1,730
Total Long-term debt	$ 16,562	$ 15,123

LONG-TERM DEBT AND CREDIT AGR_5

LONG-TERM DEBT AND CREDIT AGREEMENTS - Narrative (Details) € in Millions	May 17, 2023 USD ($)	Mar. 24, 2023 USD ($)	Mar. 20, 2023 USD ($)	Nov. 02, 2022 USD ($)	Dec. 31, 2023 USD ($)	Dec. 01, 2023	May 17, 2023 EUR (€)	Feb. 22, 2023	Dec. 31, 2022 USD ($)	Nov. 02, 2022 EUR (€)	Aug. 19, 2022	Aug. 08, 2022
Three Hundred Sixty Four Day Credit Agreement | Line of Credit
Debt Instrument [Line Items]
Short term debt, maximum borrowing capacity		$ 1,500,000,000	$ 1,500,000,000
Debt instrument, term		364 days	364 days
Short-term line of credit					$ 0
4.25% notes due 2029
Debt Instrument [Line Items]
Various interest rates	4.25%				4.25%		4.25%
Senior notes	$ 750,000,000				$ 750,000,000				$ 0
4.50% notes due 2034
Debt Instrument [Line Items]
Various interest rates	4.50%				4.50%		4.50%
Senior notes	$ 1,000,000,000				$ 1,000,000,000				0
Notes
Debt Instrument [Line Items]
Proceeds from issuance of long-term debt	1,800,000,000			$ 2,000,000,000
Payments of debt issuance costs	$ 20,000,000			$ 22,000,000
3.500% Senior Notes due 2027
Debt Instrument [Line Items]
Various interest rates	3.50%				3.50%		3.50%
Senior notes					$ 711,000,000		€ 650		0
3.750% Senior Notes due 2032
Debt Instrument [Line Items]
Various interest rates	3.75%				3.75%		3.75%
Senior notes					$ 547,000,000		€ 500		0
Euro Notes
Debt Instrument [Line Items]
Proceeds from issuance of long-term debt	$ 1,200,000,000
Payments of debt issuance costs	$ 12,000,000
1.30% Euro notes due 2023
Debt Instrument [Line Items]
Various interest rates					1.30%			1.30%
Senior notes					$ 0				1,334,000,000
Line of Credit | Five Year Credit Agreement
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		$ 4,000,000,000	$ 4,000,000,000
Debt instrument, term		5 years	5 years
Line of credit facility, maximum borrowing capacity upon terms			$ 4,500,000,000
Long-term line of credit					$ 0
4.85% notes due 2024
Debt Instrument [Line Items]
Various interest rates				4.85%	4.85%					4.85%
Senior notes				$ 400,000,000	$ 400,000,000				400,000,000
4.95% notes due 2028
Debt Instrument [Line Items]
Various interest rates				4.95%	4.95%					4.95%
Senior notes				$ 500,000,000	$ 500,000,000				500,000,000
5.00% notes due 2033
Debt Instrument [Line Items]
Various interest rates				5%	5%					5%
Senior notes				$ 1,100,000,000	$ 1,100,000,000				1,100,000,000
4.125% Euro notes due 2034
Debt Instrument [Line Items]
Various interest rates				4.125%	4.125%					4.125%
Senior notes					$ 1,094,000,000				1,067,000,000	€ 1,000
Proceeds from issuance of long-term debt				$ 990,000,000
Payments of debt issuance costs				$ 17,000,000
2.15% notes due 2022
Debt Instrument [Line Items]
Various interest rates												2.15%
0.483% notes due 2022
Debt Instrument [Line Items]
Various interest rates											0.483%
3.35% notes due 2023
Debt Instrument [Line Items]
Various interest rates					3.35%	3.35%
Senior notes					$ 0				$ 300,000,000

LEASES - Narrative (Details)

LEASES - Narrative (Details)	Dec. 31, 2023
Minimum
Lessee, Lease, Description [Line Items]
Operating lease, term of contract	1 year
Operating lease, renewal term	5 years
Maximum
Lessee, Lease, Description [Line Items]
Operating lease, term of contract	20 years

LEASES - Schedule of Lease Cost

LEASES - Schedule of Lease Cost (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Operating lease cost	$ 239	$ 224
Variable lease cost	4	8
Short-term lease cost	13	18
Finance lease cost
Amortization of right-of-use assets	74	72
Interest on lease liability	19	21
Total finance lease cost	93	93
Total lease cost	$ 349	$ 343

LEASES - Supplemental Cash Flow

LEASES - Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows for operating leases	$ 237	$ 225
Operating cash flows for finance leases	19	21
Financing cash flows for finance leases	87	79
Right-of-use assets obtained in exchange for lease obligations
Operating leases	339	251
Finance leases	$ 42	$ 61

LEASES - Supplemental Balance S

LEASES - Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Operating leases
Other assets	$ 1,004	$ 881
Accrued liabilities	196	192
Other liabilities	897	775
Total operating lease liabilities	1,093	967
Finance leases
Property, plant and equipment	402	383
Accumulated depreciation	(204)	(161)
Property, plant and equipment—net	198	222
Current maturities of long-term debt	86	77
Long-term debt	99	145
Total finance lease liabilities	$ 185	$ 222
Weighted average remaining lease term
Operating leases	9 years	8 years
Finance leases	3 years	4 years
Weighted average discount rate
Operating leases	3%	2.10%
Finance leases	8.50%	7.80%
Operating lease, right-of-use asset, statement of financial position	Other assets	Other assets
Operating lease, liability, current, statement of financial position	Accrued Liabilities, Current	Accrued Liabilities, Current
Operating lease, liability, noncurrent, statement of financial position	Other liabilities	Other liabilities
Finance lease, right-of-use asset, statement of financial position	Property, plant and equipment—net	Property, plant and equipment—net
Finance lease, liability, current, statement of financial position	Less: Current maturities of long-term debt	Less: Current maturities of long-term debt
Finance lease, liability, noncurrent, statement of financial position	Total Long-term debt	Total Long-term debt

LEASES - Maturities of Lease Li

LEASES - Maturities of Lease Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Operating Leases
2024	$ 222
2025	185
2026	155
2027	131
2028	105
Thereafter	443
Total lease payments	1,241
Less: Interest	148
Total maturities of lease liabilities	1,093	$ 967
Finance Leases
2024	98
2025	53
2026	24
2027	12
2028	11
Thereafter	7
Total lease payments	205
Less: Interest	20
Total maturities of lease liabilities	$ 185	$ 222

DERIVATIVE INSTRUMENTS AND HE_3

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, notional amount		$ 17,897	$ 18,727
Gain (loss) on interest rate swap agreements		121	(347)	$ (135)
Foreign Exchange Forward
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, notional amount		8,910	10,545
Amount of hedged item		$ 6,099	$ 3,836
Foreign Exchange Forward | Forecast
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amounts reclassified from accumulated other comprehensive income (loss)	$ 24

DERIVATIVE INSTRUMENTS AND HE_4

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS - Schedule of Derivative Instruments in Statement of Financial Position (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Derivative [Line Items]
Notional	$ 17,897	$ 18,727
Fair Value Asset	53	199
Fair Value (Liability)	(339)	(312)
Fair value of hedging instruments
Derivative [Line Items]
Notional	9,699	9,048
Fair Value Asset	46	125
Fair Value (Liability)	(334)	(309)
Fair value of hedging instruments | Derivatives in fair value hedging relationships | Interest rate swap agreements
Derivative [Line Items]
Notional	4,717	4,984
Fair Value Asset	18	16
Fair Value (Liability)	(184)	(303)
Fair value of hedging instruments | Derivatives in cash flow hedging relationships | Foreign currency exchange contracts
Derivative [Line Items]
Notional	712	866
Fair Value Asset	28	19
Fair Value (Liability)	(4)	(5)
Fair value of hedging instruments | Derivatives in cash flow hedging relationships | Commodity contracts
Derivative [Line Items]
Notional	6	9
Fair Value Asset	0	0
Fair Value (Liability)	(1)	(1)
Fair value of hedging instruments | Derivatives in net investment hedging relationships | Cross currency swap agreements
Derivative [Line Items]
Notional	4,264	3,189
Fair Value Asset	0	90
Fair Value (Liability)	(145)	0
Derivatives not designated as hedging instruments | Foreign currency exchange contracts
Derivative [Line Items]
Notional	8,198	9,679
Fair Value Asset	7	74
Fair Value (Liability)	$ (5)	$ (3)

DERIVATIVE INSTRUMENTS AND HE_5

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS - Schedule of Derivative Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged Liability, Statement of Financial Position [Extensible Enumeration]	Total Long-term debt	Total Long-term debt
Fair value of hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying Amount of Hedged Item	$ 4,551	$ 4,696
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of Hedged Item	$ (166)	$ (287)

DERIVATIVE INSTRUMENTS AND HE_6

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS - Derivative Instruments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Net Sales	$ 36,662	$ 35,466	$ 34,392
Cost of products and services sold	22,995	22,347	22,061
Selling, general and administrative expenses	5,127	5,214	4,798
Other (income) expense	840	366	1,378
Interest and other financial charges	765	414	343
Foreign currency exchange contracts | Net Sales
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency exchange contracts	0	0	0
Foreign currency exchange contracts | Selling, General and Administrative Expenses
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency exchange contracts	0	0	0
Foreign currency exchange contracts | Other (Income) Expense
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency exchange contracts	(116)	351	195
Foreign currency exchange contracts | Interest and Other Financial Charges
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency exchange contracts	0	0	0
Fair value of hedging instruments | Gain or (loss) on cash flow hedges | Foreign currency exchange contracts | Losses (gains) on cash flow hedges | Net Sales
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from accumulated other comprehensive income (loss) into income	15	13	5
Fair value of hedging instruments | Gain or (loss) on cash flow hedges | Foreign currency exchange contracts | Losses (gains) on cash flow hedges | Selling, General and Administrative Expenses
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from accumulated other comprehensive income (loss) into income	10	(3)	9
Fair value of hedging instruments | Gain or (loss) on cash flow hedges | Foreign currency exchange contracts | Losses (gains) on cash flow hedges | Other (Income) Expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from accumulated other comprehensive income (loss) into income	0	0	0
Fair value of hedging instruments | Gain or (loss) on cash flow hedges | Foreign currency exchange contracts | Losses (gains) on cash flow hedges | Interest and Other Financial Charges
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from accumulated other comprehensive income (loss) into income	0	0	0
Fair value of hedging instruments | Gain or (loss) on cash flow hedges | Commodity contracts | Net Sales
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from accumulated other comprehensive income into income		0
Fair value of hedging instruments | Gain or (loss) on cash flow hedges | Commodity contracts | Selling, General and Administrative Expenses
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from accumulated other comprehensive income into income		0
Fair value of hedging instruments | Gain or (loss) on cash flow hedges | Commodity contracts | Other (Income) Expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from accumulated other comprehensive income into income		0
Fair value of hedging instruments | Gain or (loss) on cash flow hedges | Commodity contracts | Interest and Other Financial Charges
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from accumulated other comprehensive income into income		0
Fair value of hedging instruments | Gain or (loss) on fair value hedges | Interest rate swap agreements | Losses (gains) on cash flow hedges | Net Sales
Derivative Instruments, Gain (Loss) [Line Items]
Hedged items	0	0	0
Derivatives designated as hedges	0	0	0
Fair value of hedging instruments | Gain or (loss) on fair value hedges | Interest rate swap agreements | Losses (gains) on cash flow hedges | Selling, General and Administrative Expenses
Derivative Instruments, Gain (Loss) [Line Items]
Hedged items	0	0	0
Derivatives designated as hedges	0	0	0
Fair value of hedging instruments | Gain or (loss) on fair value hedges | Interest rate swap agreements | Losses (gains) on cash flow hedges | Other (Income) Expense
Derivative Instruments, Gain (Loss) [Line Items]
Hedged items	0	0	0
Derivatives designated as hedges	0	0	0
Fair value of hedging instruments | Gain or (loss) on fair value hedges | Interest rate swap agreements | Losses (gains) on cash flow hedges | Interest and Other Financial Charges
Derivative Instruments, Gain (Loss) [Line Items]
Hedged items	(121)	347	135
Derivatives designated as hedges	121	(347)	(135)
Fair value of hedging instruments | Gain or (loss) on net investment hedges | Foreign currency exchange contracts | Net Sales
Derivative Instruments, Gain (Loss) [Line Items]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		0	0
Fair value of hedging instruments | Gain or (loss) on net investment hedges | Foreign currency exchange contracts | Selling, General and Administrative Expenses
Derivative Instruments, Gain (Loss) [Line Items]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		0	0
Fair value of hedging instruments | Gain or (loss) on net investment hedges | Foreign currency exchange contracts | Other (Income) Expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		0	0
Fair value of hedging instruments | Gain or (loss) on net investment hedges | Foreign currency exchange contracts | Interest and Other Financial Charges
Derivative Instruments, Gain (Loss) [Line Items]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		13	16
Product
Derivative Instruments, Gain (Loss) [Line Items]
Net Sales	25,773	25,960	25,643
Cost of products and services sold	16,977	16,955	17,082
Product | Foreign currency exchange contracts | Cost of products and services sold
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency exchange contracts	0	0	0
Product | Fair value of hedging instruments | Gain or (loss) on cash flow hedges | Foreign currency exchange contracts | Losses (gains) on cash flow hedges | Cost of products and services sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from accumulated other comprehensive income (loss) into income	28	50	8
Product | Fair value of hedging instruments | Gain or (loss) on cash flow hedges | Commodity contracts | Cost of products and services sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from accumulated other comprehensive income into income		(2)
Product | Fair value of hedging instruments | Gain or (loss) on fair value hedges | Interest rate swap agreements | Losses (gains) on cash flow hedges | Cost of products and services sold
Derivative Instruments, Gain (Loss) [Line Items]
Hedged items	0	0	0
Derivatives designated as hedges	0	0	0
Product | Fair value of hedging instruments | Gain or (loss) on net investment hedges | Foreign currency exchange contracts | Cost of products and services sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		0	0
Service
Derivative Instruments, Gain (Loss) [Line Items]
Net Sales	10,889	9,506	8,749
Cost of products and services sold	6,018	5,392	4,979
Service | Foreign currency exchange contracts | Cost of products and services sold
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency exchange contracts	0	0	0
Service | Fair value of hedging instruments | Gain or (loss) on cash flow hedges | Foreign currency exchange contracts | Losses (gains) on cash flow hedges | Cost of products and services sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from accumulated other comprehensive income (loss) into income	10	14	2
Service | Fair value of hedging instruments | Gain or (loss) on cash flow hedges | Commodity contracts | Cost of products and services sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from accumulated other comprehensive income into income		0
Service | Fair value of hedging instruments | Gain or (loss) on fair value hedges | Interest rate swap agreements | Losses (gains) on cash flow hedges | Cost of products and services sold
Derivative Instruments, Gain (Loss) [Line Items]
Hedged items	0	0	0
Derivatives designated as hedges	$ 0	0	0
Service | Fair value of hedging instruments | Gain or (loss) on net investment hedges | Foreign currency exchange contracts | Cost of products and services sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		$ 0	$ 0

DERIVATIVE INSTRUMENTS AND HE_7

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS - Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) (Details) - Fair value of hedging instruments - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Foreign currency exchange contracts
Derivative [Line Items]
Gain (loss) on net investment hedges recognized in accumulated other comprehensive income	$ 0	$ 34
Euro-denominated long-term debt
Derivative [Line Items]
Gain (loss) on net investment hedges recognized in accumulated other comprehensive income	(84)	196
Euro-denominated commercial paper
Derivative [Line Items]
Gain (loss) on net investment hedges recognized in accumulated other comprehensive income	(42)	39
Cross currency swap agreements
Derivative [Line Items]
Gain (loss) on net investment hedges recognized in accumulated other comprehensive income	$ (193)	$ (65)

FAIR VALUE MEASUREMENTS - Asset

FAIR VALUE MEASUREMENTS - Assets and Liabilities Accounted for at Fair Value (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Assets
Fair value asset	$ 53	$ 199
Liabilities
Fair value liability	339	312
Fair Value Measurements Recurring
Assets
Available for sale investments	280	646
Right to HWI Net Sale Proceeds	9	295
Total assets	364	1,194
Liabilities
Total liabilities	339	312
Fair Value Measurements Recurring | Foreign currency exchange contracts
Assets
Fair value asset	35	93
Liabilities
Fair value liability	9	8
Fair Value Measurements Recurring | Interest rate swap agreements
Assets
Fair value asset	18	16
Liabilities
Fair value liability	184	303
Fair Value Measurements Recurring | Cross currency swap agreements
Assets
Fair value asset	0	90
Liabilities
Fair value liability	145	0
Fair Value Measurements Recurring | Commodity contracts
Liabilities
Fair value liability	1	1
Fair Value Measurements Recurring | Investments in equity securities
Assets
Investments in equity securities	22	54
Level 1 | Fair Value Measurements Recurring
Assets
Available for sale investments	63	87
Right to HWI Net Sale Proceeds	0	0
Total assets	85	109
Liabilities
Total liabilities	0	0
Level 1 | Fair Value Measurements Recurring | Foreign currency exchange contracts
Assets
Fair value asset	0	0
Liabilities
Fair value liability	0	0
Level 1 | Fair Value Measurements Recurring | Interest rate swap agreements
Assets
Fair value asset	0	0
Liabilities
Fair value liability	0	0
Level 1 | Fair Value Measurements Recurring | Cross currency swap agreements
Assets
Fair value asset	0	0
Liabilities
Fair value liability	0	0
Level 1 | Fair Value Measurements Recurring | Commodity contracts
Liabilities
Fair value liability	0	0
Level 1 | Fair Value Measurements Recurring | Investments in equity securities
Assets
Investments in equity securities	22	22
Level 2 | Fair Value Measurements Recurring
Assets
Available for sale investments	217	559
Right to HWI Net Sale Proceeds	0	0
Total assets	270	790
Liabilities
Total liabilities	339	312
Level 2 | Fair Value Measurements Recurring | Foreign currency exchange contracts
Assets
Fair value asset	35	93
Liabilities
Fair value liability	9	8
Level 2 | Fair Value Measurements Recurring | Interest rate swap agreements
Assets
Fair value asset	18	16
Liabilities
Fair value liability	184	303
Level 2 | Fair Value Measurements Recurring | Cross currency swap agreements
Assets
Fair value asset	0	90
Liabilities
Fair value liability	145	0
Level 2 | Fair Value Measurements Recurring | Commodity contracts
Liabilities
Fair value liability	1	1
Level 2 | Fair Value Measurements Recurring | Investments in equity securities
Assets
Investments in equity securities	0	32
Level 3 | Fair Value Measurements Recurring
Assets
Available for sale investments	0	0
Right to HWI Net Sale Proceeds	9	295
Total assets	9	295
Liabilities
Total liabilities	0	0
Level 3 | Fair Value Measurements Recurring | Foreign currency exchange contracts
Assets
Fair value asset	0	0
Liabilities
Fair value liability	0	0
Level 3 | Fair Value Measurements Recurring | Interest rate swap agreements
Assets
Fair value asset	0	0
Liabilities
Fair value liability	0	0
Level 3 | Fair Value Measurements Recurring | Cross currency swap agreements
Assets
Fair value asset	0	0
Liabilities
Fair value liability	0	0
Level 3 | Fair Value Measurements Recurring | Commodity contracts
Liabilities
Fair value liability	0	0
Level 3 | Fair Value Measurements Recurring | Investments in equity securities
Assets
Investments in equity securities	$ 0	$ 0

FAIR VALUE MEASUREMENTS - Sched

FAIR VALUE MEASUREMENTS - Schedule of Level 3 Fair Value Assets and Liabilities (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period		$ 295	$ 295	$ 0
Recognition of right to HWI Net Sale Proceeds			0	295
Receipt of HWI Net Sale Proceeds	$ (19)	$ (256)	(275)	0
Fair value adjustment of HWI Net Sale Proceeds			(11)	0
Balance at end of period			$ 9	$ 295

FAIR VALUE MEASUREMENTS - Finan

FAIR VALUE MEASUREMENTS - Financial Assets and Liabilities not Carried at Fair Value (Details) - Level 2 - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Carrying Value
Assets
Long-term receivables	$ 232	$ 229
Liabilities
Long-term debt and related current maturities	18,358	16,853
Fair Value
Assets
Long-term receivables	173	183
Liabilities
Long-term debt and related current maturities	$ 17,706	$ 15,856

FAIR VALUE MEASUREMENTS - Narra

FAIR VALUE MEASUREMENTS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, settlements	$ 19	$ 256	$ 275	$ 0
Fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, period increase (decrease)	$ (11)

ACCRUED LIABILITIES (Details)

ACCRUED LIABILITIES (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Accrued Liabilities, Current [Abstract]
Customer advances and deferred income	$ 3,499	$ 3,555
Compensation, benefit and other employee related	1,322	1,218
Repositioning	279	309
Asbestos-related liabilities	154	110
Income taxes	680	549
Other taxes	176	174
Environmental costs	227	222
Operating lease liabilities	196	192
Product warranties and performance guarantees	182	175
Insurance	69	68
Accrued interest	217	122
NARCO Buyout	0	1,325
Other (primarily operating expenses)	808	1,143
Total Accrued liabilities	$ 7,809	$ 9,162

OTHER LIABILITIES (Details)

OTHER LIABILITIES (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Other Liabilities Disclosure [Abstract]
Income taxes	$ 1,742	$ 1,939
Pension and other employee related	1,342	1,306
Deferred income	1,171	1,334
Operating lease liabilities	897	775
Environmental costs	414	393
Insurance	248	289
Product warranties and performance guarantees	37	38
Asset retirement obligations	17	24
Other	397	371
Total Other liabilities	$ 6,265	$ 6,469

STOCK-BASED COMPENSATION PLAN_2

STOCK-BASED COMPENSATION PLANS - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares received for each restricted stock unit (in shares)	1
2016 Plan | Share-based Payment Arrangement, Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of Honeywell common stock available for future grants (in shares)	28,946,133
Vesting periods	4 years
Expiration period	10 years
Options exercisable (in shares)	9,593,986	9,509,606	10,664,625
Weighted average exercise price per share (in dollars per share)	$ 138.24	$ 127.99	$ 113.30
Unrecognized compensation on nonvested stock options	$ 96
Nonvested options recognized over weighted average period, years	2 years 5 months 26 days
Fair value of options vested	$ 48	$ 49	$ 52
2016 Plan | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation on nonvested stock options	$ 250
Nonvested options recognized over weighted average period, years	1 year 10 months 28 days
2016 Plan | Restricted Stock Units (RSUs) | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting periods	3 years
2016 Plan | Restricted Stock Units (RSUs) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting periods	6 years
2016 Directors Plan | Share-based Payment Arrangement, Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of Honeywell common stock available for future grants (in shares)	781,768

STOCK-BASED COMPENSATION PLAN_3

STOCK-BASED COMPENSATION PLANS - Income Statement Impact from Stock Options (Details) - 2016 Plan - Share-based Payment Arrangement, Option - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 48	$ 45	$ 55
Future income tax benefit recognized	$ 11	$ 10	$ 11

STOCK BASED COMPENSATION PLANS

STOCK BASED COMPENSATION PLANS - Share-based Compensation Fair Value Assumptions (Details) - 2016 Plan - Share-based Payment Arrangement, Option - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average fair value per share of options granted during the year (in dollars per share)	$ 38.84	$ 31.22	$ 32.42
Assumptions
Expected annual dividend yield	2.50%	2.58%	2.31%
Expected volatility	22.42%	23.05%	24.69%
Risk-free rate of return	3.94%	1.97%	0.48%
Expected option term (years)	4 years 10 months 9 days	4 years 8 months 26 days	4 years 6 months 14 days

STOCK-BASED COMPENSATION PLAN_4

STOCK-BASED COMPENSATION PLANS - Stock Options Activity (Details) - 2016 Plan - Share-based Payment Arrangement, Option - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Number of Options
Outstanding at beginning of period (in shares)	14,052,288	15,852,939	16,568,529
Granted (in shares)	1,573,520	2,150,910	2,065,574
Exercised (in shares)	(1,640,952)	(3,046,107)	(2,016,489)
Lapsed or canceled (in shares)	(548,842)	(905,454)	(764,675)
Outstanding at end of period (in shares)	13,436,014	14,052,288	15,852,939
Vested and Expected to Vest at December 31 (in shares)	12,420,005
Options exercisable (in shares)	9,593,986	9,509,606	10,664,625
Weighted Average Exercise Price
Outstanding at beginning of period (in dollars per share)	$ 147.14	$ 135.31	$ 125.75
Granted (in dollars per share)	195.27	189.53	204.99
Exercised (in dollars per share)	123.12	103.89	113.01
Lapsed or canceled (in dollars per share)	192.22	186.35	175.42
Outstanding at end of period (in dollars per share)	153.86	147.14	135.31
Vested and Expected to Vest at December 31 (in dollars per share)	150.58
Weighted average exercise price per share (in dollars per share)	$ 138.24	$ 127.99	$ 113.30
Options Activity Footnote [Abstract]
Vested options (in shares)	9,600,000
Options expected to vest (in shares)	2,800,000
Outstanding unvested options (in shares)	3,800,000

STOCK-BASED COMPENSATION PLAN_5

STOCK-BASED COMPENSATION PLANS - Schedule of Share Based Compensation by Price Ranges (Details) - 2016 Plan - Share-based Payment Arrangement, Option - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Options Outstanding
Number outstanding (in shares)	13,436,014
Weighted average period	4 years 10 months 24 days
Weighted average exercise price per share (in dollars per share)	$ 153.86
Aggregate Intrinsic Value	$ 752
Options Exercisable
Number exercisable (in shares)	9,593,986
Weighted average exercise price per share (in dollars per share)	$ 138.24	$ 127.99	$ 113.30
Aggregate Intrinsic Value	$ 730
$65.00–$89.99
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Lower range of exercise prices	$ 65
Upper range of exercise prices	$ 89.99
Options Outstanding
Number outstanding (in shares)	687,158
Weighted average period	1 month 28 days
Weighted average exercise price per share (in dollars per share)	$ 89.46
Aggregate Intrinsic Value	$ 83
Options Exercisable
Number exercisable (in shares)	687,158
Weighted average exercise price per share (in dollars per share)	$ 89.46
Aggregate Intrinsic Value	$ 83
$90.00–$99.99
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Lower range of exercise prices	$ 90
Upper range of exercise prices	$ 99.99
Options Outstanding
Number outstanding (in shares)	2,285,249
Weighted average period	1 year 6 months 7 days
Weighted average exercise price per share (in dollars per share)	$ 98.79
Aggregate Intrinsic Value	$ 253
Options Exercisable
Number exercisable (in shares)	2,285,249
Weighted average exercise price per share (in dollars per share)	$ 98.79
Aggregate Intrinsic Value	$ 253
$100.00–$134.99
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Lower range of exercise prices	$ 100
Upper range of exercise prices	$ 134.99
Options Outstanding
Number outstanding (in shares)	1,814,529
Weighted average period	3 years 7 days
Weighted average exercise price per share (in dollars per share)	$ 119.30
Aggregate Intrinsic Value	$ 164
Options Exercisable
Number exercisable (in shares)	1,787,835
Weighted average exercise price per share (in dollars per share)	$ 119.15
Aggregate Intrinsic Value	$ 163
$135.00–$189.99
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Lower range of exercise prices	$ 135
Upper range of exercise prices	$ 189.99
Options Outstanding
Number outstanding (in shares)	5,737,860
Weighted average period	5 years 9 months 29 days
Weighted average exercise price per share (in dollars per share)	$ 170.92
Aggregate Intrinsic Value	$ 222
Options Exercisable
Number exercisable (in shares)	4,078,279
Weighted average exercise price per share (in dollars per share)	$ 164.61
Aggregate Intrinsic Value	$ 209
$190.00–$232.60
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Lower range of exercise prices	$ 190
Upper range of exercise prices	$ 232.6
Options Outstanding
Number outstanding (in shares)	2,911,218
Weighted average period	8 years 7 days
Weighted average exercise price per share (in dollars per share)	$ 200.23
Aggregate Intrinsic Value	$ 30
Options Exercisable
Number exercisable (in shares)	755,465
Weighted average exercise price per share (in dollars per share)	$ 204.77
Aggregate Intrinsic Value	$ 22

STOCK-BASED COMPENSATION PLAN_6

STOCK-BASED COMPENSATION PLANS - Financial Statement Impact From Stock Options Exercised (Details) - 2016 Plan - Share-based Payment Arrangement, Option - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Intrinsic value	$ 122	$ 310	$ 219
Tax benefit realized	$ 27	$ 71	$ 48

STOCK-BASED COMPENSATION PLAN_7

STOCK-BASED COMPENSATION PLANS - Restricted Stock Units Activity (Details) - 2016 Plan - Restricted Stock Units (RSUs) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Number of Restricted Stock Units
Non-vested at beginning of period (in shares)	2,708,008	2,957,536	3,396,523
Granted (in shares)	1,109,307	1,056,869	992,854
Vested (in shares)	(919,496)	(864,944)	(1,123,547)
Forfeited (in shares)	(290,982)	(441,453)	(308,293)
Non-vested at end of period (in shares)	2,606,837	2,708,008	2,957,536
Weighted Average Grant Date Fair Value Per Share
Non-vested at beginning of period (in dollars per share)	$ 181.10	$ 171.73	$ 148.23
Granted (in dollars per share)	194.81	186.48	214.61
Vested (in dollars per share)	171.92	157.21	144.34
Forfeited (in dollars per share)	187.13	177.38	156.74
Non-vested at end of period (in dollars per share)	$ 189.18	$ 181.10	$ 171.73

STOCK-BASED COMPENSATION PLAN_8

STOCK-BASED COMPENSATION PLANS - Income Statement Impact from RSUs (Details) - 2016 Plan - Restricted Stock Units (RSUs) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 154	$ 143	$ 162
Future income tax benefit recognized	$ 32	$ 29	$ 23

EARNINGS PER SHARE - Schedule o

EARNINGS PER SHARE - Schedule of Earnings per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Basic
Net income attributable to Honeywell	$ 5,658	$ 4,966	$ 5,542
Weighted average shares outstanding (in shares)	663	677.1	692.3
Earnings per share of common stock - basic (in dollars per share)	$ 8.53	$ 7.33	$ 8.01
Assuming Dilution
Net income attributable to Honeywell	$ 5,658	$ 4,966	$ 5,542
Average shares
Weighted average shares outstanding (in shares)	663	677.1	692.3
Dilutive securities issuable - stock plans (in shares)	5.2	6	8.1
Total weighted average diluted shares outstanding (in shares)	668.2	683.1	700.4
Earnings per share of common stock - assuming dilution (in dollars per share)	$ 8.47	$ 7.27	$ 7.91

EARNINGS PER SHARE - Additional

EARNINGS PER SHARE - Additional Information (Details) - shares shares in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Earnings Per Share [Abstract]
Stock options excluded from diluted computations (in shares)	4.5	3.5	1.7
Total shareowners' equity (in shares)	651.8	667.6	684.8
Common stock, par value (in shares)	957.6	957.6

ACCUMULATED OTHER COMPREHENSI_3

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
After-Tax
Foreign exchange translation adjustment	$ (274)	$ (372)	$ 302
Pension and other postretirement benefit adjustments	(407)	(233)	186
Changes in fair value of available for sale investments	5	(8)	(3)
Changes in fair value of cash flow hedges	11	15	(3)
Components of other comprehensive income (loss), net of tax	(665)	(598)	482
Accumulated other comprehensive income (loss)
Pre-tax
Foreign exchange translation adjustment	(269)	(354)	302
Pension and other postretirement benefit adjustments	(538)	(280)	245
Changes in fair value of available for sale investments	5	(8)	(3)
Changes in fair value of cash flow hedges	17	9	(4)
Changes in accumulated other comprehensive income, pretax	(785)	(633)	540
Tax
Foreign exchange translation adjustment	0	0	0
Pension and other postretirement benefit adjustments	131	47	(59)
Changes in fair value of available for sale investments	0	0	0
Changes in fair value of cash flow hedges	(6)	6	1
Other comprehensive income (loss), tax	125	53	(58)
After-Tax
Foreign exchange translation adjustment	(269)	(354)	302
Pension and other postretirement benefit adjustments	(407)	(233)	186
Changes in fair value of available for sale investments	5	(8)	(3)
Changes in fair value of cash flow hedges	11	15	(3)
Components of other comprehensive income (loss), net of tax	$ (660)	$ (580)	$ 482

ACCUMULATED OTHER COMPREHENSI_4

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Components of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Cumulative foreign exchange translation adjustment	$ (3,101)	$ (2,832)
Pension and other postretirement benefit adjustments	(1,055)	(648)
Fair value adjustments of available for sale investments	(2)	(7)
Fair value adjustments of cash flow hedges	23	12
Accumulated other comprehensive income (loss)	$ (4,135)	$ (3,475)

ACCUMULATED OTHER COMPREHENSI_5

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Change in Other Comprehensive Income (Loss) By Component (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 17,319	$ 19,242
Net current period other comprehensive income (loss)	(665)	(598)	$ 482
Ending balance	16,434	17,319	19,242
Foreign Exchange Translation Adjustment
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(2,832)	(2,478)	(2,780)
Other comprehensive income (loss) before reclassifications	(269)	(344)	314
Amounts reclassified from accumulated other comprehensive income (loss)	0	(10)	(12)
Net current period other comprehensive income (loss)	(269)	(354)	302
Ending balance	(3,101)	(2,832)	(2,478)
Pension and Other Postretirement Benefit Adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(648)	(415)	(601)
Other comprehensive income (loss) before reclassifications	(477)	(623)	268
Amounts reclassified from accumulated other comprehensive income (loss)	70	390	(82)
Net current period other comprehensive income (loss)	(407)	(233)	186
Ending balance	(1,055)	(648)	(415)
Changes in Fair Value of Available for Sale Investments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(7)	1	4
Other comprehensive income (loss) before reclassifications	5	(8)	(3)
Amounts reclassified from accumulated other comprehensive income (loss)	0	0	0
Net current period other comprehensive income (loss)	5	(8)	(3)
Ending balance	(2)	(7)	1
Changes in Fair Value of Cash Flow Hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	12	(3)	0
Other comprehensive income (loss) before reclassifications	60	71	17
Amounts reclassified from accumulated other comprehensive income (loss)	(49)	(56)	(20)
Net current period other comprehensive income (loss)	11	15	(3)
Ending balance	23	12	(3)
Total
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(3,475)	(2,895)	(3,377)
Other comprehensive income (loss) before reclassifications	(681)	(904)	596
Amounts reclassified from accumulated other comprehensive income (loss)	21	324	(114)
Net current period other comprehensive income (loss)	(660)	(580)	482
Ending balance	$ (4,135)	$ (3,475)	$ (2,895)

ACCUMULATED OTHER COMPREHENSI_6

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Reclassifications Out of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net Sales	$ (36,662)	$ (35,466)	$ (34,392)
Cost of products and services sold	22,995	22,347	22,061
Selling, General and Administrative Expenses	5,127	5,214	4,798
Other (Income) Expense	(840)	(366)	(1,378)
Interest and other financial charges	765	414	343
Total before tax	(7,159)	(6,379)	(7,235)
Tax (expense) benefit	(1,487)	(1,412)	(1,625)
Total reclassifications for the period, net of tax	(5,672)	(4,967)	(5,610)
Product
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net Sales	(25,773)	(25,960)	(25,643)
Cost of products and services sold	16,977	16,955	17,082
Service
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net Sales	(10,889)	(9,506)	(8,749)
Cost of products and services sold	6,018	5,392	4,979
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net Sales	(15)	(13)	(5)
Selling, General and Administrative Expenses	(10)	3	(9)
Other (Income) Expense	78	432	(109)
Interest and other financial charges	0	(13)	(16)
Total before tax	15	347	(149)
Tax (expense) benefit	6	(23)	35
Total reclassifications for the period, net of tax	21	324	(114)
Reclassification out of Accumulated Other Comprehensive Income | Product
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of products and services sold	(28)	(48)	(8)
Reclassification out of Accumulated Other Comprehensive Income | Service
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of products and services sold	(10)	(14)	(2)
Reclassification out of Accumulated Other Comprehensive Income | Actuarial losses recognized
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net Sales	0	0	0
Selling, General and Administrative Expenses	0	0	0
Other (Income) Expense	141	516	7
Interest and other financial charges	0	0	0
Total before tax	141	516	7
Reclassification out of Accumulated Other Comprehensive Income | Actuarial losses recognized | Product
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of products and services sold	0	0	0
Reclassification out of Accumulated Other Comprehensive Income | Actuarial losses recognized | Service
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of products and services sold	0	0	0
Reclassification out of Accumulated Other Comprehensive Income | Prior service (credit) recognized
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net Sales	0	0	0
Selling, General and Administrative Expenses	0	0	0
Other (Income) Expense	(63)	(84)	(116)
Interest and other financial charges	0	0	0
Total before tax	(63)	(84)	(116)
Reclassification out of Accumulated Other Comprehensive Income | Prior service (credit) recognized | Product
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of products and services sold	0	0	0
Reclassification out of Accumulated Other Comprehensive Income | Prior service (credit) recognized | Service
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of products and services sold	0	0	0
Reclassification out of Accumulated Other Comprehensive Income | Losses (gains) on cash flow hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net Sales	(15)	(13)	(5)
Selling, General and Administrative Expenses	(10)	3	(9)
Other (Income) Expense	0	0	0
Interest and other financial charges	0	0	0
Total before tax	(63)	(72)	(24)
Reclassification out of Accumulated Other Comprehensive Income | Losses (gains) on cash flow hedges | Product
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of products and services sold	(28)	(48)	(8)
Reclassification out of Accumulated Other Comprehensive Income | Losses (gains) on cash flow hedges | Service
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of products and services sold	(10)	(14)	(2)
Reclassification out of Accumulated Other Comprehensive Income | Losses (gains) on excluded component of net investment hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net Sales	0	0	0
Selling, General and Administrative Expenses	0	0	0
Other (Income) Expense	0	0	0
Interest and other financial charges	0	(13)	(16)
Total before tax	0	(13)	(16)
Reclassification out of Accumulated Other Comprehensive Income | Losses (gains) on excluded component of net investment hedges | Product
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of products and services sold	0	0	0
Reclassification out of Accumulated Other Comprehensive Income | Losses (gains) on excluded component of net investment hedges | Service
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of products and services sold	$ 0	$ 0	$ 0

CAPITAL STOCK (Details)

CAPITAL STOCK (Details)	12 Months Ended
	Dec. 31, 2023 USD ($) vote $ / shares shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares	Apr. 24, 2023 USD ($)
Equity, Class of Treasury Stock [Line Items]
Number of votes for each share of common stock | vote	1
Stock repurchase program, authorized amount				$ 10,000,000,000
Stock repurchase program remaining authorized repurchase amount				$ 2,100,000,000
Reacquired stock or repurchases of common stock	$ 200,000,000	$ 0
Treasury stock
Equity, Class of Treasury Stock [Line Items]
Stock repurchased during period (in shares) | shares	19,200,000	21,900,000	15,800,000
Reacquired stock or repurchases of common stock	$ 3,715,000,000	$ 4,200,000,000	$ 3,380,000,000
Common stock, par value
Equity, Class of Treasury Stock [Line Items]
Common stock, shares authorized (in shares) | shares	2,000,000,000
Common shares par value (in dollars per share) | $ / shares	$ 1
Treasury stock
Equity, Class of Treasury Stock [Line Items]
Authorized amount of common stock value of share repurchase program	$ 10,000,000,000
Stock repurchase program remaining authorized repurchase amount	$ 7,100,000,000	$ 2,900,000,000
Stock repurchased during period (in shares) | shares		21,900,000
Reacquired stock or repurchases of common stock		$ 4,200,000,000
Preferred Stock
Equity, Class of Treasury Stock [Line Items]
Preferred stock, shares authorized (in shares) | shares	40,000,000
Preferred stock, shares outstanding (in shares) | shares	0

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Environmental Matters (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accrual for Environmental Loss Contingencies [Roll Forward]
Beginning of year	$ 615	$ 618	$ 660
Accruals for environmental matters deemed probable and reasonably estimable	222	186	168
Environmental liability payments	(196)	(211)	(210)
Other	0	22	0
End of year	$ 641	$ 615	$ 618
Environmental Loss Contingency, Statement of Financial Position [Extensible Enumeration]	Other liabilities	Other liabilities	Other liabilities
Loss Contingency, Classification of Accrual [Abstract]
Accrued liabilities	$ 227	$ 222
Other liabilities	414	393
Total environmental liabilities	$ 641	$ 615	$ 618
Environmental Loss Contingency, Current, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities, Current	Accrued Liabilities, Current
Environmental Loss Contingency, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other liabilities	Other liabilities
Environmental Liabilities | Resideo
Loss Contingency, Classification of Accrual [Abstract]
Indemnification and reimbursement agreement, cash payment of environmental annual spending, percent	90%
Indemnification and reimbursement agreement annual cap	$ 140
Indemnification and reimbursement agreement minimum amount	25
Reimbursements from indemnification and reimbursement agreement	$ 140	$ 140
Reimbursements from indemnification, receivable as a percentage of environmental costs incurred	90%
Reimbursement receivable indemnification and reimbursement agreement	$ 187	157
Indemnity and reimbursement receivable recorded in other current assets	140	140
Indemnity and reimbursement receivable recorded in other assets	$ 521	$ 474

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES - Asbestos-Related Liabilities (Details) - USD ($) $ in Millions		3 Months Ended		12 Months Ended
	Nov. 18, 2022	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Loss Contingency Accrual [Roll Forward]
Asbestos-related liability payments				$ (174)	$ (271)	$ (286)
NARCO Buyout payment				(1,325)	0	0
Asbestos Related Liabilities Insurance Recoveries [Roll Forward]
Insurance receivables settlements and write-offs				(26)	(68)	0
Insurance recoveries for asbestos-related liabilities				170	224
Accrued liabilities				154	110
Asbestos-related liabilities				1,490	1,180
Fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, settlements		$ 19	$ 256	275	0
Total
Loss Contingency Accrual [Roll Forward]
Asbestos related liabilities, beginning of period			2,616	2,616	2,061	2,220
Accrual for update to estimated liability				48	(541)	95
Change in estimated cost of future claims				423	41	29
Update of expected resolution values for pending claims				56	1	3
Asbestos-related liability payments				(174)	(271)	(286)
NARCO Buyout payment				(1,325)	1,325	0
Asbestos related liabilities, end of period				1,644	2,616	2,061
Asbestos Related Liabilities Insurance Recoveries [Roll Forward]
Insurance recoveries, beginning of period			265	265	363	402
Probable insurance recoveries related to estimated liability				11	7	7
Insurance receipts for asbestos-related liabilities				(39)	(37)	(46)
Insurance receivables settlements and write-offs				(26)	(68)	0
Insurance recoveries, end of period				211	265	363
Other current assets				41	41
Insurance recoveries for asbestos-related liabilities				170	224
Total assets				211	265	363
Accrued liabilities				154	1,436
Asbestos-related liabilities				1,490	1,180
Total liabilities				1,644	2,616	2,061
Bendix
Loss Contingency Accrual [Roll Forward]
Asbestos related liabilities, beginning of period			1,291	1,291	1,372	1,441
Accrual for update to estimated liability				43	93	64
Change in estimated cost of future claims				423	41	29
Update of expected resolution values for pending claims				56	1	3
Asbestos-related liability payments				(169)	(216)	(165)
NARCO Buyout payment				0	0	0
Asbestos related liabilities, end of period				1,644	1,291	1,372
Asbestos Related Liabilities Insurance Recoveries [Roll Forward]
Insurance recoveries, beginning of period			130	130	142	148
Probable insurance recoveries related to estimated liability				11	5	7
Insurance receipts for asbestos-related liabilities				(18)	(17)	(13)
Insurance receivables settlements and write-offs				0	0	0
Insurance recoveries, end of period				123	130	142
Total assets				123	130	142
Total liabilities				1,644	1,291	1,372
Loss contingency accrual, period increase (decrease)				(522)
Bendix | Settlement Agreement
Asbestos Related Liabilities Insurance Recoveries [Roll Forward]
Accrued liabilities				10
NARCO
Loss Contingency Accrual [Roll Forward]
Asbestos related liabilities, beginning of period			1,325	1,325	689	779
Accrual for update to estimated liability				5	(634)	31
Change in estimated cost of future claims				0	0	0
Update of expected resolution values for pending claims				0	0	0
Asbestos-related liability payments				(5)	(55)	(121)
NARCO Buyout payment				(1,325)	1,325	0
Asbestos related liabilities, end of period				0	1,325	689
Asbestos Related Liabilities Insurance Recoveries [Roll Forward]
Insurance recoveries, beginning of period			$ 135	135	221	254
Probable insurance recoveries related to estimated liability				0	2	0
Insurance receipts for asbestos-related liabilities				(21)	(20)	(33)
Insurance receivables settlements and write-offs				(26)	(68)	0
Insurance recoveries, end of period				88	135	221
Total assets				88	135	221
Total liabilities				0	1,325	$ 689
NARCO Buyout	$ 1,325
Loss contingency, annual cap					$ 30
Loss contingency accrual, period increase (decrease)				688
Loss contingency, buyout agreement, proceeds from sale				$ 295

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES - Bendix-Related Asbestos Claims Activity (Details) - Bendix - claim	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Claims unresolved at the beginning of period	5,608	6,401
Claims filed	1,803	2,014
Claims resolved	(1,894)	(2,807)
Claims unresolved at the end of year	5,517	5,608

COMMITMENTS AND CONTINGENCIES_4

COMMITMENTS AND CONTINGENCIES - Disease Distribution of Unresolved Claims (Details) - Bendix - claim	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Loss Contingencies [Line Items]
Mesothelioma and other cancer claims	3,244	3,283
Nonmalignant claims	2,273	2,325
Total claims	5,517	5,608	6,401

COMMITMENTS AND CONTINGENCIES_5

COMMITMENTS AND CONTINGENCIES - Bendix Products Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Loss Contingency, Narco and Bendix Asbestos Related Balances by Balance Sheet Caption [Line Items]
Accrued liabilities	$ 154	$ 110
Bendix
Loss Contingency, Narco and Bendix Asbestos Related Balances by Balance Sheet Caption [Line Items]
Loss contingency accrual, period increase (decrease)	(522)
Bendix | Shortening Look-Back Period
Loss Contingency, Narco and Bendix Asbestos Related Balances by Balance Sheet Caption [Line Items]
Loss contingency accrual, period increase (decrease)	434
Bendix | Settlement Agreement
Loss Contingency, Narco and Bendix Asbestos Related Balances by Balance Sheet Caption [Line Items]
Accrued liabilities	$ 10

COMMITMENTS ND CONTINGENCIES -

COMMITMENTS ND CONTINGENCIES - Garrett Litigation and Bankruptcy Proceedings (Details) - USD ($) shares in Millions, $ in Millions		12 Months Ended
	Apr. 30, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jun. 28, 2022	Mar. 31, 2022	Feb. 19, 2022	Feb. 18, 2022	Dec. 28, 2021	Dec. 16, 2021
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Receipts from Garrett Motion Inc.		$ 0	$ 409	$ 586
Non-cash amounts related to shares of Garrett Series B Preferred Stock (in shares)	834.8
Long-term investments		0	0	$ 577
Series B Preferred Stock | Level 2
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Investments in equity securities						$ 212		$ 207	$ 197
Garrett Indemnity And Tax Matters Agreement
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Reimbursement receivables charge					$ 509
The Confirmed Plan
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Garrett minimum EBITDA		425
The Confirmed Plan | Series B Preferred Stock | First Partial Redemption
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Preferred stock, redemption amount										$ 211
Long-term investments							$ 400
The Confirmed Plan | Series B Preferred Stock | Second Partial Redemption
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Long-term investments											$ 207
The Confirmed Plan | Year One After Effective Date of Plan | Series B Preferred Stock
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Preferred stock, redemption amount			$ 35
The Confirmed Plan | Payment Over Time | Series B Preferred Stock
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Preferred stock, redemption amount		$ 100
The Confirmed Plan | Garrett Indemnity And Tax Matters Agreement | Initial Payment
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Receipts from Garrett Motion Inc.	$ 375
Non-cash amounts related to shares of Garrett Series B Preferred Stock (in shares)	834.8

COMMITMENTS AND CONTINGENCIES_6

COMMITMENTS AND CONTINGENCIES - Resolution Values Per Claim Excluding Legal Costs (Details) - Bendix - $ / claim	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loss Contingencies [Line Items]
Malignant claims (in dollars per claim)	66,200	59,200	56,000	61,500	50,200
Nonmalignant claims (in dollars per claim)	1,730	520	400	550	3,900

COMMITMENTS AND CONTINGENCIES_7

COMMITMENTS AND CONTINGENCIES - Other Matters (Details) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Jan. 31, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Loss Contingencies [Line Items]
Accrual for environmental loss contingencies, payments		$ 196	$ 211	$ 210
Petrobras
Loss Contingencies [Line Items]
Accrual for environmental loss contingencies, payments	$ 202.7

COMMITMENTS AND CONTINGENCIES_8

COMMITMENTS AND CONTINGENCIES - Warranties and Guarantees (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Movement in Standard Product Warranty Accrual [Roll Forward]
Beginning of year	$ 213	$ 223	$ 243
Accruals for warranties/guarantees issued during the year	139	117	146
Adjustment of pre-existing warranties/guarantees	(27)	(12)	(7)
Settlement of warranty/guarantee claims	(106)	(115)	(159)
End of year	219	213	223
Standard Product Warranty Accrual, Balance Sheet Classification [Abstract]
Accrued liabilities	182	175
Other liabilities	37	38
Total obligations for product warranties and product performance guarantees	$ 219	$ 213	$ 223

PENSION AND OTHER POSTRETIREM_3

PENSION AND OTHER POSTRETIREMENT BENEFITS - Balance Sheet Impact (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Change in plan assets
Postretirement benefit obligations other than pensions	$ (134)	$ (146)
Pension ongoing income—non-service | U.S. Plans
Change in benefit obligation
Benefit obligation at beginning of year	13,290	17,391
Service cost	29	86	$ 105
Interest cost	645	380	306
Plan amendments	0	0
Actuarial (gains) losses	337	(3,135)
Benefits paid	(1,509)	(1,421)
Settlements and curtailments	0	(13)
Foreign currency translation	0	0
Other	0	2
Benefit obligation at end of year	12,792	13,290	17,391
Change in plan assets
Fair value of plan assets at beginning of year	17,005	20,560
Actual return on plan assets	1,070	(2,161)
Company contributions	28	37
Benefits paid	(1,509)	(1,421)
Settlements and curtailments	0	(13)
Foreign currency translation	0	0
Other	0	3
Fair value of plan assets at end of year	16,594	17,005	20,560
Funded status of plans	3,802	3,715
Prepaid pension benefit cost	4,052	3,970
Accrued pension liabilities - current	(26)	(28)
Accrued pension liabilities - noncurrent	(224)	(227)
Net amount recognized	3,802	3,715
Pension ongoing income—non-service | Non-U.S. Plans
Change in benefit obligation
Benefit obligation at beginning of year	4,400	6,999
Service cost	11	19	26
Interest cost	200	103	77
Plan amendments	0	0
Actuarial (gains) losses	191	(1,929)
Benefits paid	(250)	(261)
Settlements and curtailments	0	0
Foreign currency translation	165	(533)
Other	1	2
Benefit obligation at end of year	4,718	4,400	6,999
Change in plan assets
Fair value of plan assets at beginning of year	5,304	8,396
Actual return on plan assets	267	(2,187)
Company contributions	22	17
Benefits paid	(250)	(261)
Settlements and curtailments	0	0
Foreign currency translation	205	(664)
Other	1	3
Fair value of plan assets at end of year	5,549	5,304	8,396
Funded status of plans	831	904
Prepaid pension benefit cost	1,335	1,356
Accrued pension liabilities - current	(15)	(14)
Accrued pension liabilities - noncurrent	(489)	(438)
Net amount recognized	831	904
Other Postretirement Benefits
Change in benefit obligation
Benefit obligation at beginning of year	133	196
Service cost	0	0	0
Interest cost	6	5	5
Plan amendments	0	0
Actuarial (gains) losses	3	(54)
Benefits paid	(26)	(14)
Benefit obligation at end of year	116	133	196
Change in plan assets
Fair value of plan assets at beginning of year	0	0
Actual return on plan assets	0	0
Company contributions	0	0
Benefits paid	0	0
Fair value of plan assets at end of year	0	0	$ 0
Funded status of plans	(116)	(133)
Accrued pension liabilities - current	(12)	(21)
Postretirement benefit obligations other than pensions	(104)	(112)
Net amount recognized	(116)	(133)
Foreign plans excluded from postretirement benefits other than pensions	$ 30	$ 34

PENSION AND OTHER POSTRETIREM_4

PENSION AND OTHER POSTRETIREMENT BENEFITS - Accumulated Other Comprehensive (Income) Loss Associated With Other Postretirement Benefit Plans (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Prior service (credit) cost	$ (7)	$ (50)
Net actuarial (gain) loss	1,191	814
Net amount recognized	1,184	764
Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Prior service (credit) cost	18	18
Net actuarial (gain) loss	422	360
Net amount recognized	440	378
Other Postretirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Prior service (credit) cost	(30)	(50)
Net actuarial (gain) loss	(68)	(84)
Net amount recognized	$ (98)	$ (134)

PENSION AND OTHER POSTRETIREM_5

PENSION AND OTHER POSTRETIREMENT BENEFITS - Net Periodic Benefit (Income) Cost Recognized in Other Comprehensive (Income) Loss (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Other Postretirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 0	$ 0	$ 0
Interest cost	6	5	5
Amortization of prior service (credit) cost	(20)	(42)	(74)
Recognition of actuarial (gains) losses	(13)	(4)	(2)
Net periodic benefit (income) cost	(27)	(41)	(71)
Actuarial (gains) losses	3	(54)	(8)
Prior service (credit) cost	0	0	0
Prior service credit recognized during year	20	42	74
Actuarial (gains) losses recognized during year	13	4	2
Total recognized in Other comprehensive (income) loss	36	(8)	68
Total recognized in net periodic benefit (income) cost and Other comprehensive (income) loss	9	(49)	(3)
Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	29	86	105
Interest cost	645	380	306
Expected return on plan assets	(1,111)	(1,281)	(1,220)
Amortization of prior service (credit) cost	(42)	(42)	(42)
Recognition of actuarial (gains) losses	0	(14)	31
Settlements and curtailments	0	(2)	0
Net periodic benefit (income) cost	(479)	(873)	(820)
Actuarial (gains) losses	378	307	(14)
Prior service (credit) cost	0	0	0
Prior service credit recognized during year	42	43	43
Actuarial (gains) losses recognized during year	0	15	0
Foreign currency translation	0	0	0
Total recognized in Other comprehensive (income) loss	420	365	29
Total recognized in net periodic benefit (income) cost and Other comprehensive (income) loss	(59)	(508)	(791)
Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	11	19	26
Interest cost	200	103	77
Expected return on plan assets	(274)	(278)	(348)
Amortization of prior service (credit) cost	0	0	0
Recognition of actuarial (gains) losses	153	537	9
Settlements and curtailments	0	0	0
Net periodic benefit (income) cost	90	381	(236)
Actuarial (gains) losses	198	294	(221)
Prior service (credit) cost	0	0	(3)
Prior service credit recognized during year	0	(1)	(1)
Actuarial (gains) losses recognized during year	(153)	(537)	(9)
Foreign currency translation	17	204	(1)
Total recognized in Other comprehensive (income) loss	62	(40)	(235)
Total recognized in net periodic benefit (income) cost and Other comprehensive (income) loss	$ 152	$ 341	$ (471)

PENSION AND OTHER POSTRETIREM_6

PENSION AND OTHER POSTRETIREMENT BENEFITS - Actuarial Assumptions (Details)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Discount rate	4.97%	5.17%	2.87%
Expected annual rate of compensation increase	3.25%	3.25%	3.25%
Discount rate—benefit obligation	5.17%	2.87%	2.50%
Discount rate—service cost	5.26%	2.98%	2.68%
Discount rate—interest cost	5.07%	2.26%	1.76%
Expected rate of return on plan assets	6.75%	6.40%	6.15%
Expected annual rate of compensation increase	3.25%	3.25%	3.25%
Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Discount rate	4.15%	4.50%	1.79%
Expected annual rate of compensation increase	2.68%	2.69%	2.56%
Discount rate—benefit obligation	4.49%	1.77%	1.24%
Discount rate—service cost	3.81%	1.48%	1%
Discount rate—interest cost	4.56%	1.59%	1%
Expected rate of return on plan assets	5.15%	3.61%	4.03%
Expected annual rate of compensation increase	2.68%	2.56%	2.43%
Other Postretirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Discount rate	5%	5.32%	2.66%
Discount rate	5.32%	2.66%	2.20%

PENSION AND OTHER POSTRETIREM_7

PENSION AND OTHER POSTRETIREMENT BENEFITS - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Reacquired stock or repurchases of common stock		$ 200,000,000	$ 0
U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Pension notional amount		4,025,000,000	2,567,000,000
Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Pension notional amount		124,000,000	$ 120,000,000
Cash pension contributions		$ 12,000,000
Minimum | Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Target allocations percentage		45%
Minimum | Equity Securities
Defined Benefit Plan Disclosure [Line Items]
Target allocations percentage		25%
Minimum | Real Estate
Defined Benefit Plan Disclosure [Line Items]
Target allocations percentage		5%
Minimum | Other than Securities Investment
Defined Benefit Plan Disclosure [Line Items]
Target allocations percentage		10%
Maximum | Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Target allocations percentage		65%
Maximum | Equity Securities
Defined Benefit Plan Disclosure [Line Items]
Target allocations percentage		40%
Maximum | Real Estate
Defined Benefit Plan Disclosure [Line Items]
Target allocations percentage		10%
Maximum | Other than Securities Investment
Defined Benefit Plan Disclosure [Line Items]
Target allocations percentage		20%
Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Expected rate of return on plan assets		6.75%	6.40%	6.15%
Accumulated benefit obligation		$ 12,800,000,000	$ 13,300,000,000
Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Expected rate of return on plan assets		5.15%	3.61%	4.03%
Accumulated benefit obligation		$ 4,700,000,000	$ 4,400,000,000
Forecast | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Contributions to pension plans	$ 12,000,000
Forecast | Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Discount rate, service costs	5.06%
Discount rate, interest costs	4.89%
Expected rate of return on plan assets	7%

PENSION AND OTHER POSTRETIREM_8

PENSION AND OTHER POSTRETIREMENT BENEFITS - Pension Benefits (Details) - Pension ongoing income—non-service - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation	$ 251	$ 255
Accumulated benefit obligation	249	253
Fair value of plan assets	0	0
Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation	753	682
Accumulated benefit obligation	736	664
Fair value of plan assets	$ 249	$ 230

PENSION AND OTHER POSTRETIREM_9

PENSION AND OTHER POSTRETIREMENT BENEFITS - Fair Value of Pension Plan Assets (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	$ 16,594	$ 17,005	$ 20,560
Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	5,549	5,304	8,396
Honeywell common stock | Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	3,049	3,336
Honeywell common stock | Pension ongoing income—non-service | Level 1 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	3,049	3,336
Honeywell common stock | Pension ongoing income—non-service | Level 2 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Honeywell common stock | Pension ongoing income—non-service | Level 3 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
U.S. equities | Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	6
U.S. equities | Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	195	144
U.S. equities | Pension ongoing income—non-service | Level 1 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	6
U.S. equities | Pension ongoing income—non-service | Level 1 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	2
U.S. equities | Pension ongoing income—non-service | Level 2 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
U.S. equities | Pension ongoing income—non-service | Level 2 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	195	142
U.S. equities | Pension ongoing income—non-service | Level 3 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
U.S. equities | Pension ongoing income—non-service | Level 3 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Short-term investments | Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	2,942	855
Short-term investments | Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	387	341
Short-term investments | Pension ongoing income—non-service | Level 1 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	283	855
Short-term investments | Pension ongoing income—non-service | Level 1 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	168	341
Short-term investments | Pension ongoing income—non-service | Level 2 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	2,659	0
Short-term investments | Pension ongoing income—non-service | Level 2 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	219	0
Short-term investments | Pension ongoing income—non-service | Level 3 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Short-term investments | Pension ongoing income—non-service | Level 3 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Government securities | Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	532	1,492
Government securities | Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	1,635	2,045
Government securities | Pension ongoing income—non-service | Level 1 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Government securities | Pension ongoing income—non-service | Level 1 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Government securities | Pension ongoing income—non-service | Level 2 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	532	1,492
Government securities | Pension ongoing income—non-service | Level 2 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	1,635	2,045
Government securities | Pension ongoing income—non-service | Level 3 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Government securities | Pension ongoing income—non-service | Level 3 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Corporate bonds | Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	5,733	6,632
Corporate bonds | Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	1,103	1,031
Corporate bonds | Pension ongoing income—non-service | Level 1 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Corporate bonds | Pension ongoing income—non-service | Level 1 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Corporate bonds | Pension ongoing income—non-service | Level 2 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	5,733	6,632
Corporate bonds | Pension ongoing income—non-service | Level 2 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	1,103	1,031
Corporate bonds | Pension ongoing income—non-service | Level 3 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Corporate bonds | Pension ongoing income—non-service | Level 3 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Mortgage/Asset-backed securities | Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	676	1,119
Mortgage/Asset-backed securities | Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	10	31
Mortgage/Asset-backed securities | Pension ongoing income—non-service | Level 1 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Mortgage/Asset-backed securities | Pension ongoing income—non-service | Level 1 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Mortgage/Asset-backed securities | Pension ongoing income—non-service | Level 2 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	676	1,119
Mortgage/Asset-backed securities | Pension ongoing income—non-service | Level 2 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	10	31
Mortgage/Asset-backed securities | Pension ongoing income—non-service | Level 3 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Mortgage/Asset-backed securities | Pension ongoing income—non-service | Level 3 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Insurance contracts | Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	7	8
Insurance contracts | Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	108	115
Insurance contracts | Pension ongoing income—non-service | Level 1 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Insurance contracts | Pension ongoing income—non-service | Level 1 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Insurance contracts | Pension ongoing income—non-service | Level 2 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	7	8
Insurance contracts | Pension ongoing income—non-service | Level 2 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	108	115
Insurance contracts | Pension ongoing income—non-service | Level 3 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Insurance contracts | Pension ongoing income—non-service | Level 3 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Direct private investments | Level 3 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	1,293	1,284	1,336
Direct private investments | Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	1,293	1,284
Direct private investments | Pension ongoing income—non-service | Level 1 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Direct private investments | Pension ongoing income—non-service | Level 2 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Direct private investments | Pension ongoing income—non-service | Level 3 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	1,293	1,284
Real estate properties | Level 3 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	977	1,005	843
Real estate properties | Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	977	1,005
Real estate properties | Pension ongoing income—non-service | Level 1 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Real estate properties | Pension ongoing income—non-service | Level 2 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Real estate properties | Pension ongoing income—non-service | Level 3 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	977	1,005
Total | Pension ongoing income—non-service | Level 1 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	3,332	4,197
Total | Pension ongoing income—non-service | Level 1 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	168	343
Total | Pension ongoing income—non-service | Level 2 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	9,607	9,251
Total | Pension ongoing income—non-service | Level 2 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	3,676	3,792
Total | Pension ongoing income—non-service | Level 3 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	2,270	2,289
Total | Pension ongoing income—non-service | Level 3 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	1,695	1,116
Total | Pension ongoing income—non-service | Fair Value, Inputs, Level 1, Level 2, and Level 3 | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	15,209	15,737
Total | Pension ongoing income—non-service | Fair Value, Inputs, Level 1, Level 2, and Level 3 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	5,539	5,251
Private funds | Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	1,265	1,258
Private funds | Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	8	10
Real estate funds | Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	8	10
Real estate funds | Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	2	43
Commingled funds | Pension ongoing income—non-service | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	112	0
Non-U.S. equities | Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	365	374
Non-U.S. equities | Pension ongoing income—non-service | Level 1 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Non-U.S. equities | Pension ongoing income—non-service | Level 2 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	365	374
Non-U.S. equities | Pension ongoing income—non-service | Level 3 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Insurance buy-in contracts | Level 3 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	1,605	950	691
Insurance buy-in contracts | Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	1,605	950
Insurance buy-in contracts | Pension ongoing income—non-service | Level 1 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Insurance buy-in contracts | Pension ongoing income—non-service | Level 2 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Insurance buy-in contracts | Pension ongoing income—non-service | Level 3 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	1,605	950
Private funds | Level 3 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	74	36	33
Private funds | Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	115	90
Private funds | Pension ongoing income—non-service | Level 1 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Private funds | Pension ongoing income—non-service | Level 2 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	41	54
Private funds | Pension ongoing income—non-service | Level 3 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	74	36
Real estate funds | Level 3 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	16	130	$ 163
Real estate funds | Pension ongoing income—non-service | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	16	130
Real estate funds | Pension ongoing income—non-service | Level 1 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Real estate funds | Pension ongoing income—non-service | Level 2 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	0	0
Real estate funds | Pension ongoing income—non-service | Level 3 | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of pension plan assets	$ 16	$ 130

PENSION AND OTHER POSTRETIRE_10

PENSION AND OTHER POSTRETIREMENT BENEFITS - Changes in Level 3 Fair Value (Details) - Level 3 - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Direct private investments | U.S. Plans
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	$ 1,284	$ 1,336
Relating to assets still held at year-end	(34)	(66)
Relating to assets sold during the year	159	98
Purchases	131	75
Sales and settlements	(247)	(159)
Fair value of plan assets at end of year	1,293	1,284
Real estate properties | U.S. Plans
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	1,005	843
Relating to assets still held at year-end	(115)	88
Relating to assets sold during the year	0	(24)
Purchases	88	148
Sales and settlements	(1)	(50)
Fair value of plan assets at end of year	977	1,005
Private funds | Non-U.S. Plans
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	36	33
Relating to assets still held at year-end	3	11
Relating to assets sold during the year	1	0
Purchases	39	0
Sales and settlements	(5)	(8)
Fair value of plan assets at end of year	74	36
Real estate funds | Non-U.S. Plans
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	130	163
Relating to assets still held at year-end	0	(33)
Relating to assets sold during the year	(3)	1
Purchases	0	0
Sales and settlements	(111)	(1)
Fair value of plan assets at end of year	16	130
Insurance buy-in contracts | Non-U.S. Plans
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	950	691
Relating to assets still held at year-end	68	(477)
Relating to assets sold during the year	0	0
Purchases	587	736
Sales and settlements	0	0
Fair value of plan assets at end of year	$ 1,605	$ 950

PENSION AND OTHER POSTRETIRE_11

PENSION AND OTHER POSTRETIREMENT BENEFITS - Benefit Payments (Details) - Pension ongoing income—non-service $ in Millions	Dec. 31, 2023 USD ($)
U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
2024	$ 1,094
2025	1,077
2026	1,062
2027	1,044
2028	1,022
2029-2033	4,699
Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
2024	257
2025	253
2026	260
2027	266
2028	268
2029-2033	$ 1,270

PENSION AND OTHER POSTRETIRE_12

PENSION AND OTHER POSTRETIREMENT BENEFITS - Other Postretirement Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Other Postretirement Benefits
Assumed health care cost trend rate
Health care cost trend rate assumed for next year	7%	7.50%
Rate that the cost trend rate gradually declines to	5%	5%
Year that the rate reaches the rate it is assumed to remain at	2031	2031
Without Impact of Medicare Subsidy
Assumed health care cost trend rate
2024	$ 13
2025	12
2026	12
2027	11
2028	11
2029-2033	46
Net of Medicare Subsidy
Assumed health care cost trend rate
2024	12
2025	12
2026	11
2027	11
2028	10
2029-2033	$ 44

OTHER (INCOME) EXPENSE (Details

OTHER (INCOME) EXPENSE (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Other Income and Expenses [Line Items]
Interest income	$ (321)	$ (138)	$ (102)
Equity income of affiliated companies	(100)	(61)	(67)
Gain on sale of non-strategic businesses and assets	(5)	(22)	(102)
Foreign exchange (gain) loss	9	48	25
Expense related to UOP Matters	0	45	160
Expense (benefit) related to Russia-Ukraine conflict	(3)	45	0
Net expense related to the NARCO Buyout and HWI Sale	11	342	0
Other, net	39	18	(19)
Total Other (income) expense	(840)	(366)	(1,378)
Pension ongoing income—non-service
Other Income and Expenses [Line Items]
Ongoing income - non-service	(441)	(602)	(1,202)
Other postretirement income—non-service
Other Income and Expenses [Line Items]
Ongoing income - non-service	$ (29)	$ (41)	$ (71)

SEGMENT FINANCIAL DATA (Details

SEGMENT FINANCIAL DATA (Details) $ in Millions	1 Months Ended	12 Months Ended
	Oct. 31, 2023 segment	Dec. 31, 2023 USD ($) segment	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | segment		4
Number of reportable segments | segment	2
Net Sales		$ 36,662	$ 35,466	$ 34,392
Segment profit		8,304	7,689	7,212
Capital expenditures		1,039	766	895
Total assets		61,525	62,275
Operating Segments
Segment Reporting Information [Line Items]
Net Sales		36,662	35,466	34,392
Depreciation and amortization		1,176	1,204	1,138
Segment profit		8,304	7,689	7,212
Operating Segments | Aerospace Technologies
Segment Reporting Information [Line Items]
Net Sales		13,624	11,827	11,026
Depreciation and amortization		267	285	278
Segment profit		3,741	3,228	3,051
Capital expenditures		310	246	284
Total assets		12,976	12,189
Operating Segments | Aerospace Technologies | Cost of Products Sold
Segment Reporting Information [Line Items]
Net Sales		7,316	6,330	6,158
Operating Segments | Aerospace Technologies | Cost of Services Sold
Segment Reporting Information [Line Items]
Net Sales		6,308	5,497	4,868
Operating Segments | Industrial Automation
Segment Reporting Information [Line Items]
Net Sales		10,756	11,638	12,425
Depreciation and amortization		386	422	439
Segment profit		1,967	1,896	1,824
Capital expenditures		194	77	232
Total assets		22,026	21,337
Operating Segments | Industrial Automation | Cost of Products Sold
Segment Reporting Information [Line Items]
Net Sales		8,176	9,439	10,403
Operating Segments | Industrial Automation | Cost of Services Sold
Segment Reporting Information [Line Items]
Net Sales		2,580	2,199	2,022
Operating Segments | Building Automation
Segment Reporting Information [Line Items]
Net Sales		6,031	6,000	5,539
Depreciation and amortization		107	92	67
Segment profit		1,505	1,439	1,238
Capital expenditures		79	74	62
Total assets		6,723	6,599
Operating Segments | Building Automation | Cost of Products Sold
Segment Reporting Information [Line Items]
Net Sales		4,599	4,591	4,098
Operating Segments | Building Automation | Cost of Services Sold
Segment Reporting Information [Line Items]
Net Sales		1,432	1,409	1,441
Operating Segments | Energy and Sustainability Solutions
Segment Reporting Information [Line Items]
Net Sales		6,239	5,996	5,402
Depreciation and amortization		253	247	252
Segment profit		1,483	1,538	1,325
Capital expenditures		374	291	223
Total assets		8,048	7,442
Operating Segments | Energy and Sustainability Solutions | Cost of Products Sold
Segment Reporting Information [Line Items]
Net Sales		5,682	5,600	4,984
Operating Segments | Energy and Sustainability Solutions | Cost of Services Sold
Segment Reporting Information [Line Items]
Net Sales		557	396	418
Corporate and All Other
Segment Reporting Information [Line Items]
Net Sales		12	5	0
Depreciation and amortization		163	158	102
Segment profit		(392)	(412)	(226)
Capital expenditures		82	78	94
Total assets		11,752	14,708
Corporate and All Other | Cost of Services Sold
Segment Reporting Information [Line Items]
Net Sales		$ 12	$ 5	$ 0

SEGMENT FINANCIAL DATA- Reconci

SEGMENT FINANCIAL DATA- Reconciliation of Operating Profit Loss From Segments to Consolidated (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment profit	$ 8,304	$ 7,689	$ 7,212
Interest and other financial charges	(765)	(414)	(343)
Interest income	321	138	102
Repositioning and other charges	(860)	(1,266)	(569)
Total Income before taxes	7,159	6,379	7,235
Segment Reconciling Items
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Interest and other financial charges	(765)	(414)	(343)
Interest income	321	138	102
Stock compensation expense	(202)	(188)	(217)
Pension mark-to-market expense	(153)	(523)	(40)
Repositioning and other charges	(860)	(1,266)	(569)
Other income	(43)	(91)	(64)
Total Income before taxes	7,159	6,379	7,235
Segment Reconciling Items | Pension ongoing income—non-service
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Pension ongoing income (expense) and postretirement income	528	993	1,083
Segment Reconciling Items | Other postretirement income—non-service
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Pension ongoing income (expense) and postretirement income	$ 29	$ 41	$ 71

GEOGRAPHIC AREAS - FINANCIAL _3

GEOGRAPHIC AREAS - FINANCIAL DATA (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales	$ 36,662	$ 35,466	$ 34,392
Long-Lived Assets	5,660	5,471	5,562
U.S. Plans
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales	20,907	21,262	20,662
Long-Lived Assets	4,107	3,949	3,964
Export sales included in United States net sales	4,708	4,187	4,037
Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales	8,052	6,840	6,800
Long-Lived Assets	555	537	566
Other international
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales	7,703	7,364	6,930
Long-Lived Assets	$ 998	$ 985	$ 1,032

SUPPLEMENTAL CASH FLOW INFORM_3

SUPPLEMENTAL CASH FLOW INFORMATION (Details) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Apr. 30, 2021
Net payments for repositioning and other charges
Severance and exit cost payments	$ (294)	$ (275)	$ (382)
Environmental payments	(196)	(211)	(210)
Reimbursement receipts	140	140	140
Insurance receipts for asbestos-related liabilities	39	37	46
Insurance receivables settlements and write-offs	26	68	0
Asbestos-related liability payments	(174)	(271)	(286)
Net payments for repositioning and other charges	(459)	(512)	(692)
Interest paid, net of amounts capitalized	649	375	339
Income taxes paid, net of refunds	1,581	1,324	1,202
Non-cash investing and financing activities
Common stock contributed to savings plans	216	196	191
Marketable securities contributed to non-U.S. pension plans	0	0	81
Impact of Quantinuum contribution	0	0	460
Noncontrolling interest non-cash contribution	0	0	419
Loan in exchange for prepaid assets	0	0	25
Receipt of Garrett Series B Preferred Stock	$ 0	$ 0	$ 577
Non-cash amounts related to shares of Garrett Series B Preferred Stock (in shares)				834.8